Indocyanine Green Angiography - PMC

The choroid plays an important role in the pathophysiology of the eye. Multimodal imaging offers different techniques to examine the choroid. Fundus fluorescein angiography offers limited visualization of the deep layers of the fundus due to the barrier property of the retinal pigment epithelium. Therefore, indocyanine green angiography (ICGA) is widely used in the angiographic examination of the choroidal structure. ICGA is an important component of multimodal imaging in the diagnosis and treatment of many degenerative, tumoral, and inflammatory diseases of the choroid and retina. This review presents the general characteristics of ICGA and a practical approach to its clinical use.

Introduction

While indocyanine green (ICG) dye has long been used in heart and liver function tests, its introduction into ophthalmology as an angiography dye dates back to approximately 40 years ago.1,2,3

Its limited leakage from the choroidal vessels and ability to penetrate into the deep layers with little absorption by xanthophyll pigment and the retinal pigment epithelium (RPE) when exposed with infrared light make ICG angiography (ICGA) advantageous in the examination of the choroidal circulation. However, difficulty obtaining quality images because of the low-intensity fluorescence of ICG dye delayed the adoption of this method in ophthalmic diagnosis.

Thanks to the combination of this method with infrared-sensitive high-resolution fundus cameras and scanning laser ophthalmoscopy (SLO), ICGA has taken its place in the diagnosis and monitoring of pathophysiological processes involving the choroidal vasculature.3,4,5,6 The introduction of wide-angle lenses has also expanded ICGA’s area of use.

ICGA is an important component of multimodal imaging in centers performing the diagnosis and treatment of posterior segment diseases. This article aims to provide information about the basic features of ICGA and its role in clinical use.

History

ICG infrared absorption angiography was first used by Kogure and Choromokos7 in 1969 to examine the pial circulation in dogs. The same study group introduced the fundus infrared absorption angiography technique into ophthalmology by administering the dye intraarterially in monkeys.8 Using this method, David9 performed intraarterial ICG infrared absorption choroid angiography in humans for the first time in 1971. Hochheimer10 obtained a better quality image by administering intravenous ICG to cats and using black and white film instead of infrared-sensitive color film.

As the infrared absorption technique did not provide sufficient choroidal detail, Flower and Hochheimer2 took advantage of the fluorescent property of ICG and described choroidal ICG fluorescence angiography in 1973. Tokoro et al.11 enhanced ICG choroid angiography with an infrared-sensitive modified camera and the video angiography technique in 1984. In the following years, Hayashi et al.12,13,14,15 used this method to detect choroidal blood flow and examine central serous chorioretinopathy (CSCR) and subretinal choroidal neovascular membranes (CNV). In 1989, Scheider and Schroedel5 performed ICG videoangiography with SLO. The ICG digital videoangiography technique was used in patients with CNV in 1991.16 Thereafter, ICGA was widely used in the evaluation of retinal and posterior segment diseases, especially cases of occult CNV.17

In the following years, ICGA was also used to visualize tumors and inflammatory diseases in the fundus, and images specific to many diseases were published.18,19,20,21

Physical and Chemical Properties of ICG

ICG is a tricarbocyanine dye with a molecular weight of 775 g/mol and chemical formula of C43H47N2NaO6S2. It differs from sodium fluorescein (NaFl) in two main ways. First is its high rate of plasma protein bonding, which is 98% for ICG compared to 70-90% for NaFl.22,23 The second important difference is that its maximum absorption is at 805 nm and its maximum fluorescence is at 835 nm, which is in the near-infrared part of the electromagnetic spectrum. For NaFl, these wavelengths are 465 nm and 525 nm, respectively ( ).4

Table 1

Open in a separate window

Unlike NaFl, ICG shows very little leakage from choroidal and pathological vessels due to its high plasma protein binding. Light at its maximum fluorescence wavelength of 835 nm is not absorbed by macular xanthophyll pigments and only 10% is absorbed by the RPE.24 These features of ICG together with its ability to penetrate into the deep tissues enable visualization of the choroidal vascular structures, especially the submacular area where NaFl is insufficient.

ICG Metabolism

ICG is excreted from the body exclusively by the liver. In people with normal liver function, the half-life of ICG in the circulation is approximately 2.6 minutes. Its rapid elimination from the circulation allows angiography to be repeated after a short time when needed.25

ICGA Procedure

After dissolving crystallized ICG in 5 mL of solvent, a bolus of 25-50 mg or 1-2 mg/kg is administered via the antecubital vein. Some researchers follow this with an injection of 5 mL of sterile saline solution.

The early phase is very short, so even if no dye is observed in the fundus at 10 seconds after ICG administration, serial images should be obtained and the light level should be kept as low as possible during imaging. This reduces the “blooming artifact” (i.e., a white field that obscures detail) which occurs due to choroidal fluorescence in the first few seconds after the dye reaches the choroid. Dark images can be improved by adjusting the light and contrast during the angiography analysis phase. Immediately after the first early phase images are obtained in one eye, imaging of the fellow eye should be started. Afterwards, ICGA images should be acquired at 1-minute intervals until minute 5 and then typically at 5-minute intervals from minute 10 to 20. These intervals can be adjusted according to the characteristics of each case. Pseudostereoscopic imaging may be helpful in the analysis.

Some devices allow fluorescein angiography (FA) and ICGA to be performed simultaneously. Although this may be advantageous when interpreting the angiograms, it is rarely done in practice. A disadvantage of this method is the difficulty of revealing the exact cause of a side effect after injecting two different dyes at the same time.

ICGA recordings can also be obtained as video, which enables the determination of circulation times and a dynamic examination of the vasculature.25 This allows the feeding vessels of vascular anomalies to be identified more easily, and can also demonstrate the pulsation feature of lesions such as polypoidal choroidal vasculopathy (PCV).

Side Effects of ICGA

ICGA has a safer side effect profile compared to FA. Moderate side effects have been reported at a rate of 1:63, serious side effects at a rate of 1:1900, and death at a rate of 1:222000 after FA.26

Adverse effects after the use of ICG are rare. Rates of mild, moderate, and severe reactions have been reported as 0.15%, 0.02%, and 0.05-0.07%, respectively.27,28

ICG dye contains up to 5% sodium iodide as an additive to prevent recrystallization. Therefore, caution should be exercised considering the potential side effects in patients with thyroid hyperfunction. Thyroid function tests performed after ICGA give inaccurate results. On the other hand, it is argued that since iodine is naturally found in the human body, there can be no risk of antibody formation or the development of an immune-mediated allergic reaction against it.29 The allergies that develop after consuming shellfish and other seafood are attributed to the proteins in the food, not the iodine.30

The cause of side effects following ICGA has not been fully explained. Non-allergic histamine release due to iodine or ICG, IgE-mediated hypersensitivity, complement system activation, or the release of other inflammation mediators are suggested mechanisms.31

Moreover, although very rare, adequate preparation is necessary in the event of anaphylactic shock after ICG injection.32

ICG dye can also be prepared without the addition of iodine, but severe side effects have also been reported after iodine-free ICGA.33

As ICG separates bilirubin from protein in in vitro studies, it should not be administered to preterm infants and neonates who require transfusion due to hyperbilirubinemia. The indication should also be reviewed in patients with uremia, severe liver failure, or a history of severe multiple allergy ( ).3

Table 2

Open in a separate window

It has been reported that ICG shows minimal passage across the placenta and that the placenta has a protective effect against its passage to the fetus.34 Although there is no proven teratogenic effect, its indication for use in pregnancy should be carefully discussed.

Non-specific side effects following angiographic dye delivery are usually recorded as allergic reactions. This leads to the restriction of new angiographic examinations needed in the future. For this reason, it is important to reevaluate a patient’s history of post-angiography side effects and other possible factors in detail.

ICGA Phases

Early phase: Filling of the choroidal arteries, choriocapillaris, and choroidal veins. It includes the few seconds after the ICG dye reaches the choroidal circulation.

Middle phase: Late venous phase, lasting up to minute 10. In this phase, contrast differences between the choroidal vessels and background fluorescence decrease slowly.

Late phase: Between 10 and 20 minutes. The fundus is dominated by homogeneous fluorescence (i.e., isofluorescence). Hypofluorescent silhouettes of the large choroidal veins are observed on this background. This phase is also called the inversion phase due to the reversal of the contrast pattern.35

ICGA Interpretation

The logic of ICGA and FA interpretation is similar. However, because the infrared excitation light used in ICGA penetrates beneath the RPE and ICG shows less leakage due to high plasma protein binding, the images appear more “whitish” in the early phase compared to FA in normal eyes. The contrast between the vascular structures and the background is low. ICGA interpretation should be made in conjunction with color fundus photographs and FA images from the same eye. In eyes that have undergone multimodal imaging, these data should also be considered when interpreting ICGA.

Hypofluorescence: Appears as dark or black areas caused by filling defects and blockage. Filling defects (i.e., failure of the ICG dye to reach the vessel) is mostly seen in pathologies that directly affect the circulation of the choriocapillaris. Blocked hypofluorescence is the result of a formation that prevents tissue fluorescence from reaching the imaging device. A pigmented lesion in the fundus (e.g., choroidal nevus), thick subretinal hemorrhage, or infiltrations in the choroidal stroma are the most common causes.

Hyperfluorescence: Appears as a white area. Window defect often causes the underlying vascular structures to appear brighter after thinning or atrophy of the RPE or choriocapillaris. The best example of this is that in age-related macular degeneration (AMD), large choroidal veins in atrophic areas show more hyperfluorescence than the choroidal vessels observed in other areas of the macula. Leakage can be observed in severe stromal choroiditis, although it is considerably less with ICG compared to FA. Another cause of hyperfluorescence is abnormal vessel formations, such as choroidal hemangioma or nodular formations in PCV.

ICGA in Clinical Practice

1. Neovascular Age-Related Macular Degeneration

ICGA was used extensively in the mid-90s to visualize occult CNVs. Hyperfluorescent lesions (generally referred to as “hot spots”) that appear in the middle phase and are smaller than one disc diameter were considered to be the active part of occult CNV. A larger “plaque” type lesion seen in the late phase was considered the silent or less active component of the occult CNV.36,37 Another application area, dynamic ICGA, enabled visualization of CNV feeder vessels.38 However, after the results of laser photocoagulation to both hot spots and feeder vessels demonstrated its limited effectiveness and the superiority of photodynamic therapy to laser photocoagulation, the use of ICGA in neovascular AMD declined.

ICGA has an important place in the differential diagnosis of neovascular AMD subgroups. ICGA can demonstrate nodular hyperfluorescent lesions in PCV and the accompanying abnormal vascular network ( ).39

Open in a separate window

In type 3 CNV or retinal angiomatous proliferation lesions, the retinochoroidal vascular anomaly can be visualized more clearly with ICGA than FA due to the low leakage.40

In recent years, the causal relationship between pachychoroid (thick choroid) and neovascular AMD has been intensively studied. ICGA plays an important role in visualizing the choroidal vasculature in the macula.41

2. Central Serous Chorioretinopathy

Although the pathogenesis is not completely understood, exudation resulting from permeability of the choroidal vasculature in CSCR causes RPE detachment and serous retinal detachment. Areas of leakage in the choroid can be visualized in more detail with ICGA compared to FA ( ). The hyperfluorescent areas detected on ICGA reveal targets for the application of photodynamic therapy. Due to their choroidal thickening, ICGA plays a central role in the differentiation of CSCR, PCV, and other pachychoroidal entities.41,42

Open in a separate window

In cases of neovascular AMD that do not respond to treatment with anti-vascular endothelial growth factors, ICGA imaging is also used for the differential diagnosis of possible PCV, CSCR, or secondary CNV associated with CSCR.

4. Intraocular Tumors

The most important contribution of ICGA is in the diagnosis of choroidal hemangiomas. ICGA particularly helpful in the differential diagnosis of thin, amelanotic fundus tumors and choroidal metastases from choroidal hemangioma.19,44 In the choroidal filling phase, the tumor shows rapid, bright hyperfluorescence. In the late phase, the intensity of hyperfluorescence decreases as the ICG dye leaves the vessels (“wash-out phenomenon”). This feature enables the differentiation of choroidal hemangioma from amelanotic malignant melanoma of the choroid ( ).

Open in a separate window

In cases where FA is insufficient or cannot be applied, ICGA also facilitates the examination of vascular tumors of the fundus. Due to rapid leakage and masking, FA has limited ability to determine the topographic location and vascular structure of pathologies that present with intense exudation at the papillary margin and retinal thickening. ICGA is advantageous in recognizing lesions because of the deep penetration and low leakage of ICG. Thus, it aids in the differential diagnosis of masses and pathologies around the optic disc, such as juxtapapillary retinal capillary angioma, PCV, and CNV.

5. Hemorrhagic Diseases of the Fundus

Retinal arterial macroaneurysms may cause bleeding in the posterior segment. They may be located in the inferior or superior temporal arcade and can usually be recognized as white-yellowish round formations along the arteries. However, in cases where intense hemorrhage covers the lesion or blocks FA, ICGA can be used to visualize the vascular anomaly despite bleeding. Distinguishing retinal artery macroaneurysms from CNV and PCV in hemorrhages localized to the macula is an important area of use of ICGA.

ICGA is also used as a diagnostic tool for the differentiation of CNV, PCV, and vasoproliferative retinal tumors in eyes with large hemorrhagic lesions in the peripheral fundus ( ).

Open in a separate window

6. Unexplained Vision Loss

In patients with unexplained vision loss, ICGA can be performed if choroidal involvement is suspected and other multimodal diagnostic methods are inconclusive.

Number: 0111

Table Of Contents

Policy

Applicable CPT / HCPCS / ICD-10 Codes

Background

References

Policy

Scope of Policy

This Clinical Policy Bulletin addresses indocyanine green angiography.

1. Medical Necessity

   Aetna considers the following interventions medically necessary: 

   1. Indocyanine green angiography when it is used as an adjunct to fluorescein angiography in the diagnosis and management/treatment of any of the following conditions:

      1. Acute posterior multi-focal placoid pigment epitheliopathy; or
      2. Evaluation of choroidal hemangioma; or
      3. Exudative senile macular degeneration; or
      4. Hemorrhagic detachment of retinal pigment epithelium; or
      5. Monitoring birdshot chorioretinitis; or
      6. Monitoring of foveo-macular vitelliform dystrophy (also known as Best disease); or
      7. Retinal hemorrhage; or
      8. Retinal neovascularization; or
      9. Serous detachment of retinal pigment epithelium.

      Note: Documentation in the member's medical record should indicate one of the following:

      1. Evidence of ill-defined subretinal neovascular membrane or suspicious membrane on previous fluorescein angiography; or
      2. Presence of subretinal hemorrhage or hemorrhagic retinal pigment epithelium. A fluorescein angiography need not have been previously done; or
      3. Retinal pigment epithelium does not show subretinal neovascular membrane on current fluorescein angiography.

      The physician's documentation should support the frequency and medical necessity of this procedure;

   2. The intra-operative use of indocyanine green angiography for intracranial aneurysm surgery;
   3. Near-infrared angiography with indocyanine green (e.g., Spy Elite System) for breast reconstruction surgery. Note: Intraoperative imaging of tissue perfusion is considered integral to the primary surgical procedure and is not separately reimbursed;
   4. The use of indocyanine green for sentinel lymph node mapping in cervical cancer, endometrial cancer, and endometrial intraepithelial neoplasia.

2. Experimental, Investigational, or Unproven

   The following interventions are considered experimental, investigational, or unproven because the effectiveness of these approaches has not been established:

   1. Indocyanine green angiography with the following:

      1. For use in the following procedures (not an all-inclusive list) because the safety and effectiveness of this approach has not been established:

         1. Anatomical dissection during robot-assisted radical prostatectomy
         2. Evaluation of anastomotic leak/perfusion during or after esophagectomy
         3. Evaluation of anastomotic leakage/perfusion in colorectal surgery
         4. Evaluation of anastomotic perfusion after bowel resection for recto-sigmoid endometriosis
         5. Evaluation of anastomotic stenosis of reconstructed superior mesenteric artery aneurysm
         6. Evaluation of chorioretinal scars
         7. Evaluation of complaint of vision loss
         8. Evaluation of perfusion of the supra-clavicular artery island flap in head and neck reconstruction
         9. Evaluation of residual parathyroid glands function and prediction of post-operative hypocalcemia risk after total thyroidectomy
         10. Follow-up of branch retinal vein occlusion status post bevacizumab
         11. Guidance in redo ileocolic resection for Crohn's disease
         12. Identification of the superficial temporal artery and vein in forehead flaps for facial reconstruction
         13. Indocyanine green angiography-assisted internal limiting membrane peeling in macular hole surgery
         14. Indocyanine green fluorescent imaging in bariatric surgery
         15. Intraoperative evaluation of flap perfusion in skull base reconstruction
         16. Intraoperative use for pancreas stump perfusion assessment during pancreaticoduodenectomy
         17. Intraoperative use for prevention of anastomotic leakage after rectal cancer surgery
         18. Intraoperative use in microsurgical subinguinal varicocelectomy
         19. Intraoperative use to reduce of the incidence of anastomotic leakage in colorectal surgery
         20. Prediction of post-operative thrombosis in the internal jugular vein
         21. Prediction of wound complications in ventral hernia repair
         22. Prevention of surgical morbidity (e.g., anastomotic leakage, chylothorax, and graft necrosis) during esophagectomy;

      2. In the management of the following conditions (not an all-inclusive list) because it has not been demonstrated to add information that is useful in the management of these conditions:

         1. Behcet's disease (Behcet's syndrome)
         2. Choroidal melanoma
         3. Critical limb ischemia
         4. Diabetic macular edema
         5. Drusen differentiation
         6. Macular schisis
         7. Parasagittal meningioma
         8. Pseudo-Moyamoya disease
         9. Sarcoidosis
         10. Scleritis and posterior scleritis
         11. Spinal dural arteriovenous fistula
         12. Vogt-Koyanagi-Harada disease;
   2. The use of indocyanine green for sentinel lymph node mapping of other cancers (e.g., bladder, breast, colon, kidney, melanoma, ovary, penis, prostate, and stomach; not an all-inclusive list);
   3. Indocyanine green video-angiography for removal of deep-seated arterio-venous malformation.

Table:

CPT Codes / HCPCS Codes / ICD-10 Codes

Code Code Description

CPT codes covered if selection criteria are met:

92240 Indocyanine-green angiography (includes multi-frame imaging) with interpretation and report 92242 Fluorescein angiography and indocyanine-green angiography (includes multiframe imaging) performed at the same patient encounter with interpretation and report, unilateral or bilateral

Other CPT codes related to the CPB:

15740 Flap; island pedicle requiring identification and dissection of an anatomically named axial vessel 15750      neurovascular pedicle 15756 Free muscle or myocutaneous flap with microvascular anastomosis 15757 Free skin flap with microvascular anastomosis 15758 Free fascial flap with microvascular anastomosis 15860 Intravenous injection of agent (eg, fluorescein) to test vascular flow in flap or graft 21179 Reconstruction, entire or majority of forehead and/or supraorbital rims; with grafts (allograft or prosthetic material) 21180 Reconstruction, entire or majority of forehead and/or supraorbital rims; with autograft (includes obtaining grafts) 35121 Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, hepatic, celiac, renal, or mesenteric artery 35122 Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for ruptured aneurysm, hepatic, celiac, renal, or mesenteric artery +38900 Intraoperative identification (eg, mapping) of sentinel lymph node(s) includes injection of non-radioactive dye, when performed (List separately in addition to code for primary procedure) 43107 - 43113 Total or near total esophagectomy 43116 - 43123 Partial esophagectomy 43124 Total or partial esophagectomy, without reconstruction (any approach), with cervical esophagostomy 43286 Esophagectomy, total or near total, with laparoscopic mobilization of the abdominal and mediastinal esophagus and proximal gastrectomy, with laparoscopic pyloric drainage procedure if performed, with open cervical pharyngogastrostomy or esophagogastrostomy (ie, laparoscopic transhiatal esophagectomy) 43287 Esophagectomy, distal two-thirds, with laparoscopic mobilization of the abdominal and lower mediastinal esophagus and proximal gastrectomy, with laparoscopic pyloric drainage procedure if performed, with separate thoracoscopic mobilization of the middle and upper mediastinal esophagus and thoracic esophagogastrostomy (ie, laparoscopic thoracoscopic esophagectomy, Ivor Lewis esophagectomy) 43288 Esophagectomy, total or near total, with thoracoscopic mobilization of the upper, middle, and lower mediastinal esophagus, with separate laparoscopic proximal gastrectomy, with laparoscopic pyloric drainage procedure if performed, with open cervical pharyngogastrostomy or esophagogastrostomy (ie, thoracoscopic, laparoscopic and cervical incision esophagectomy, McKeown esophagectomy, tri-incisional esophagectomy) 43644 - 43645 Laparoscopy, surgical, gastric restrictive procedure 43770 - 43775 Laparoscopy, surgical, gastric restrictive procedure 43482 Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty 43483      other than vertical-banded gastroplasty 43845 - 43847 Gastric restrictive procedure 43848 Revision, open, of gastric restrictive procedure for morbid obesity, other than adjustable gastric restrictive device (separate procedure) 43886 - 43888 Gastric restrictive procedure 44160 Colectomy, partial, with removal of terminal ileum with ileocolostomy 44205 Laparoscopy, surgical; colectomy, partial, with removal of terminal ileum with ileocolostomy 48150 - 48154 Pancreatectomy, proximal subtotal 55530 Excision of varicocele or ligation of spermatic veins for varicocele; (separate procedure) 55535 Excision of varicocele or ligation of spermatic veins for varicocele; abdominal approach 55540 Excision of varicocele or ligation of spermatic veins for varicocele; with hernia repair

Other HCPCS codes related to the CPB:

C9257 Injection, bevacizumab, 0.25 mg J9035 Injection, bevacizumab, 10 mg Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg Q5118 Injection, bevacizumab-bvzr, biosimilar, (Zirabev), 10 mg Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg

ICD-10 codes covered if selection criteria are met:

C53.0 - C53.9 Malignant neoplasm of cervix uteri C54.1 Malignant neoplasm of endometrium C69.30 - C69.32 Malignant neoplasm of choroid [not covered for choroidal melanoma] D06.0 - D06.9 Carcinoma in situ of cervix uteri D07.0 Carcinoma in situ of endometrium D18.09 Hemangioma of other sites [choroidal] H30.141 - H30.149 Acute posterior multifocal placoid pigment epitheliopathy H30.891 – H30.899 Other chorioretinal inflammations [birdshot chorioretinitis] H30.90 - H30.93 Unspecified chorioretinal inflammation H31.8 Other specified disorders of choroid H35.051 - H35.059 Retinal neovascularization, unspecified H35.09 Other intraretinal microvascular abnormalities H35.3210 - H35.3293 Exudative age-related macular degeneration H35.54 Dystrophies primarily involving the retinal pigment epithelium H35.60 - H35.63 Retinal hemorrhage [subretinal hemorrhage or hemorrhagic retinal pigment epithelium] H35.711 - H35.719 Central serous chorioretinopathy H35.721 - H35.729 Serous detachment of retinal pigment epithelium H35.731 - H35.739 Hemorrhagic detachment of retinal pigment epithelium N85.02 Endometrial intraepithelial neoplasia [EIN]

ICD-10 codes not covered for indications listed in the CPB (not all-inclusive):

C16.0 - C16.9 Malignant neoplasm of stomach C18.0 - C18.9 Malignant neoplasm of colon C43.0 - C43.9 Malignant melanoma of skin C50.011 - C50.929 Malignant neoplasm of breast C56.1 - C56.9 Malignant neoplasm of ovary C60.0 - C60.9 Malignant neoplasm of penis C61 Malignant neoplasm of prostate C64.1 - C64.9 Malignant neoplasm of kidney, except renal pelvis C67.0 - C67.9 Malignant neoplasm of bladder C70.0 Malignant neoplasm of cerebral meninges [parasagittal meningioma] D00.2 Carcinoma in situ of stomach D03.0 - D03.9 Melanoma in situ D05.00 - D05.92 Carcinoma in situ of breast D07.4 Carcinoma in situ of penis D07.5 Carcinoma in situ of prostate D09.0 Carcinoma in situ of bladder D32.0 Benign neoplasm of cerebral meninges [parasagittal meningioma] D86.0 - D86.9 Sarcoidosis E08.311, E08.3211 - E08.3219, E08.3311 - E08.3319, E08.3411 - E08.3419, E08.3511 - E08.3559, E09.311, E09.3211 - E09.3219, E09.3311 - E09.3319, E09.3411 - E09.3419, E09.3511 - E09.3559, E10.311, E10.3211 - E10.3219, E10.3311 - E10.3319, E10.3411 - E10.3419, E10.3511 - E10.3559, E11.311, E11.3211 - E11.3219, E11.3311 - E11.3319, E11.3411 - E11.3419, E11.3511 - E11.3559, E13.311, E13.3211 - E13.3219, E13.3311 - E13.3319, E13.3411 - E13.3419, E13.3511 - E13.3559 Diabetes mellitus with diabetic retinopathy with macular edema H15.001 - H15.129 Scleritis and episcleritis H20.821 - H20.829 Vogt-Koyanagi syndrome H30.811 - H30.819 Harada's disease H31.001 – H31.099 Chorioretinal scars H31.101 - H31.109 Unspecified choriodal degeneration [hereditary drusen] H33.101 - H33.199 Retinoschisis and retinal cysts H34.8310 – H34.8392 Tributary (branch) retinal vein occlusion [status post bevacizumab] H35.361 - H35.369 Drusen (degenerative) of macula H47.011 – H47.019 Ischemic optic neuropathy [non-arteritic] H47.321 - H47.329 Drusen of optic disc H53.121 – H53.129 Transient visual loss H53.131 – H53.139 Sudden visual loss H54.3 Unqualified visual loss, both eyes H54.60 – H54.62 Unqualified visual loss, one eye H54.7 Unspecified visual loss H59.811 – H59.819 Chorioretinal scars after surgery for detachment I72.8 Aneurysm of other specified arteries [superior mesenteric artery] I77.0 Arteriovenous fistula, acquired I89.8 Other specified noninfective disorders of lymphatic vessels and lymph nodes [prevention of chylothorax] K43.0 - K43.9 Ventral hernia K50.00 - K50.919 Crohn's disease [regional enteritis] K91.81 Other intraoperative complications of digestive system [anastomotic leakage in colorectal surgery] [prevention of surgical morbidity][prevention of anastomotic leakage after rectal cancer surgery] K91.89 Other postprocedural complications and disorders of digestive system [anastomotic leakage in colorectal surgery] [prevention of surgical morbidity][anastomotic stenosis of superior mesenteric artery] M35.2 Behcet's disease Q27.30 – Q27.39 Arteriovenous malformation (peripheral) Q28.8 Other specified congenital malformations of circulatory system T81.710A - T81.710S Complication of mesenteric artery following a procedure, not elsewhere classified [anastomotic stenosis]

Non-ophthalmic:

Other CPT codes related to the CPB:

19357 Breast reconstruction, immediate or delayed, with tissue expander, including subsequent expansion 19361 Breast reconstruction with latissimus dorsi flap, without prosthetic implant 19364 Breast reconstruction with free flap 19366 Breast reconstruction with other technique 19367 Breast reconstruction with transverse rectus abdominis myocutaneous flap (TRAM), single pedicle, including closure of donor site 19368 Breast reconstruction with transverse rectus abdominis myocutaneous flap (TRAM), single pedicle, including closure of donor site; with microvascular anastomosis (supercharging) 19369 Breast reconstruction with transverse rectus abdominis myocutaneous flap (TRAM), double pedicle, including closure of donor site 43644 - 43645 Laparoscopy, surgical, gastric restrictive procedure 43770 - 43775 Laparoscopy, surgical, gastric restrictive procedure 43482 Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical-banded gastroplasty 43483      other than vertical-banded gastroplasty 43848 Revision, open, of gastric restrictive procedure for morbid obesity, other than adjustable gastric restrictive device (separate procedure) 43886 - 43888 Gastric restrictive procedure 44140 Colectomy, partial; with anastomosis 45110 Proctectomy; complete, combined abdominoperineal, with colostomy 45111 Proctectomy; partial resection of rectum, transabdominal approach 45112 Proctectomy, combined abdominoperineal, pull-through procedure (eg, colo-anal anastomosis) 45114 Proctectomy, partial, with anastomosis; abdominal and transsacral approach 45116 Proctectomy, partial, with anastomosis; transsacral approach only (Kraske type) 45119 Proctectomy, combined abdominoperineal pull-through procedure (eg, colo-anal anastomosis), with creation of colonic reservoir (eg, J-pouch), with diverting enterostomy when performed 48150 - 48154 Pancreatectomy, proximal subtotal 55866 Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed 55867 Laparoscopy, surgical prostatectomy, simple subtotal (including control of postoperative bleeding, vasectomy, meatotomy, urethral calibration and/or dilation, and internal urethrotomy), includes robotic assistance, when performed

HCPCS codes covered for indications listed in the CPB:

C9733 Non-ophthalmic fluorescent vascular angiography [Spy Elite System]

ICD-10 codes covered if selection criteria are met::

A52.05 Other cerebrovascular syphilis [syphilitic ruptured cerebral aneurysm] E89.0 Postprocedural hypothyroidism [total thyroidectomy or esophagectomy] I60.00 - I60.9 Nontraumatic subarachnoid hemorrhage I67.1 Cerebral aneurysm, nonruptured Q28.3 Other malformations of cerebral vessels [cerebral arteriovenous aneurysm, congenital] Z90.49 Acquired absence of other specified parts of digestive tract [total thyroidectomy or esophagectomy] Z98.890 Other specified postprocedural states [total thyroidectomy or esophagectomy]

ICD-10 codes not covered for indications listed in the CPB (not all-inclusive):

N80.50, N80.511, N80.512, N80.519, N80.521, N80.522, N80.529, N80.531, N80.532, N80.539, N80.541, N80.542, N80.549, N80.551, N80.552, N80.559, N80.561, N80.562, N80.569, N80.A0, N80.A1, N80.A2, N80.A41, N80.A42, N80.A43, N80.A49, N80.A51, N80.A52, N80.A53, N80.A59, N80.A61, N80.A62, N80.A63, N80.A69, N80.B1, N80.B2, N80.B31, N80.B32, N80.B39, N80.B4, N80.B5, N80.B6, N80.C0, N80.C10, N80.C11, N80.C19, N80.C2, N80.C3, N80.C4, N80.C9, N80.D0, N80.D1, N80.D2, N80.D3, N80.D4, N80.D5, N80.D6, N80.D9 Endometriosis of intestine

Background

Fluorescein angiography allows visualization of blood flow in retinal and choroidal tissues, permitting diagnostic support in many ocular diseases. In particular, fluorescein angiography has become a very important tool in the diagnosis and treatment of chorio-retinal diseases. However, limitations of fluorescein angiography in imaging the choroidal circulation and associated pathologies prompted the use of alternative dyes to improve choroidal angiography.

Indocyanine green angiography is a diagnostic study where indocyanine green, a fluorescent dye, is injected intravenously, and observations of the retina are made at intervals as increasing intensity of retinal and choroidal circulation is displayed. Indocyanine green angiography is used for the imaging of retinal and choroidal vasculatures. It is effective when used as an adjunct to fluorescein angiography in the diagnosis and treatment of ill-defined choroidal neovascularization (i.e., associated with age-related macular degeneration). It is generally used in evaluating retinal neovascularization, serous detachment of retinal pigment epithelium, hemorrhagic detachment of retinal pigment epithelium, and retinal hemorrhage.

Indocyanine green angiography has been under development for the past 30 years as an imaging method for the choroidal vasculature.  Although standard fluorescein angiography is widely used to evaluate exudative and proliferative lesions of the retina, its diagnostic ability in imaging the choroid is limited because of dye scatter by the overlying pigmented structures of the fundus, and also due to leakage of fluorescein through the fenestrated capillaries of the choroid.  Improvements in indocyanine green angiography, specifically the development of high resolution digital imaging systems, have permitted the technical feasibility and commercialization of the technology.

The most commonly proposed application of indocyanine green angiography is the detection of choroidal neovascularization, a common component of age related macular degeneration.  A series of randomized studies in the 1980s (called the Macular Photocoagulation Study) showed that patients with "classic" choroidal neovascularization could benefit from photocoagulation treatment. Those with diffuse or poorly defined disease or disease involving the foveal avascular zone were considered poor candidates for photocoagulation. With these criteria, it has been estimated that only about half of patients would be candidates for treatment. In as much as the key to the success of photocoagulation was accurate delineation of choroidal neovascularization, it was hoped that the improved diagnostic capabilities of indocyanine green angiography would lead to the identification of more patients who would be appropriate candidates for treatment.

Given the above discussion, an appropriate outcome for indocyanine green angiography would be its diagnostic capabilities compared to fluorescein angiography in the evaluation of patients with choroidal neovascularization.  Yannuzzi and colleagues (1992) performed indocyanine green angiography on 129 patients with age related macular degeneration and ill-defined or occult neovascularization as identified by a previous fluorescein angiography. In 50 (39 %) of the patients, indocyanine green angiography provided additional information such that occult choroidal neovascularization could be reclassified as a classic pattern.  A total of 12 patients underwent laser photocoagulation based on the indocyanine green videoangiography (ICGA) findings.  Although the exact techniques may vary from study to study, several subsequent reports have also documented improved diagnostic capabilities of indocyanine green angiography compared to fluorescein angiography.

As discussed in the studies above, indocyanine green angiography is used as a second level diagnostic test to further evaluate patients with choroidal neovascularization.  Typically all patients will first undergo a fluorescein angiography which will simultaneously evaluate the retinal vasculature, and give initial information regarding the choroidal vasculature.  Fluorescein angiography can definitively identify some patients who are not candidates for photocoagulation (i.e. those with neovascularization involving the fovea) and also those who do not have neovascularization.  Indocyanine green angiography is then appropriate in those patients with equivocal results with fluorescein angiography, or who require more accurate definition of the neovascularization before proceeding to photocoagulation therapy. Therefore the appropriateness of indocyanine green angiography is contingent upon the results of fluorescein angiography.  

In an evidence review on the use of indocyanine green angiography in chorio-retinal diseases, Stanga et al (2003) stated that they do not recommend ICGA for scleritis and posterior scleritis, drusen differentiation, Behcet's disease (Behcet's syndrome), or sarcoidosis, because it has not been demonstrated to add useful clinical information.

Surgical management of macular holes consists of pars plana vitrectomy, removal of the posterior hyaloid facia, and peeling of the epi-retinal membranes (ERM).  Additionally, removal of the internal limiting membrane (ILM) may enable an increase in the anatomical and functional success rates.  However, recognition of fine ILM is difficult; thus increasing the time that the macula is exposed to intra-operative light.  Staining the ILM with indocyanine green (ICG) dye during vitrectomy has been reported to facilitate recognition of the ILM and assures that all adjacent ERM are removed.  Therefore, ICG-assisted ILM peeling has gained popularity among vitreo-retinal surgeons.  However, there are some concerns about the intra-vitreal ICG application.  Reports in the literature described a variety of application techniques using different concentrations.  The post-operative outcomes were controversial reporting heterogeneous anatomical and functional outcomes after ICG application, as well as descriptions of adverse effects related to the dye.

Nakamura et al (2005) examined the duration of post-operative persistence of ICG dye used during vitreous surgery.  They found that ICG dye used during macular surgery can persist in the macular region for up to 7 months following surgery, and seems to remain for a longer period of time in cases with macular hole than in cases with other diseases.  Caution is needed regarding light exposure by post-operative fundus examinations, daylight, and other natural light.  Cheng et al (2005) report 6 cases of ICG-related ocular toxicity after intra-vitreal ICG usage.  Five cases had pre-operative diagnosis of macular hole, 1 case had pre-operative rhegmatogenous retinal detachment complicated with proliferative vitreo-retinopathy.  All cases received vitrectomy, ICG-assisted ILM peeling and air-fluid exchange.  All eyes had residual ICG left at the end of surgery.  The authors noted that ocular toxicity caused by ICG may present as pigment epithelial atrophy, which is characteristically larger than the previous area of macular hole and surrounding cuff.  Disc atrophy, retinal toxicity, and ocular hypotony were also observed in some cases.  In addition, Tognetto et al (2005) reported a case of massive macular edema and visual loss following ICG-assisted macular pucker surgery.

An American Academy of Ophthalmology Preferred Practice Pattern on idiopathic macular hole (AAO, 2003) states that "there are no randomized controlled studies to prove the benefit of ILM peeling and there are many reports of similar results without peeling; current evidence is inconclusive." Regarding the use of ICG, the AAO Preferred Practice Pattern (2003) states: "Some surgeons recommend visualizing the ILM with indocyanine green (ICG) dye staining to aid peeling. There have been reports of damage to the retinal pigment epithelium with the use of ICG dye. The current evidence is inconclusive to recommend for or against the use of ICG during surgery."

In an observational case series (n = 31), Uemoto et al (2005) ascertained the changes in the retinal pigment epithelium (retinal pigment epithelium) and secondary changes in the choroid and fovea following ICG staining of the internal limiting lamina during surgery for an idiopathic macular hole (MH).  The authors concluded that the use of ICG dye with illumination may increase the risk of retinal pigment epithelium damage and secondary choroidal and foveal morphological changes.

In a retrospective review, Husson-Danan et al (2006) examined the role of ICG in macular hole surgery.  This study included a total of 38 consecutive eyes with macular hole, operated on with ILM, using or not using ICG, diluted in glucose 5 % and filtered.  Anatomical and functional results were analyzed in each group, using visual field testing, fluorescein fundus angiography and particularly blue filter fundus photographs for the detection of retinal pigment epithelial changes and lesions of optic nerve fibers layer.  Fifteen eyes underwent surgery without ICG and 23 eyes with ICG.  The mean period of follow-up was 10 months.  The duration of surgery was significantly lower in the group with ICG than without (p < 0.001).  Overall, 84 % of the holes closed without difference between both groups.  The improvement in vision at 1, 6 and 12 months was similar in both groups.  Fewer defects in the optic nerve fibers layer were observed in the group with ICG than without (p = 0.02).  Staining with ICG revealed the presence of an associated ERM in 61 % of eyes, whereas it was clinically visible in only 17.5 % before surgery.  These researchers concluded that using ICG for ILM peeling produced similar visual results to those obtained without ICG.  It reduced significantly the duration of surgery and the trauma to the optic nerve fibers layer, without increasing the risk of retinal pigment epithelial damage.  However, in light of recent reports concerning the possible toxicity of ICG, its use should be limited in clinical practice to difficult cases.

In a non-randomized comparative study (n = 32), Oie et al (2007) examined the effect of using ICG to stain the ILM during vitrectomy in eyes with retinal detachment resulting from macular hole (MHRD).  The medical records of the cases were reviewed retrospectively.  During the initial vitrectomy, the ILM was peeled in 22 eyes with ICG (group A) and in 10 eyes without ICG (group B).  Main outcome measures included anatomical re-attachment, visual acuity, and optical coherence tomography-determined closure of macular hole.  The initial re-attachment rate in group A (86 %) was significantly higher than in group B (40 %; p = 0.013, Fisher exact test).  The post-operative visual acuity at 6 months and the visual improvements at 6 and 12 months in eyes with an initial re-attachment were not significantly different between the 2 groups (p = 0.123, Mann-Whitney rank-sum test; p = 0.17, t test; p = 0.237, t test).  The post-operative visual acuity at 12 months with an initial re-attachment in group A was significantly better than in group B (p = 0.039, t test).  The macular hole closure rate with an initial re-attachment was 6 of 17 eyes (35 %) in group A and 0 of 4 eyes (0 %) in group B, and this difference was not significant (p = 0.281, Fisher exact test).  The authors concluded that these results show that ICG staining improves the initial reattachment rate and is associated with better post-operative visual acuity at 12 months.  Thus, ICG staining should be used during vitrectomy for MHRD because the complete removal of the ILM with ICG ensures the removal of the tangential traction by an ERM and the inverse traction by the retina that cannot follow the posterior enlargement of a staphyloma.  Moreover, these researchers noted that the number of patients in this study was small, and a further prospective, randomized controlled trial is needed to ascertain the effect of ICG.  Confirmation of the present findings with a randomized study using a larger sample size and a longer follow-up would be ideal.

Beutel et al (2007) reported on anatomical and visual outcomes after vitrectomy and ILM peeling for idiopathic macular hole repair.  A total of 40 patients with stage II to IV idiopathic macular holes were randomly assigned (1:1) in a 2-arm, single-center, randomized controlled.  Internal limiting membrane delamination was performed using ICG solution (n = 20) or trypan blue (TB) (n = 20).  Two patients did not complete the study, for a total of 19 in each group.  Follow-up examinations included Early Treatment of Diabetic Retinopathy Study visual acuity, scanning laser ophthalmoscope micro-perimetry, optical coherence tomography, and fluorescein angiography.  Main outcome measure was visual acuity 3 months after surgery.  Visual acuity did not show a significant difference between study groups (95 % confidence interval [CI]: -2 to 1 lines).  The rate of macular hole closures was identical (84 %; 95 % CI: 60 % to 97 %).  Within-group visual recovery was significant only in the TB group.  Central scotomata despite hole closure persisted in 8 patients (42 %) in the ICG group and in 5 (26 %) in the TB group.  The authors concluded that although no statistically significant difference was detected for the primary end point, the better visual recovery in the TB group and the higher rate of persistent central scotomata in the ICG group justify a larger clinical trial.

Kwok et al (2005) evaluated the visual outcome and recurrence rate of ERM formation following vitreo-retinal surgery with and without ILM peel.  The medical records of 42 consecutive patients who underwent surgery for macular ERM by a single surgeon were reviewed.  All patients underwent pars plana vitrectomy and ERM removal with a subset undergoing ILM peel.  Recurrence of macular ERM within 18 months and the final visual outcome after surgery were compared between patients with and without ILM removal.  Twenty-five patients (59.5 %) underwent ERM surgery with ILM peeling and 17 patients (40.5 %) underwent ERM surgery without ILM peeling.  The mean pre-operative logMAR visual acuity was 0.77 and 0.96 for the ILM peeling and non-ILM peeling groups, respectively.  Visual acuity improved significantly in both the ILM and non-ILM peeling groups after ERM surgery (p < 0.001 and p = 0.003, respectively).  Eighteen months after surgery, 3/17 eyes without ILM peeling (17.6 %) developed recurrent macular ERM, compared with none of the 25 eyes with ILM peeling (log-rank test, p = 0.030).  These investigators concluded that ILM removal during macular ERM surgery may minimize the recurrence of ERM, without adverse visual outcome.  Moreover, they noted that further controlled prospective studies are needed to determine the role of ILM peeling in ERM surgery.

In a randomized controlled clinical trial, Hillenkamp and colleagues (2007) performed a prospective investigation of the functional and morphological outcome of idiopathic epiretinal membrane (IEM) surgery with or without the assistance of ICG.  A total of 60 patients who underwent vitrectomy with removal of IEM combined with cataract surgery were randomly allocated to two groups:

1. 27 patients were operated on with ICG 0.1 % in glucose 5 %, and
2. 33 patients without ICG. 

Functional outcome was assessed 3 to 4 months post-operatively with improvement of best-corrected visual acuity (BCVA), Amsler grid test, and automated and kinetic perimetry.  Post-operative residual or recurrent IEM was assessed with bio-microscopy, and macular edema with optical coherence tomography (OCT).  Improvement in BCVA was the main outcome measure.  BCVA improved in 49 patients, remained unchanged in 5 and decreased in 5.  Improvement in BCVA and reduction of macular edema were statistically significant within both groups (p < 0.01).  Improvement in BCVA was not statistically significantly different whether ICG was used or not [0.17 (logarithm of minimum angle of resolution; logMAR) with ICG and 0.24 (logMAR) without ICG] (p = 0.59).  There was no statistically significant difference in pre-operative or post-operative BCVA, reduction of macular edema, post-operative Amsler grid test, or incidence of residual or recurrent IEM between the two groups.  Visual field defects were detected in 2 patients operated on with ICG.  The authors concluded that removal of IEM with or without the assistance of ICG equally improved visual function and macular morphology.

Vogt-Koyanagi-Harada (VKH) disease is a multi-systemic autoimmune disorder characterized by granulomatous panuveitis with exudative retinal detachments that is frequently associated with neurological and cutaneous manifestations.  Bouchenaki and Herbort (2011) reported the management of VKH disease based on ICGA. Subjects with acute episodes of inflammation (inaugural or recurrent) who had received standard ICGA-guided care were studied retrospectively.  Standard of care included high-dose systemic corticosteroids at presentation and close ICGA follow-up with addition of immunosuppressive agents and/or intensification of ongoing therapy when recurrent choroidal lesions were detected by ICGA.  Visual acuity, number of sub-clinical recurrences, type and duration of therapy, proportion of quiescent patients after therapy, and ICGA findings were recorded.  A total of 9 patients (8 females and 1 male) were studied; 5 had inaugural disease and 4 presented with recurrent acute episodes.  Visual acuity increased from 0.86 +/- 0.36 to 1.14 +/- 0.34 in the right eyes, and from 0.77 +/- 0.34 to 1.05 +/- 0.33 in the left eyes.  The number of ICGA-detected occult choroidal recurrences amounted to 13.  Mean duration of treatment was 30.1 +/- 34.6 months leading to recurrence-free status after discontinuation of therapy in 6 cases with mean duration of 29.5 months.  The authors concluded that continuous monitoring and aggressive therapy guided by ICGA in VKH disease prolonged treatment as compared to textbook guidelines but offered the prospect of reaching inflammation-free status after discontinuation of therapy.

Chee and Jap (2013) compared outcomes of ICGA versus clinically monitored immunotherapy in VKH disease.  Consecutive patients of Singapore National Eye Centre with VKH receiving high-dose corticosteroids within 4 weeks of onset of symptoms had therapy titrated to clinical signs of activity (controls) or ICGA findings (ICGA).  Charts were reviewed for demographics, interval to treatment, duration of therapy and number of systemic immunosuppressants required.  Outcome measures were BCVA, disease activity, presence of sun-set glow (SSG) fundus and peri-papillary atrophy (PPA) at 2 years.  A total of 52 patients were included (38 controls, 14 ICGA).  Duration of treatment was shorter in the control group (17 versus 42 months, p < 0.001) and they required fewer systemic immunosuppressants than the ICGA group (16 % versus 96 %, p < 0.001).  The majority (49 eyes, 96.1 %) had 6/12 or better vision and were clinically quiet (43 eyes, 84.3 %) in both groups.  Sun-set glow fundus and PPA were similar in both groups.  Treatment within 2 weeks of onset was the main factor affecting their occurrence on multi-variate analysis (odds ratio [OR] 0.18, 95 % CI: 0.03 to 0.9, p = 0.047; OR 0.08, 95 % CI: 0.01 to 0.51, p = 0.007, respectively).  The authors concluded that ICGA-guided immunotherapy did not result in significantly better outcomes with respect to visual acuity and disease activity in VKH eyes treated within 1 month of onset.

Indocyanine green angiography has been used intra-operatively in the management of intracranial aneurysms.  Raabe et al (2005) described the technical integration of ICG near-infrared technology into the optical path of the surgical microscope and reported on the image quality achieved by this method.  These researchers hypothesized that ICG angiography permits a simple and quick intra-operative assessment of vessel patency and aneurysm occlusion after clip placement.  A special arrangement of filters was designed to allow the passage of near-infrared light required for the excitation of ICG fluorescence (700 to 850 nm) from a modified microscope light source into the surgical field and the passage of ICG fluorescence (780 to 950 nm) from the surgical field back into the optical path of the surgical microscope.  Thus, ICG angiography could be completely performed with a surgical microscope.   A total of 20 patients with intracranial aneurysms were included in the technical evaluation of the new method.  Image quality and spatial resolution were excellent and permitted a real-time assessment of vessel patency and aneurysm occlusion if the structures of interest were visible to the surgeon's eye under the microscope, including perforating arteries with a diameter of less than 1 millimeter.  In 1 patient, vessel occlusion by the clip was found and in 1 case residual filling of the aneurysm was diagnosed.  Both cases could be treated by clip correction within 2 mins after primary placement of the clip.  In all cases, the intra-operative findings correlated with the post-operative digital subtraction angiography.  The authors concluded that ICG angiography using a surgical microscope is valuable for the intra-operative imaging of arterial and venous flow in all visible vessels including small perforating arteries.  The simplicity of the method and the speed with which the investigation can be performed indicate that this technique may help to improve the quality and outcome of surgical procedures and reduce the need for intra- or post-operative angiography in selected cases.

de Oliveira et al (2007) described the usefulness of near-infrared ICGA for the intra-operative assessment of blood flow in perforating arteries that are visible in the surgical field during clipping of intracranial aneurysms.  In addition, these researchers analyzed the incidence of perforating vessels involved during the aneurysm surgery and the incidence of ischemic infarct caused by compromised small arteries.  A total of 60 patients with 64 aneurysms were surgically treated and prospectively included in this study.  Intra-operative ICGA was performed using a surgical microscope with integrated ICGA technology.  The presence and involvement of perforating arteries were analyzed in the microsurgical field during surgical dissection and clip application.  Assessment of vascular patency after clipping was also investigated.  Only those small arteries that were not visible on pre-operative digital subtraction angiography were considered for analysis.  The ICGA was able to visualize flow in all patients in whom perforating vessels were found in the microscope field.  Among 36 patients whose perforating vessels were visible on ICGA, 11 (30 %) presented a close relation between the aneurysm and perforating arteries.  In 1 (9 %) of these 11 patients, ICGA showed occlusion of a P1 perforating artery after clip application, which led to immediate correction of the clip confirmed by immediate re-establishment of flow visible with ICGA without clinical consequences.  Four patients (6.7 %) presented with post-operative perforating artery infarct, 3 of whom had perforating arteries that were not visible or distant from the aneurysm.  The authors concluded that the involvement of perforating arteries during clip application for aneurysm occlusion is a usual finding.  Intra-operative ICGA may provide visual information with regard to the patency of these small vessels.

Imizu et al (2008) evaluated the clinical use and the completeness of clipping with total occlusion of the aneurysmal lumen, real-time assessment of vascular patency in the parent, branching and perforating vessels, intra-operative assessment of blood flow, image quality, spatial resolution and clinical value in difficult aneurysms using near infrared ICGA integrated on to an operative Pentero neurosurgical microscope.  A total of 13 patients with aneurysms were operated upon.  An infrared camera with near infrared technology was adapted on to the OPMI Pentero microscope with a special filter and infrared excitation light to illuminate the operating field which was designed to allow passage of the near infrared light required for excitation of ICG, which was used as the intravascular marker.  The intravascular fluorescence was imaged with a video camera attached to the microscope.  ICG fluorescence (700 to 850 nm) from a modified microscope light source on to the surgical field and passage of ICG fluorescence (780 to 950 nm) from the surgical field, back into the optical path of the microscope was used to detect the completeness of aneurysmal clipping.  Incomplete clipping in 3 patients (1 female and 2 males) with unruptured complicated aneurysms was detected using ICGA.  There were no adverse effects after injection of ICG.  The completeness of clipping was inadequately detected by Doppler ultrasound mini-probe and rigid endoscopy and was thus complemented by ICGA.  The authors concluded that the operative microscope-integrated ICGA as a new intra-operative method for detecting vascular flow, was found to be quick, reliable, cost-effective and possibly a substitute or adjunct for Doppler ultrasonography or intra-operative digital subtraction angiography (DSA), which is presently the gold standard.  The simplicity of the method, the speed with which the investigation can be performed, the quality of the images, and the outcome of surgical procedures have all reduced the need for angiography.  This technique may be useful during routine aneurysm surgery as an independent form of angiography and/or as an adjunct to intra-operative or post-operative DSA.

Dashti et al (2009) evaluated the reliability of ICGA in the evaluation of neck residuals and patency of branches after micro-neurosurgical clipping of intra-cranial aneurysms (IAs).  During a period of 14 months, 289 patients with intra-cranial aneurysms were operated on in the authors' institution.  Intra-operative ICGA was performed during micro-neurosurgical clipping of 239 IAs in 190 patients.  Post-operative computed tomography and computed tomography angiography (CTA) were performed for all patients.  Intra-operative interpretation of ICGA in assessing the neck residual or the patency of vessels after clipping of each single aneurysm were recorded and correlated with post-operative CTA and/or DSA.  Post-operative imaging studies revealed no incomplete occlusions of aneurysm domes.  Unexpected neck residuals were observed in 14 aneurysms (6 %).  There were no parent artery occlusions.  Unexpected branch occlusions including both major and minor branching arteries were observed in 15 aneurysms (6 %).  The authors concluded that ICGA is a simple and fast method of blood flow assessment with acceptable reliability.  Indocyanine green videoangiography can provide real-time information to assess blood flow in vessels of different size as well as the occlusion of the aneurysm.  Intra-operative assessment of blood flow in the perforating branches is one of the most important advantages.  In selected cases such as giant, complex, and deep-sited aneurysms or when the quality of image in ICGA is not adequate, other methods of intra-operative blood flow assessment should be considered.

Wang et al (2009) assessed the effects of surgical microscope-based ICGA in aneurysm surgery and compared the values of ICGA and post-operative DSA.  A total of 101 patients with intracranial aneurysm underwent clipping of 113 aneurysms.  A microscope-integrated light source containing infrared excitation light illuminated the operating field.  The dye ICG was injected intravenously, and the intravascular fluorescence was recorded by a video camera attached to the microscope with optical filtering to block ambient and laser light for collection of only ICG-induced fluorescence.  All patients underwent DSA 6-13 days post-operatively.  The results of patency of parent, branching, and perforating arteries and documentation of aneurysm obliteration shown by ICGA and DSA were compared.  A total of 219 times of ICGA was performed in these 101 patients with excellent image quality and resolution, allowing intra-operative real-time assessment of the cerebral circulation.  The ICG angiographic results could be divided into arterial, capillary, and venous phases, comparable to those observed with DSA.  In all cases, the post-operative angiographic results corresponded to the intra-operative ICG video angiographic findings.  In 3 cases, the information provided by intra-operative ICGA significantly changed the surgical procedure.  The authors concluded that simple and repeatable, microscope-based ICGA provides real-time information about vessels and aneurysm sac.  This technique may be useful during routine aneurysm surgery as an adjunct to intra-operative microvascular Doppler ultrasonography and DSA.

Li et al (2009) assessed the clinical value of ICG in intracranial aneurysm surgery by comparing the findings with post-operative angiographic results.  A total of 120 patients with 148 intracranial aneurysms were included.  Indocyanine green angiography was performed before and/or after the aneurysm clipping.  A near-infrared excitation light illuminated the operation field, ICG was injected intravenously.  The intravenous fluorescence was imaged with a video camera integrated into the microscope.  A total of 208 investigations of ICGA were performed.  Aneurysm clipping was applied in 120 patients.  Incomplete clipping was detected in 4 patients.  Parent and/or branching artery stenosis was found in 5 patients.  Delayed perfusion of ICG was detected in 1 patient.  Post-operative DSA was performed in 108 patients.  The post-operative angiographic results were consistent with findings on intra-operative ICG angiograms in 100 patients (92.6 %).  In 3 cases, a mild stenosis was seen on DSA, which was not detected intra-operatively using ICG angiogram.  In 1 patient, middle cerebral artery stenosis was found.  Three patients had small residual aneurysms found by post-operative DSA.  The remaining 1 developed a severe cerebral vasospasm.  The authors concluded that ICGA is a simple, reliable and cost-effective method.  It provides real-time information in detecting the patency of parent, branching, perforating arteries and residual aneurysm.  This technique may be a useful adjunct to improve the quality of intracranial aneurysm surgery.

Ma et al (2009) illustrated the use of intra-operative ICGA in the surgical management of intracranial aneurysms, including microsurgical clipping and re-vascularization.  This study included a series of 45 patients who were surgically treated between June 2007 and May 2008 for intracranial aneurysms; 43 had anterior circulation aneurysms, and 2 had posterior circulation aneurysms.  Forty-one patients were treated with microsurgical clipping; and 4 patients underwent re-vascularization combined with aneurysm dissection or trapping.  Intra-operative ICGA was used to visualize the aneurysm clipping, patency of parent artery or graft.  The ICGA technique was described, with particular reference to evaluation of the aneurysm clipping and re-vascularization.  A total of 89 ICGA procedures were performed in 45 patients with intracranial aneurysms.  The aneurysms were completely obliterated for all patients, and the grafts were patented for all except 1 patient.  Pre-clipping ICGA showed the relationship of aneurysm and its parent artery clearly.  After aneurysms being clipped, intra-operative ICGA found remnant of aneurysms, stenosis or occlusion of parent arteries and grafts in 8 cases, which were revised in the same surgical procedure.  The results of ICGA correlated well with post-operative DSA in 97 % patients.  The authors concluded that ICGA can provide real-time information and guide revision in the same surgical procedure for the management of intracranial aneurysms.

Hanel and colleagues (2010) stated that identification and complete interruption of fistulae are essential but not always obvious during the surgical treatment of spinal dural arteriovenous fistulae (dAVFs).  These researchers examined cases in which they identified and confirmed surgical obliteration of a spinal dAVF with the aid of microscope-integrated near-infrared ICGA, which was performed during 6 surgical interventions in which 6 intra-dural dorsal AVFs (type I) were interrupted.  An operating microscope-integrated light source containing infrared excitation light illuminated the operating field and was used to visualize an intravenous bolus of ICG.  The locations of fistulae, feeding arteries, and draining veins and documentation of occlusion of the fistulae were compared with findings on pre-operative and post-operative digital subtraction angiography.  Indocyanine green videoangiography identified the fistulous point(s), feeding arteries, and draining veins in all 6 cases, as confirmed by immediate post-operative selective spinal angiography.  In 1 case, intra-operative ICG ruled out an additional questionable fistula at a contiguous level suspected on the pre-operative angiography.  The authors concluded that microscope-based ICGA is simple and provides real-time information about the precise location of spinal dAVFs.  During spinal dAVF surgery, this technique can be useful as an independent form of angiography or as an adjunct to intra- or post-operative digital subtraction angiography.  They stated that larger series are needed to determine whether use of this modality could reduce the need for immediate post-operative spinal angiography after obliteration of intra-dural dorsal AVFs.

Polom et al (2011) stated that ever since Kitai first performed fluorescent navigation of sentinel lymph nodes (SLNs) using ICG dye with a charge-couple device and light emitting diodes, the intra-operative use of near infrared fluorescence has served a critical role in increasing the understanding in various fields of surgical oncology.  These investigators reviewed the emerging role of the ICG fluorophore and its use in SLN mapping and biopsy in various cancers.  In addition, they introduced the novel role of ICG-guided video angiography as a new intra-operative method of assessing microvascular circulation.  The authors discussed the promising potential in addition to assessing several challenges and limitations in the context of specific surgical procedures and ICG as a whole.  PubMed and Medline literature databases were searched for ICG use in clinical surgical settings.  Despite ICG's significant impact in various fields of surgical oncology, ICG is still in its nascent stages, and more in-depth studies need to be carried out to fully evaluate its potential and limitations.

Braun et al (2013) noted that patients requiring lower extremity re-vascularization are increasingly complex.  Traditional means of evaluating perfusion before and after re-vascularization are often limited by the presence of medial calcinosis, open wounds, prior toe or fore-foot amputations, and infection.  These researchers evaluated the initial application of ICGA to patients with severe lower extremity ischemia to develop quantitative, reproducible parameters to assess perfusion.  Indocyanine green angiography uses a charge-coupled device camera, a laser, and intravenous contrast to visually assess skin surface perfusion.  From January 2011 to April 2012, they performed ICGA within 5 days of 31 re-vascularization procedures in patients with Rutherford class 5 and 6 ischemia.  They also compared ICGA before and after re-vascularization in a subset of 13 patients.  These researchers evaluated multiple, quantitative parameters to assess perfusion.  A total of 24 patients underwent ICGA associated with 31 re-vascularization procedures (26 endovascular, 4 open, 1 hybrid) for 26 lower limb wounds; 92 % were diabetic and 20 % were dialysis-dependent.  In 50 % of these patients, it was not possible to measure ankle-brachial indexes due to medial calcinosis.  Paired analysis of ingress (increase in pixel strength [PxS]), ingress rate (slope of increase in PxS), curve integral (area under the curve in PxS over time), end intensity (PxS at end of study), egress (decrease in PxS from maximum), and egress rate (slope of decrease in PxS) increased significantly (p < 0.05) after re-vascularization.  The authors concluded that ICGA provides rapid visual and quantitative information about regional foot perfusion.  They believed this is the first report describing quantification of foot perfusion before and after lower extremity re-vascularization for severe limb ischemia.  Moreover, they stated that further study is needed to help define the utility of this intriguing new technology to assess perfusion, response to re-vascularization, and potentially, to predict likelihood of wound healing.

The Spy Elite System (LifeCell Corp., Branchburg, NJ) is designed to aid surgeons in identifying and attaching viable tissue during breast reconstruction surgery.  The Spy Elite System (using near-infrared light technology) enables surgeons performing breast reconstruction to capture images while in the operating room and allow them to objectively evaluate the quality of blood flow in vessels and tissue.  In this regard, the Spy Elite System gives the surgeon real-time confirmation that perfusion of blood to the flap is adequate.  Inadequate blood flow into or out of the flap could potentially result in partial or total loss of the flap.  The blood flow pattern to the breast skin will be monitored by means of ICGA; the dye highlights areas of tissue with a healthy blood supply, while those areas where circulation is less robust remain darker.  Seeing these differences enables surgeons to ascertain which tissue is healthiest and also to evaluate circulation following the procedure.

Newman and associates (2010) stated that skin-sparing mastectomy has been associated with flap ischemia and necrosis.  Current clinical methods for assessment of flap viability following mastectomy are largely subjective and lack objective data to guide intra-operative decisions.  Intra-operative laser-assisted ICGA (LA-ICGA) was performed on 20 skin sparing mastectomy flaps; L A-ICGA data were retrospectively compared with clinical outcome.  Pre-operative, intra-operative, and post-operative digital photographs along with clinical course were evaluated in an effort to identify potential complications.  Laser-assisted-ICGA was performed on 20 breasts in 12 patients.  Eleven breasts (55 %) demonstrated no wound-healing issues.  Nine breasts (45 %) experienced wound-healing issues, which were stratified as follows: 1 (5 %) mild, 1 (5 %) moderate, and 7 (35 %) severe.  Of these 7 severe wound-healing issues, 5 (25 %) required debridement and 2 (10 %) required complete removal of the prosthetic device.  Retrospective analysis demonstrated a 95 % correlation between intra-operative imaging and clinical course with 100 % sensitivity and 91 % specificity.  There was a false-positive rate of 9 %.  This series suggested LA-ICGA is a useful adjunct to determine mastectomy flap viability.  The authors stated that further quantitative advances in this technology may provide objective numerical thresholds to guide intra-operative mastectomy flap debridement when indicated.

Liu et al (2011) noted that in flap reconstruction of complex defects the perfusion of the reconstructive flap is critical to the ultimate success of the reconstruction.  This is especially true in perforator-based flaps where it can be difficult to assess the adequacy of perfusion in the operating room.  However, the ability to definitively determine the degree of flap perfusion is imperative to clinical decision-making.  The authors stated that an emerging technology using near-infrared angiography with ICG dye may significantly improve the immediacy and accuracy of the assessment of flap perfusion.

Phillips et al (2012) noted that intra-operative vascular imaging can assist assessment of mastectomy skin flap perfusion to predict areas of necrosis.  No head-to-head study has compared modalities such as LA-ICGA and fluorescein dye angiography with clinical assessment.  The authors conducted a prospective clinical trial of tissue expander-implant breast reconstruction with intra-operative evaluation of mastectomy skin flaps by clinical assessment, LA-ICGA, and fluorescein dye angiography.  Intra-operatively predicted regions of necrosis were photographically documented, and clinical assessment guided excision.  Post-operative necrosis was directly compared with each prediction.  The primary outcome was all-inclusive skin necrosis.  A total of 51 tissue expander-implant breast reconstructions (32 patients) were completed, with 21 cases of all-inclusive necrosis (41.2 %).  Laser-assisted ICGA and fluorescein dye angiography correctly predicted necrosis in 19 of 21 of cases where clinical judgment had failed.  Only 6 of 21 cases were full-thickness necrosis, and 5 of 21 required an intervention (9.8 %).  Risk factors such as smoking, obesity, and breast weight greater than 1,000 g were statistically significant.  Laser-assisted ICGA and fluorescein dye angiography over-predicted areas of necrosis by 72 % and 88 % (p = 0.002).  Quantitative analysis for LA-ICGA in necrotic regions showed absolute perfusion units less than 3.7, with 90 % sensitivity and 100 % specificity.  The authors concluded that LA-ICGA is a better predictor of mastectomy skin flap necrosis than fluorescein dye angiography and clinical judgment.  They stated that both methods over-predict without quantitative analysis; LA-ICGA is more specific and correlates better with the criterion standard diagnosis of necrosis.

Sood and Glat (2013) evaluated the use of intra-operative laser angiography using the Spy Elite System for the assessment of perfusion in mastectomy flaps for immediate breast reconstruction.  The Spy Elite System uses the contrast ICG, which has an excellent safety profile and pharmacokinetics that allow for repeat evaluations during the same surgical procedure.  In recent work, the Spy Elite System has demonstrated high sensitivity and specificity for detection of tissues at risk for ischemia and necrosis during reconstructive surgery.  Using a retrospective, chart-review design, the authors compared consecutive cases of immediate breast reconstruction using a prosthesis, before and after implementation of the Spy Elite System.  A total of 91 subjects were included in the analysis: 52 prior to Spy (Pre-Spy) and 39 after implementation of Spy (Post-Spy).  Baseline characteristics were similar between the groups.  Both groups had high rates of co-morbidities, chemotherapy, and radiation therapy.  The rate of post-operative complications was 2-fold higher in the Pre-Spy group compared to the Post-Spy group (36.5 % versus 17.9 %); this difference was of borderline significance (p = 0.0631).  However, mean number of repeat visits to the OR per patient was significantly higher in the Pre-Spy group (1.21 ± 1.47 versus 0.41 ± 0.71; p = 0.0023).  Of the 7 patients with complications in the Post-Spy group, 5 were identified by the Spy Elite System as having poor flap perfusion; none was identified by clinical judgment alone.  The authors concluded that the findings of this study suggested that the Spy Elite System can contribute to reduced ischemia-related complications in a population of women undergoing immediate breast reconstruction following mastectomy for breast cancer.

Wu and colleagues (2013) stated that LA-ICGA has been promoted to assess perfusion of random skin, pedicled, and free flaps.  Few studies address its potential limitations.  In this study, a total of 37 patients who underwent reconstructive procedures with LA-ICGA were studied retrospectively to determine the correlation between clinical findings and LA-ICGA.  Indocyanine green angiography under-estimated perfusion when areas of less than or equal to 25 % uptake were not debrided and remained perfused.  Indocyanine green angiography over-estimated perfusion when areas with greater than 25 % uptake developed necrosis.  Of 14 random skin flaps, LA-ICGA under-estimated perfusion in 14 % and over-estimated in 14 %.  In 16 patients undergoing perforator flap breast reconstruction, LA-ICGA correlated with computed tomographic angiogram (CTA) in 85 %.  Indocyanine green angiography under-estimated perfusion in 7 % and over-estimated in 7 %.  In 8/11 patients undergoing fasciocutaneous flaps, LA-ICGA aided in donor site selection.  In 3/6 ALT flaps, a better unilateral blush was found that correlated with Doppler.  In all 3, a dominant perforator was found.  In 11 patients, there was a 9 % under-estimation of flap perfusion.  In 3 pedicled flaps, there was a 66 % under-estimation and 33 % over-estimation of perfusion.  The authors concluded that ICGA often confirmed the clinical/radiologic findings in abdominal perforator and fasciocutaneous flaps.  It tended to under-estimate perfusion in pedicle and skin flaps.  When clinical examination was obvious, LA-ICGA rendered clear-cut findings.  When clinical examination was equivocal, LA-ICGA tended to provide ambiguous findings, demonstrating that a distinct cut-off point does not exists for every patient or flap.  They stated that ICGA is a promising but expensive technology that would benefit from standardization.  They noted that further research is needed before LA-ICGA can become a reliable tool for surgeons.

Griffiths et al (2016) stated that fluorescent angiography (FA) has been useful for assessing blood flow and assessing tissue perfusion in ophthalmology and other surgical disciplines for decades.  In plastic surgery, indocyanine green (ICG) dye-based FA is a relatively novel imaging technology with high potential in various applications.  These investigators reviewed the various FA detector systems currently available and critically appraise its utility in breast reconstruction.  They performed a review of the published English literature dating from 1950 to 2015 using databases, such as PubMed, Medline, Web of Science, and Embase.  In comparison to the old fluorescein dye, ICG has a superior side effect profile and can be accurately detected by various commercial devices, such as SPY Elite (Novadaq, Canada), FLARE (Curadel LLC, USA), PDE-Neo (Hamamatsu Photonics, Japan), Fluobeam 800 (Fluoptics, France), and IC-View (Pulsion Medical Systems AG, Germany).  In breast reconstruction, ICG has established as a safer, more accurate tracer agent, in lieu of the traditional blue dyes, for detection of sentinel lymph nodes with radioactive isotopes ((99m)-Technetium).  In prosthesis-based breast reconstruction, intraoperative assessment of the mastectomy skin flap to guide excision of hypo-perfused areas translates to improved clinical outcomes.  Similarly, in autologous breast reconstructions, FA can be utilized to detect poorly perfused areas of the free flap, evaluate microvascular anastomosis for patency, and assess SIEA vascular territory for use as an alternative free flap with minimal donor site morbidity.  The authors concluded that ICG-based FA is a novel, useful tool for various applications in breast reconstruction.  However, they stated that more studies with higher level of evidence are currently lacking to validate this technology.

Robertson et al (2017) noted that ICG contrast agent has shown some encouraging results in the intraoperative assessment of mastectomy flap perfusion and prediction of subsequent flap necrosis.  A large case series from Emory University has looked specifically at ICGA in predicting mastectomy skin flap necrosis (MSFN) in a prospective cohort of 118 patients undergoing skin-sparing mastectomy (SSM) and breast reconstruction.  In all, 14 patients experienced post-operative skin flap necrosis.  Skin with less than or equal to 25 % perfusion was not viable 90 % of the time, while areas with greater than or equal to 45 % perfusion survived 98 % of the time.  This may be a useful adjunct to the prediction and avoidance of MSFN.  Intraoperative indocyanine laser perfusion assessment tools, such as the SPY system (LifeCell Corp., Branchburg, NJ), have been used to identify mastectomy skin flaps at risk of subsequent ischemia and necrosis.  Indocyanine green was used to evaluate mastectomy flap perfusion in 39 patients undergoing mastectomy and immediate breast reconstruction with a prosthesis, and this was compared to 52 patients in the pre-SPY era.  The post-operative complication rate in this retrospective study was reported as 2-fold higher in the pre-SPY group, but this did not reach statistical significance (p = 0.06).  However, the number of repeat visits to theater was significantly higher in the pre-SPY era; 5 of the 7 patients with complications in the post-SPY group were identified by SPY as having poor flap perfusion, but none was identified with clinical judgment alone.  The main drawbacks of this study were its small size and retrospective non-randomized design, but it still suggested that the SPY system may be able to contribute peri-operatively to the identification of tissue at risk of ischemia and necrosis.  Indocyanine green has also been used to describe specific nipple-areolar complex [NAC] perfusion patterns and may be a helpful adjunct in evaluating higher risk perfusion patterns in nipple-sparing mastectomy (NSM) to try and avoid ischemic complications

Munabi and colleagues (2014) stated that mastectomy skin flap ischemia leading to necrosis is a common occurrence.  Laser-assisted ICGA can aid in locating these poorly perfused areas intra-operatively.  In a prospective study, these researchers identified specific perfusion values produced by ICGA that accurately predicted mastectomy flap necrosis.  A total of 42 patients undergoing autologous or implant-based breast reconstruction had mastectomy flaps imaged using laser-assisted ICGA at the completion of reconstruction.  Intra-operative perfusion values were correlated with post-operative skin flap outcomes.  Risk factors for abnormal perfusion were recorded and analyzed.  A total of 62 breast reconstructions were imaged, including 48 tissue expander reconstructions, 6 transverse rectus abdominis myocutaneous (TRAM) flaps, 6 deep inferior epigastric perforator (DIEP) flaps and 2 direct-to-implant reconstructions; 8 cases (13 %) of full-thickness skin necrosis were identified post-operatively.  A SPY Elite value of less than or equal to 7 accurately predicted the development of flap necrosis at 88 % sensitivity and 83 % specificity.  False-positive cases (those with perfusion values less than or equal to 7 that did not develop necrosis) were more likely to have a smoking history and/or to have had an epinephrine-containing tumescent solution used during mastectomy.  Excluding patients with smoking or epinephrine use, a SPY value of less than or equal to 7 predicted flap necrosis with a sensitivity of 83 % and specificity of 97 %.  The authors concluded that the findings of this trial suggested that laser-assisted ICGA predicted post-operative outcomes with high accuracy.  In this series, a SPY value of less than or equal to 7 correlated well with mastectomy flap necrosis.  Furthermore, smoking and intra-operative injections containing epinephrine should be considered when evaluating low perfusion values as they could lead to false-positive test results.

Jeon and colleagues (2018) noted that accurate prediction of mastectomy skin flap viability is vital as necrosis causes significant morbidity, potentially compromising results and delaying oncological management.  Traditionally assessed by clinical judgement, a more objective evaluation can be provided using intra-operative imaging modalities.  In a systematic review, these investigators compared all intra-operative techniques for assessment of mastectomy flap viability.  A systematic literature review was performed using Medline and Embase databases.  Primary outcomes reported included specificity, sensitivity and predictive values of each test, and mean rates of mastectomy flap necrosis and re-operation; secondary outcomes included cost analysis.  Some 18 studies were included.  Designs were prospective cohort study (n = 8), retrospective case series (n = 4), prospective case series (n = 3), retrospective case-control study (n = 1), prospective pilot trial (n = 1) and cost analysis study (n = 1).  The studies compared ICGA (16 studies) and FA (3 studies) with clinical judgement.  Sensitivity and specificity were highest for ICGA (5 studies) ranging from 38 to 100 % and 68 to 91 %, respectively.  Both methods over-predicted necrosis.  Mean rates of flap necrosis and re-operation decreased with ICGA (7.9 and 5.5 %, respectively) and FA (3 and 0 %) compared with clinical judgement (19.4 and 12.9 %); 2  studies were designed to define numerical parameters corresponding to perfusion using intra-operative techniques; 2 studies performed a cost analysis for ICGA; 1 claimed a cost benefit and the other advocated its use in high-risk patients only.  The authors concluded that it has been suggested that intra-operative modalities should be used selectively for patients at high risk of mastectomy flap necrosis to facilitate cost‐effectiveness.  Patients with pigmentation or skin discoloration that poses a challenge for clinical judgement may also benefit from use of intra-operative imaging modalities.  Moreover, these researchers stated that currently intra-operative evaluation of mastectomy flaps using ICGA provides better predictive accuracy than FA and clinical judgement, leading to reduced rates of mastectomy flap necrosis.  However, owing to its tendency to over-predict areas of necrosis, leading to potential loss of viable tissue and a negative impact on reconstructive options, there is a need to establish reliable numerical thresholds to guide surgical resection.  Also, there is heterogeneity in current studies regarding the device and software being used, and a lack of consensus on whether absolute or relative perfusion should be used as the reference unit.  They stated that appropriately powered prospective studies should be performed to evaluate predictive accuracies using standardized operating protocols and patient inclusion and exclusion criteria.

Guidelines on breast reconstruction following prophylactic or therapeutic mastectomy for breast cancer from Alberta Health Services (2017) stated: "The success of immediate breast reconstruction hinges on the consistency and vascularity of the mastectomy flaps. Indocyanine green injection with near-infrared fluorescent imaging is helpful to determine intraoperatively whether the breast skin after mastectomy is sufficiently well perfused to accommodate an immediate reconstruction, or if debridement of poorly vascularized skin and/or delay of the reconstruction is advisable. A recent retrospective review comparing complication rates between immediate tissue expander-based reconstruction patients who underwent clinical assessment only (n=53) or ICG angiography (n=61) found the rates of severe flap necrosis to be significantly lower in the ICG patients (4.9% vs 8.9%, p = 0.02). Not only can ICG angiography reduce complications related to mastectomy skin necrosis, but also allow evaluation of ischemic portions of DIEP flaps to reduce partial flap necrosis."

d'Avella et al (2013) stated that maximal safe resection is the goal of correct surgical treatment of parasagittal meningiomas, and it is intimately related to the venous anatomy both near and directly involved by the tumor.  Indocyanine green videoangiography has already been advocated as an intra-operative resourceful technique in brain tumor surgery for the identification of vessels.  These researchers investigated the role of ICGV in surgery of parasagittal meningiomas occluding the superior sagittal sinus (SSS).  In this study, these investigators prospectively analyzed clinical, radiological and intra-operative findings of patients affected by parasagittal meningioma occluding the SSS, who underwent ICGA assisted-surgery.  Radiological diagnosis of complete SSS occlusion was pre-operatively established in all cases.  Indocyanine green videoangiography was performed before dural opening, before and during tumor resection, at the end of the procedure.  A total of 5 patients were included in this study.  In all cases, ICGV guided dural opening, tumor resection, and venous management.  The venous collateral pathway was easily identified and preserved in all cases.  Radical resection was achieved in 4 cases.  Surgery was uneventful in all cases.  The authors concluded that despite the small number of patients, the findings of this study showed that ICGA could play a crucial role in guiding surgery of parasagittal meningioma occluding the SSS.  Moreover, they stated that further studies are needed to define the role of this technique on functional and oncological outcome of these patients.

Della Puppa et al (2014) noted that there are no doubts about the role that ICGA can play in current vascular neurosurgery.  Conversely, in brain tumor surgery, and particularly in meningioma surgery, this role is still unclear.  Vein management is pivotal for approaching parasagittal meningiomas, because venous preservation is strictly connected to both extent of resection and clinical outcome.  These investigators presented the technical traits and the post-operative outcome of the application of ICGA in patients undergoing parasagittal meningioma surgery.  They retrospectively collected demographic, radiological, intraoperative, and follow-up data in 43 patients with parasagittal meningiomas who underwent surgery with the assistance of ICGA between October 2010 and July 2013.  Intra-operative ICGA findings at different stages (before dural opening, after dural opening, during resection, after resection) were reviewed.  Additional data on functional monitoring, temporary venous clipping, and flow measurements were also recorded.  The overall post-operative outcome was evaluated by assessing both the extent of resection and the clinical outcome data.  The ICGA studies were performed 125 times in 43 patients, providing helpful data for vein management and tumor resection in all stages of surgery.  In 16 % of meningiomas completely occluding the superior sagittal sinus, the ICGA data differed from radiological findings and changed the surgical approach.  In 20 % of cases the intra-operative ICGA findings directly guided the surgical strategy: venous sacrifice was necessary in 7 cases, without post-operative consequences; temporary clipping with neurophysiological monitoring proved to be predictive of safe venous sacrifice.  In 7 % of cases the ICGA data needed to be supplemented with flow measurements.  Simpson Grade I-II and Grade III resections were achieved in 86 % and 14 % of cases, respectively, with a 4.6 % rate of overall morbidity.  The authors concluded that this study showed that ICGA can assist the different stages of parasagittal meningiomas surgery, guiding the vein management and tumor resection strategies with a favorable final clinical outcome.  However, in the authors' experience the use of other complementary tools was mandatory in selected cases to preserve functional areas.  Moreover, they stated that further studies are needed to confirm that the application of ICGA in parasagittal meningioma surgery may improve the morbidity rate, as reported in this study.

Furthermore, UpToDate reviews on "Meningioma: Clinical presentation and diagnosis" (Park, 2015) and "Systemic treatment of recurrent meningioma" (Wen, 2015) do not mention ICG as a management tool.

Management of Diabetic Macular Edema

In a prospective, non-comparative, interventional case series, Kimura et al (2005) assessed the effectiveness of surgical removal of the ILM in diabetic cystoid macular edema (CME).  A total of 21 eyes of 18 consecutive patients with diabetic CME were included in this study.  Vitrectomy with separation of the posterior hyaloid and induction of posterior vitreous detachment had been performed previously on 9 eyes.  Pars plana vitrectomy for removal of the ILM was performed.  CME resolved in eyes that underwent initial vitrectomy and in those with long-standing (greater than 1 year) CME after previous vitrectomy.  Post-operative best-corrected visual acuity improved by greater than or equal to 2 lines of a Snellen equivalent in 14 eyes (67 %) (p < 0.01).  The mean foveal thickness (distance between the inner retinal surface and the retinal pigment epithelium) decreased from 553 microm to 221 microm at 4 weeks (p < 0.001).  No recurrences or deterioration of CME was observed during the entire follow-up period (mean, 17.8 months; range of 8 to 34 months).  These investigators concluded that surgical removal of the ILM might be an effective procedure for reducing CME in patients with diabetes.  They noted that a prospective, randomized, controlled study is needed to further evaluate the effectiveness of the procedure.

Ogura and colleagues (2015) evaluated the usefulness of ICGA to detect leaking spots and the effectiveness of ICGA-guided focal laser photocoagulation in eyes with diabetic macular edema (DME).  A total of 10 eyes (8 patients) with diffuse DME diagnosed using fluorescein angiography (FA) and refractory to a sub-Tenon injection of triamcinolone acetonide (STTA), grid laser photocoagulation, or both were enrolled.  Fluorescein angiography and ICGA were performed using the Heidelberg Retina Angiograph 2.  Hyper-fluorescent spots on early-phase FA and on early- and late-phase ICGA were super-imposed onto the macular thickness map measured by OCT and counted to calculate the spot density in the area with or without ME; ICGA-guided focal laser photocoagulation was carried out.  In 7 eyes, STTA was simultaneously performed.  The central macular thickness (CMT) and macular volume (MV) were measured by OCT.  On early-phase FA, 4.8 ± 2.3 and 2.3 ± 1.5 hyper-fluorescent spots/disk area were observed inside and outside the ME, respectively.  In contrast, the spot density was significantly decreased to 1.8 ± 0.9 inside the ME and was only 0.3 ± 0.4 outside the ME on late-phase ICGA (p < 0.01).  The mean follow-up period after ICGA-guided photocoagulation was 19.0 months.  The mean BCVA improved significantly from 0.77 ± 0.34 logarithm of the minimum angle of resolution at baseline to 0.52 ± 0.37 at the last visit (p < 0.01).  Both CMT and MV significantly decreased (p < 0.01).  Recurrence of DME was observed in 4 eyes: 3 eyes were treatable only with STTA and 1 required additional ICGA-guided laser photocoagulation.  The authors concluded that ICGA may be useful to detect leaking spots responsible for DME, enabling less invasive focal laser photocoagulation even in some of the eyes with diffuse DME.  The role of ICGA in the management of DME needs to be further investigated.

Mookiah et al (2015) stated that DME is caused by accumulation of extracellular fluid from hyper-permeable capillaries within the macula.  Diabetic macular edema is one of the leading causes of blindness among diabetes mellitus (DM) patients.  Early detection followed by laser photocoagulation can save the visual loss.  These investigators  discussed various imaging modalities including biomicroscopy, FA, OCT and color fundus photographs used for diagnosis of DME.  Various automated DME grading systems using retinal fundus images, associated retinal image processing techniques for fovea, exudate detection and segmentation were presented.  The authors also compared various imaging modalities and automated screening methods used for DME grading.  The reviewed literature indicated that FA and OCT identify DME related changes accurately; FA is an invasive method, which uses fluorescein dye, and OCT is an expensive imaging method compared to fundus photographs.  Moreover, using fundus images DME can be identified and automated.  The authors stated that DME grading algorithms can be implemented for tele-screening; fundus imaging based DME grading is more suitable and affordable method compared to biomicroscopy, FA, and OCT modalities; ICGA was not mentioned as a management tool.

Furthermore, an UpToDate review on "Diabetic retinopathy: Screening" (McCulloch, 2015) does not mention ICGA as a management tool.

Prediction of Wound Complications in Ventral Hernia Repair

Colavita et al (2016) noted that complex ventral hernia repair (VHR) is associated with a greater than 30 % wound complication rate.  Perfusion mapping using indocyanine green fluorescence angiography (ICG-FA) has been demonstrated to predict skin and soft tissue necrosis in many reconstructive procedures; however, it has yet to be evaluated in VHR.  Patients undergoing complex VHR involving component separation and/or extensive subcutaneous advancement flaps were included in a prospective, blinded study.  Patients with active infection were excluded.  Indocyanine green-FA was performed prior to incision and prior to closure, but the surgeon was not allowed to view it.  An additional blinded surgeon documented wound complications and evaluated post-operative photographs.  The operative ICG-FA was reviewed blinded, and investigators were then un-blinded to determine its ability to predict wound complications.  A total of 15 consecutive patients were enrolled with mean age of 56.1 years and average body mass index (BMI) of 34.9, of which 60 % were female.  Most (73.3 %) had prior hernia repairs (average of 1.8 prior repairs).  Mean defect area was 210.4 cm2, mean operative time was 206 mins, 66.6 % of patients underwent concomitant panniculectomy, and 40 % had component separation.  Mean follow-up was 7 months.  Two patients developed wound breakdown requiring re-operation, while 1 had significant fat necrosis and another a wound infection, requiring operative intervention; ICG-FA was objectively reviewed and predicted all 4 wound complications.  Of the 12 patients without complications, 1 had an area of low perfusion on ICG-FA.  This study found a sensitivity of 100 % and specificity of 90.9 % for predicting wound complications using ICG-FA.  The authors concluded that in complex VHR patients, subcutaneous perfusion mapping with ICG-FA is very sensitive and has the potential to reduce cost and improve patient quality of life by reducing wound complications and re-operation.  These preliminary findings need to be validated by well-designed studies.

Prediction of Post-Operative Thrombosis in the Internal Jugular Vein

Yoshimatsu et al (2015) noted that although rare, thrombosis does occur in the internal jugular vein (IJV), which often leads to detrimental results.  These researchers evaluated the feasibility of intra-operative ICGA for prediction of IJV thrombosis.  From December of 2013 to August of 2014, these investigators performed ICGA intra-operatively on patients who underwent free-flap reconstruction with head and neck cancer.  A total of 10 flaps from 8 of these patients were chosen where 1 pedicle artery of a flap was anastomosed to the superior thyroid artery in an end-to-end fashion, and 1 pedicle vein of the flap was anastomosed to the IJV in an end-to-side fashion.  For each case, the time it took for the dye to enter the pedicle artery and exit the pedicle vein into the IJV was measured in seconds (ICG time).  These data were compared in 2 groups: group 1, which showed signs of congestion post-operatively and group 2, which showed no signs of congestion.  Signs of congestions were defined as purple or blue flap color, rapid capillary refill, swollen flap, and brisk bleeding with dark blood after prick with 23-gauge needle.  Of the 10 flaps, 1 flap demonstrated signs of congestion post-operatively and was found with a thrombus in the IJV.  The ICG time in this case was significantly longer than the means of ICG time in flaps with no thrombosis (18 ± 0 seconds versus 6.0 ± 1.0).  The authors concluded that intra-operative ICGA may predict post-operative IJV thrombosis with accuracy.  The findings of this feasibility study need to be validated in well-designed studies.

Indocyanine Green fluorescence Tissue Angiography for Evaluation of the Anastomotic Leak/Perfusion During or after Esophagectomy

Karampinis and colleagues (2017) stated that optimal perfusion of the gastric conduit during esophagectomy is critical for the anastomotic healing since poor perfusion has been associated with increased morbidity due to anastomotic leaks.  Until recently surgical experience was the main tool to assess the perfusion of the anastomosis.  In a retrospective, case-control study, these researchers hypothesized that anastomoses located in the zone of optimal ICG perfusion of the gastric conduit ("optizone") have a reduced anastomotic leakage rate after esophagectomy.  Indocyanine green fluorescence tissue angiography was used to evaluate the anastomotic perfusion in 35 patients undergoing esophagectomy with gastric conduit reconstruction.  The transition point of the "optizone" to the mal-perfused area of the conduit was defined macroscopically and with the use of ICGA during the operation.  The anastomosis was performed in the optizone whenever possible.  The results of the ICG patients were retrospectively reviewed and compared with 55 patients previously operated without ICGA.  The visual assessment of the conduit perfusion concurred with the ICGA in 27 cases.  In 8 cases (22.8 %) the ICGA deviated from the visual aspect; 1 case of anastomotic leakage was observed in the group of patients in which the anastomosis could be performed in the optizone (1/33; 3 %) compared with 10 cases in the control group (18 %; p = 0.04).  In 2 cases these investigators had to perform the anastomosis in an area of compromised ICG perfusion.  Both patients developed an anastomotic leakage.  The authors concluded that ICG tissue angiography represented a feasible and reliable technical support in the evaluation of the anastomotic perfusion after esophagectomy.  In this retrospective analysis these researchers observed a significant decrease in anastomotic leakage rate when the anastomosis could be placed in the zone of good perfusion defined by ICG fluorescence.  Moreover, they stated that a prospective trial is needed in order to provide higher level evidence for the use of ICG fluorescence in reducing leakage rates after esophagectomy.

Schlottmann and Patti (2017) noted that anastomotic leakage is a determining factor of morbidity and mortality after an esophagectomy.  An adequate blood supply of the gastric conduit is vital to prevent this complication.  These investigators determined the feasibility and usefulness of ICG fluorescence imaging to evaluate the gastric conduit perfusion during an esophagectomy.  Patients with distal esophageal cancer or esophago-gastric junction cancer scheduled for esophagectomy were enrolled in this study.  After pulling up the gastric conduit into the chest and before performing the anastomosis, 5 mg of ICG was injected as a bolus.  Visual assessment of the blood supply of the gastric conduit was compared with the ICG fluorescence imaging pattern of perfusion.  A total of 5 patients were included in this study.  Hybrid Ivor-Lewis esophagectomy (laparoscopic abdomen and right thoracotomy) was performed in all cases.  In all patients, visual assessment of the perfusion of the stomach determined that the conduit was well perfused.  In 2 patients (40 %), ICG fluorescence showed an inadequate blood supply of the conduit's tip.  Resection of the de-vitalized portion of the conduit was performed in these 2 patients.  No anastomotic leaks were recorded, and all patients had an uneventful post-operative course.  The authors concluded that visual assessment of the gastric conduit may under-estimate perfusion and inadequate blood supply; ICG fluorescence imaging is a promising tool to determine the gastric conduit perfusion during an esophagectomy.  They stated that prospective studies with larger series are needed to confirm the usefulness of ICG fluorescence imaging during esophagectomy.

Evaluation of Anastomotic Perfusion in Colorectal Surgery

Ris and colleagues (2014) noted that anastomotic leakage is a devastating complication of colorectal surgery.  However, there is no technology indicative of in-situ perfusion of a laparoscopic colorectal anastomosis.  These researchers detailed the use of near-infrared (NIR) laparoscopy (PinPoint System, NOVADAQ, Canada) in association with fluorophore [ICG, 2.5 mg/ml] injection in 30 consecutive patients who underwent elective minimally invasive colorectal resection using the simultaneous appearance of the cecum or distal ileum as positive control.  The median (range) age of the patients was 64 (40 to 81) years with a median (range) BMI of 26.7 (20 to 35.5) kg/m(2); 24 patients had left-sided resections (including 6 low anterior resections) and 6 had right-sided resections.  Of the total, 25 operations were cancer resections and 5 were for benign disease [either diverticular strictures (n = 3) or Crohn's disease (n = 2)].  A high-quality intra-operative ICG angiogram was achieved in 29/30 patients.  After ICG injection, median (range) time to perfusion fluorescence was 35 (15 to 45) s.  Median (range) added time for the technique was 5 (3 to 9) mins.  Anastomotic perfusion was documented as satisfactory in every successful case and encouraged avoidance of defunctioning stomas in 3 patients with low anastomoses.  There were no post-operative anastomotic leaks.  The authors concluded that perfusion angiography of colorectal anastomosis at the time of their laparoscopic construction was feasible and readily achievable with minimal added intra-operative time.  They stated that further work is needed to determine optimum sensitivity and threshold levels for assessment of perfusion sufficiency, in particular with regard to anastomotic viability.

In a prospective, multi-center, open-label, single-arm, clinical trial, Jafari and associates (2015) examined the feasibility and utility of fluorescence angiography (FA) for intra-operative perfusion assessment during left-sided colectomy and anterior resection at 11 centers in the United States.  A total of 147 patients were enrolled, of whom 139 were eligible for analysis.  Diverticulitis (44 %), rectal cancer (25 %), and colon cancer (21 %) were the most prevalent indications for surgery.  The mean level of anastomosis was 10 ± 4 cm from the anal verge.  Splenic-flexure mobilization was performed in 81 % and high ligation of the inferior mesenteric artery in 61.9 % of patients.  There was a 99 % success rate for FA, and FA changed surgical plans in 11 (8 %) patients, with the majority of changes occurring at the time of transection of the proximal margin (7 %).  Overall morbidity rates were 17 %.  The anastomotic leak rate was 1.4 % (n = 2).  There were no anastomotic leaks in the 11 patients who had a change in surgical plan based on intra-operative perfusion assessment with FA.  The authors concluded that PinPoint was a safe and feasible tool for intra-operative assessment of tissue perfusion during colorectal resection.  There were no anastomotic leaks in patients in whom the anastomosis was revised based on inadequate perfusion with FA.  They stated that a randomized controlled clinical trial is planned to further evaluate the true clinical significance of this new technology compared with the more standard assessment of the proximal transection line.

This study had several drawbacks.  As a prospective single-arm study of moderate size, inherent biases exist; this study did not include an internal comparison group.  There was no standardization with regard to technique of operation and anastomosis or pre-operative or post-operative care.  Although total operative time was recorded, the total imaging time was not recorded.  Importantly, there was no standardization of the "standard of care" assessment of proximal bowel viability based on normal visual assessment or assessment of bleeding at the transection line.  Participants were a heterogeneous group undergoing low pelvic and relatively high-risk anastomoses.  This heterogeneous population and the sample size did not allow the authors to draw any specific conclusions regarding the consequence that patient characteristics may have on interpretation of data.

In a case-matched, retrospective study, Kin and co-workers (2015) examined if intra-operative angiography decreases colorectal anastomotic leaks.  The investigators found no significant difference in incidence of anastomotic leak in subjects managed with intra-operative fluorescence angiography compared to those managed without.  Patients who underwent colectomy or proctectomy with primary anastomoses were included; they were matched 1:1 with respect to sex, age, level of anastomosis, presence of a diverting loop ileostomy, and pre-operative pelvic radiation therapy.  The intra-operative use of FA to assess perfusion of the colon for anastomosis was studied.  Anastomotic leak within 60 days and whether FA changed surgical management were the main outcomes measured.  Case matching produced 173 pairs.  The groups were also comparable with respect to BMI, smoking status, diabetes mellitus, surgical indications, and type of resection.  In patients who had intra-operative FA, 7.5 % developed anastomotic leak, whereas 6.4 % of those without FA did (p value not significant).  Univariate analysis revealed that pre-operative pelvic radiation, more distal anastomosis, surgeon, and diverting loop ileostomy were positively associated with anastomotic leak.  Multivariate analysis demonstrated that level of anastomosis and surgeon were associated with leaks.  Poor perfusion of the proximal colon seen on FA led to additional colon resection before anastomosis in 5 % of patients who underwent intra-operative FA.  The authors concluded that the use of intra-operative FA to assess the perfusion of the colon conduit for anastomosis was not associated with colorectal anastomotic leak.  Perfusion was but one of multiple factors contributing to anastomotic leaks.  They stated that additional studies are needed to determine whether this technology is beneficial for colorectal surgery.  The main drawbacks of this study were its retrospective design with the use of historical control subjects, selection bias, and small sample size.

Keller and colleagues (2017) stated that ICG fluorescence imaging is a surgical tool with increasing applications in colorectal surgery.  This tool has received acceptance in various surgical disciplines as a potential method to enhance surgical field visualization, improve lymph node retrieval, and decrease the incidence of anastomotic leaks.  In colorectal surgery specifically, small studies have shown that intra-operative fluorescence imaging is a safe and feasible method to assess anastomotic perfusion, and its use might affect the incidence of anastomotic leaks.  Controlled trials are ongoing to validate these conclusions.  The number of new indications for ICG continues to increase, including innovative options for detecting and guiding management of colorectal metastasis to the liver.  These advances could offer great value for surgeons and patients, by improving the accuracy and outcomes of oncological resections.

In a systematic review on "ICG fluorescence-guided surgery in metastatic colorectal cancer", Liberale and associates (2017) concluded that ICG fluorescence-guided imaging is a promising  technique in the detection of small infra-clinic lymph node, hepatic, and peritoneal metastatic deposits that may allow better staging and more complete surgical resection with a potential prognostic benefit for patients.

van den Bos and co-workers (2018) determined the feasibility of near-infrared fluorescence (NIRF) angiography in anastomotic colorectal surgery and determined the effectiveness of the technique in improving imaging and quantification of vascularization, thereby aiding in decision-making as to where to establish the anastomosis.  A total of 10 studies were included; 8 of these studies made a statement about the ease of use.  In none of the studies complications due to the use of the technique occurred.  The technique changed the resection margin in 10.8 % of all NIRF cases.  The anastomotic leak rate was 3.5 % in the NIRF group and 7.4 % in the group with conventional imaging; 2 of the included studies used an objective quantification of the fluorescence signal and perfusion, using ROIs (Hamamatsu Photonics) and IC-Calc, respectively.  The authors concluded that although the feasibility of the technique appeared to be agreed on by all current research, large clinical trials are needed to further evaluate the added value of the technique.

Protyniak et al (2015) stated that the essentials for any bowel anastomosis are: adequate perfusion, tension free, accurate tissue apposition, and minimal local spillage.  Traditionally, perfusion is measured by assessing palpable pulses in the mesentery, active bleeding at cut edges, and lack of tissue discoloration.  However, subjective methods lack predictive accuracy for an anastomotic leak.  These researchers used intra-operative ICG-FA to objectively assess colon perfusion before a bowel anastomosis.  A total of 77 laparoscopic colorectal operations, between June 2013 and June 2014, were retrospectively reviewed.  The perfusion to the colon and ileum was clinically assessed, and then measured using the SPY Elite Imaging System.  The absolute value provided an objective number on a 0 to 256 gray-scale to represent differences in ICG fluorescence intensity.  The lowest absolute value was used in data analysis for each anastomosis (including small bowel) to represent the theoretical least perfused/weakest anastomotic area.  The lowest absolute value recorded was 20 in a patient who underwent a laparoscopic right hemi-colectomy for an adenoma, with no post-operative complications; 4 low anterior resection patients had additional segments of descending colon resected.  There was 1 mortality in a patient who underwent a laparoscopic right hemi-colectomy. The authors concluded that the findings of this study illustrated an initial experience with the SPY system in colorectal surgery.  They stated that the  SPY provided an objective, numerical value of bowel perfusion. However, they noted that the evidence is scant as to the significance of these numbers; and large-scale randomized controlled trials (RCTs) are needed to determine specific cut-off values correlated with surgical outcomes, specifically anastomotic leak rates.

James et al (2015) examined the literature on the use of FA in laparoscopic rectal surgery.  A PubMed search was undertaken using terms "fluorescence angiography" and "rectal surgery".  The search was expanded using the related articles function.  Studies were included if they used FA specifically for rectal surgery.  Outcomes of interest including anastomotic leak rate, change of operative strategy and time taken for FA were recorded.  A total of 11 papers detailing the use of FA in rectal surgery were outlined demonstrating that this technique may change operative strategy and lead to a reduction in anastomotic leak rate.  These investigators discussed assessment of colorectal blood supply using FA and how this technique holds great potential to detect insufficiently perfused bowel.  In so doing, the operator can adjust their operative strategy to mitigate these affects with the aim of reducing the complications of anastomotic leak and stenosis.  However, the authors concluded that there is a clear need for RCTs in order to determine this definitively.

Degett et al (2016) noted that anastomotic leakage following gastro-intestinal (GI) surgery remains a frequent and serious complication associated with a high morbidity and mortality.  Indocyanine green fluorescence angiography is a newly developed technique to measure perfusion intra-operatively.  These researchers systematically reviewed the literature concerning ICG-FA to assess perfusion during the construction of a primary GI anastomosis in order to predict anastomotic leakage.  The following 4 databases PubMed, Scopus, Embase, and Cochrane were independently searched by 2 authors.  Studies were included in the review if they assessed anastomotic perfusion intra-operatively with ICG-FA in order to predict anastomotic leakage in humans.  Of 790 screened papers, 14 studies were included in this review; 10 studies (n = 916) involved patients with colorectal anastomoses and 4 studies (n = 214) patients with esophageal anastomoses.  All the included studies were cohort studies.  Intra-operative ICG-FA assessment of colorectal anastomoses was associated with a reduced risk of anastomotic leakage (n = 23/693; 3.3 % (95 % CI: 1.97 to 4.63 %) compared with no ICG-FA assessment (n = 19/223; 8.5 %; 95 % CI: 4.8 to 12.2 %).  The anastomotic leakage rate in patients with esophageal anastomoses and intra-operative ICG-FA assessment was 14 % (n = 30/214).  None of the studies involving esophageal anastomoses had a control group without ICG-FA assessment.  The authors concluded that no RCTs have been published.  They stated that ICG-FA appeared to be a promising method to assess perfusion at the site intended for anastomosis.  However, there is insufficient evidence to determine that the method can reduce the leak rate.

Boni et al (2016) evaluated the feasibility and the usefulness of intra-operative assessment of vascular anastomotic perfusion in colorectal surgery using ICG-enhanced fluorescence.  Between May 2013 and October 2014, all anastomosis and resection margins in colorectal surgery were investigated using FA intra-operatively to evaluate colonic perfusion before and after completion of the anastomosis, both in right and left colectomies.  A total of 107 patients undergoing colorectal laparoscopic resections were enrolled: 40 right colectomies, 10 splenic flexure segmental resections, 35 left colectomies, and 22 anterior resections.  In 90 % of cases, the indication for surgery was cancer and high ligation of vessels was performed.  Based on the fluorescence intensity, the surgical team judged the distal part of the proximal bowel to be anastomosed insufficiently perfused in 4/107 patients (2 anterior, 1 sigmoid, and 1 segmental splenic flexure resections for cancer), and consequently, further proximal "re-resection" up to a "fluorescent" portion was performed.  None of these patients had a clinical leak.  The overall morbidity rate was 30 %; 1 patient undergoing right colectomy had an anastomotic leakage, apparently unrelated to ischemia; there were no clinical evident anastomotic leakages in colorectal resections including all low anterior resections.  The authors concluded that ICG-enhanced FA provided useful intra-operative information about the vascular perfusion during colorectal surgery and may lead to a change in the site of resection and/or anastomosis, possibly affecting the anastomotic leak rate.  Moreover, they stated that larger further randomized prospective trials are needed to validate this new technique.

Skrovina and colleagues (2016) stated that FA may lead to a decrease in the incidence of anastomotic dehiscence after colorectal resections.  In a retrospective study, these investigators carried out an uni-centric analysis of prospectively collected data from patients with resection of the sigmoid colon and rectum with primary anastomosis.  They examined the results of FA for evaluating anastomotic perfusion after resection of the sigmoid colon and rectum; assessed the incidence of necessary resection line re-positioning based on the quality of perfusion, and recorded any complications in anastomotic healing.  Of the 50 patients included in this analysis, 44 were indicated for resection for cancer of the sigmoid colon or rectum, while 6 patients had a benign disease; 29 patients underwent total meso-rectal excision with colo-anal mechanical or hand-sewn anastomosis and 21 underwent resection of the sigmoid colon or upper rectum with mechanical anastomosis.  Before construction of the anastomosis, assessment of perfusion of the anastomotic segments by near-infrared ICG fluorescence angoiography (NIR-ICG FA) was performed in all patients.  The quality of perfusion of the meso-colon and bowel wall and its impact on moving the resection line and complications of anastomotic healing 30 days post-operatively were all evaluated.  These researchers noted that the assessment of perfusion using FA was technically successful in all 50 patients.  In 5 cases (10 %) the resection line had to be moved for signs of poor perfusion of the bowel wall.  Post-operatively, healing of the anastomosis was complicated in 4 patients (8 %).  Dehiscence was recorded in 3 patients (10.3 %) with total meso-rectal excision and in 1 patient (4.8 %) after resection of the sigmoid colon and upper rectum.  The authors concluded that these findings indicated that FA may lead to a decrease in the incidence of anastomotic dehiscence after colorectal resections by mapping in detail the perfusion of the anastomosed segments.  This was a small (n = 50), retrospective study; its findings need to be validated by well-designed studies.

Mizrahi and associates (2018) stated that anastomotic leak (AL) after low anterior resection (LAR) for low rectal cancer is associated with increased morbidity, mortality, cost and cancer recurrence rates.  In a retrospective, single-surgeon, cohort study, these researchers evaluated the impact of FA on AL following LAR for low rectal cancer.  This trial was with a historical, consecutively sampled case matched control group.  The institution's prospectively maintained institutional review board (IRB)-approved database was queried for all patients who underwent a laparoscopic LAR for rectal neoplasia with a colorectal or colo-anal anastomosis of less than 5 cm from the anal verge between 2013 and 2016.  Patients were divided into 2 groups: patients in whom FA was employed (study group, 2015 to 2016) and those patients in whom it was not (control group, 2013 to 2015).  All patients were diverted with a loop ileostomy.  The primary outcome measured was the AL rate and the secondary outcome measured was change in surgical plan following FA.  A total of 60 patients were included in the study: 30 patients in the FA group and 30 patients in the control group.  Patients' demographics, the use of neoadjuvant chemo-radiation, tumor stage, and mean height of anastomosis were comparable between the study groups; FA led to a change in surgical plan in 4 patients (13.3 %), none of who suffered an AL; 2 patients in the control group had a clinically and radiologically confirmed AL, whereas there were no leaks in the FA group (6.7 % versus 0 %, p = 0.49).  The authors concluded that FA changed the surgical plan in 13.3 % of LAR's, potentially reducing the incidence of AL in these high-risk patients.

Ris and associates (2018) noted that decreasing anastomotic leak (AL) rates remain a major goal in colorectal surgery.  Assessing intra-operative perfusion by ICG with NIR visualization may aid in selection of intestinal transection level and subsequent anastomotic vascular sufficiency.  In a prospective, multi-center, phase-II clinical trial, these researchers examined the use of NIR-ICG imaging in colorectal surgery.  This study was of non-selected patients undergoing any elective colorectal operation with anastomosis over a 3-year interval in 3 tertiary hospitals.  A standard protocol was followed to assess NIR-ICG perfusion before and after anastomosis construction in comparison with standard operator visual assessment alone.  A total of 504 patients (median age of 64 years, 279 men) having surgery for neoplastic (n = 330) and benign (n = 174) pathology were studied.  Some 425 operations (85.3 %) were started laparoscopically, with a conversion rate of 5.9 %.  In all, 220 patients (43.7 %) underwent high anterior resection or reversal of Hartmann's operation, and 90 (17.9 %) low anterior resection; ICGA was achieved in every patient, with a median interval of 29 seconds to visualization of the signal after injection.  NIR-ICG assessment resulted in a change in the site of bowel division in 29 patients (5.8 %) with no subsequent leaks in these patients.  Leak rates were 2.4 % overall (12 of 504), 2.6 % for colorectal anastomoses and 3 % for low anterior resection.  When NIR-ICG imaging was used, the AL rates were lower than those in the participating centers from over 1,000 similar operations performed with identical technique but without NIR-ICG technology.  The authors concluded that routine NIR-ICG assessment in patients undergoing elective colorectal surgery was feasible; NIR-ICG use may change intra-operative decisions, which may lead to a reduction in AL rates.  The authors stated that the main drawbacks of this study were that it was not randomized and that it lacked a prospective case‐matched control group; thus, did not provide definitive proof of benefit.   These preliminary findings need to be validated by well-designed studies.

In a systematic review and meta-analysis, Blanco-Colino and Espin-Basany (2018) evaluated the efficacy of ICG fluorescence imaging in reducing the AL rate following colorectal surgery.  PubMed, Scopus, WOS, Google Scholar and Cochrane Library were searched up to January 2017 for studies comparing fluorescence imaging with standard care.  ClinicalTrials.gov register was searched for ongoing trials.  The primary outcome measure was AL rate with at least 1 month of follow-up.  ROBINS-I tool was used for quality assessment.  A meta-analysis with random-effects model was performed to calculate ORs from the original data.  A total of 1,302 patients from 5 non-randomized studies were included.  Fluorescence imaging significantly reduced the AL rate in patients undergoing surgery for colorectal cancer (OR 0.34; CI: 0.16 to 0.74; p = 0.006).  Low AL rates were shown in rectal cancer surgery (ICG 1.1 % versus non-ICG 6.1 %; p = 0.02).  There was no significant decrease in the AL rate when colorectal procedures for benign and malignant disease were combined.  To-date, there are no published RCTs on this subject, although 3 ongoing RCTs were identified.  The authors concluded that ICG fluorescence imaging appeared to reduce AL rates following colorectal surgery for cancer.  However, the inherent bias of the non-randomized studies included, and their differences in AL definition and diagnosis could have influenced results.  These researchers stated that large well-designed RCTs are needed to provide evidence for its routine use in colorectal surgery.

Shen and colleagues (2018) noted that AL is a life-threatening complication of colorectal surgery.  Recent studies showed that ICG-FA might be a method to prevent AL.  In a meta-analysis, these investigators examined if intra-operative ICG-FA could reduce the incidence of AL.  Potential relevant studies were identified from the following databases: PubMed, Embase, Web of Science, Cochrane Library, and China National Knowledge Infrastructure.  This meta-analysis included comparative studies investigating the association between ICG-FA and AL in patients undergoing surgery for colorectal cancer where the diagnosis of AL was confirmed by CT and the outcomes of the ICG group were compared with a control group; ICG was injected intravenously after the division of the mesentery and colon but before anastomosis.  The Newcastle-Ottawa Scale was used to assess methodologic quality of the studies; ORs and 95 % CIs were used to assess the association between ICG and AL.  In 4 studies with a total sample size of 1,177, comparing the number of ALs in the ICG and control groups, the ORs were 0.45 (95 % CI: 0.18 to 1.12), 0.30 (95 % CI: 0.03 to 2.98), 0.17 (95 % CI: 0.01 to 3.69), and 0.12 (95 % CI: 0.03 to 0.52).  The combined OR was 0.27 (95 % CI: 0.13 to 0.53).  The difference was statistically significant (p < 0.001), and there was no significant heterogeneity (p = 0.48; I = 0).  The authors concluded that the findings of this meta-analysis showed that ICG was associated with a lower rate of AL after colorectal resection.  Moreover, they stated that larger, multi-center, high-quality RCTs are needed to confirm the benefit of ICG-FA in this setting.  The main drawbacks of this study were that data could not be pooled because of the small number of studies; some differences between studies may influence the results.  Also, the pooled data were not randomized.

In a systematic review, Lauricella et al (2023) examined the data on the trans-anal application of ICG-FA for the intraluminal assessment of colorectal anastomosis.  These investigators carried out a literature search for studies published between 2011 and 2021 using PubMed and Cochrane databases, related to the use of ICG for the intraluminal assessment of colorectal anastomosis.  Original scientific manuscripts, review articles, meta-analyses, and case reports were considered eligible.  A total of 305 studies were identified.  After abstract screening for duplicates, 285 studies remained.  Of those, 271 were not related to the topic of interest, 4 were written in a language other than English, and 4 had incomplete data.  A total of 6 remained for the final analysis.  The intraluminal assessment of colorectal anastomosis with ICG-FA was feasible, safe, and may reduce the incidence of leaks.  The authors concluded that the intraluminal assessment of anastomotic perfusion via ICG-FA may be a novel, promising use of ICG technology.  Moreover, these researchers stated that further investigation is needed to support the use of this approach to reduce leak rates after colorectal surgery, and future RCTs are awaited.

Mapping of Sentinel Lymph Node in Cutaneous Melanoma

Korn et al (2014) noted that sentinel lymph node biopsy is the standard of care for intermediate-depth and high-risk thin melanomas.  Recently, ICG and near-infrared imaging have been used to aid in sentinel node biopsy.  These researchers determined the feasibility of sentinel lymph node biopsy with ICG SPY Elite navigation and evaluated the technique compared with the standard modalities.  A retrospective review of 90 consecutive cutaneous melanoma patients who underwent sentinel lymph node biopsy was performed.  Two cohorts were formed: group A, which had sentinel lymph node biopsy performed with blue dye and radioisotope; and group B, which had sentinel lymph node biopsy performed with radioisotope and ICG SPY Elite navigation.  The cohorts were compared to assess for differences in localization rates, sensitivity and specificity of sentinel node identification, and length of surgery.  The sentinel lymph node localization rate was 79.4 % using the blue dye method, 98.0 % using the ICG fluorescence method, and 97.8 %t using the radioisotope/hand-held gamma probe method.  Indocyanine green fluorescence detected more sentinel lymph nodes than the vital dye method alone (p = 0.020).  A trend toward a reduction in length of surgery was noted in the SPY Elite cohort.  The authors concluded that sentinel lymph node mapping and localization in cutaneous melanoma with the ICG SPY Elite navigation system was technically feasible and may offer several advantages over current modalities, including higher sensitivity and specificity, decreased number of lymph nodes sampled, decreased operative time, and potentially lower false-negative rates.  These preliminary findings from a feasibility study need to be validated by well-designed studies.

Intraoperative Flap Evaluation

Lohman and colleagues (2015) stated that over the last decade, micro-surgeons have used a greater variety of more complex flaps.  At the same time, micro-surgeons have also become more interested in technology, such as ICGA, dynamic infrared thermography (DIRT), and photo-spectrometry, for pre-operative planning and post-operative monitoring.  These technologies are now migrating into the operating room, and are used to optimize flap design and to identify areas of hypo-perfusion or problems with the anastomoses.  Although relatively more has been published about ICGA, information is generally lacking about the intra-operative role of these techniques.  These researchers performed a systematic analysis of articles discussing intra-operative ICGA, DIRT, and photo-spectrometry to better define the sensitivity, specificity, expected outcomes, and potential complications associated with these techniques.  For intra-operative ICGA, the sensitivity was 90.9 % (95 % CI: 77.5 to 100) and the accuracy was 98.6 % (95 % CI: 97.6 to 99.7).  The sensitivity of DIRT was 33 % (95 % CI: 11.3 to 64.6), the specificity was 100 % (95 % CI: 84.9 to 100), and the accuracy was 80 % (95 % CI: 71.2 to 89.7).  The sensitivity of intra-operative photo-spectrometry was 92 % (95 % CI: 72.4 to 98.6), the specificity was 100 % (95 % CI: 98.8 to 100), and the accuracy was also 100 % (95 % CI: 98.7 to 100).  The authors concluded that these technologies for intra-operative perfusion assessment have the potential to provide objective data that may improve decisions about flap design and the quality of microvascular anastomoses.  However, they stated that more work is needed to clearly document their value.

Monitoring of Foveo-Macular Vitelliform Dystrophy (Best Disease)

In a review on "Best disease" (also known as vitelliform macular dystrophy), Altaweel (2016) stated that "Fluorescein angiogram reveals blockage of choroidal fluorescence by the vitelliform lesion.  The angiogram is otherwise normal at this stage.  In the atrophic stage, a transmission defect is noted …  If a choroidal neovascular membrane develops, then a corresponding area of hyperfluorescence with leakage will be found in fluorescein or indocyanine green angiography".

Intra-Operative ICGA During Microsurgical Subinguinal Varicocelectomy

Shibata and colleagues (2015) stated that microsurgical subinguinal varicocelectomy is one of the best treatment modalities for varicoceles.  However, the difficulty in identifying testicular arteries that should be spared is a limitation of this technique.  In a pilot study, these researchers evaluated the effectiveness of intra-operative ICGA during microsurgical subinguinal varicocelectomy in 3 cases.  These investigators performed microsurgical subinguinal varicocelectomy using a surgical microscope for observing infrared fluorescence in patients with infertility or chronic pain associated with varicoceles.  After the exposure of the spermatic cord blood vessels, ICG was injected intravenously to identify and isolate the testicular artery.  Thereafter, the varicose veins were repeatedly ligated, while preserving a few lymphatic vessels and the spermatic duct.  The testicular artery could be clearly identified by ICGA and were able to separate under ICGA.  The preserved arteries were confirmed by ICGA at the end of microsurgical operation.; all the internal spermatic veins could be safely ligated while sparing the testicular arteries and lymphatic vessels.  The authors concluded that microsurgical subinguinal varicocelectomy using intra-operative ICGA facilitated safe and quick surgery by enabling the visualization of the spermatic cord blood vessels.  They stated that this was the first report to indicate the usefulness of vessel visualization by ICGA during microsurgical subinguinal varicocelectomy.

Indocyanine Green Angiography for Coronary Artery Bypass Graft Surgery

Takahashi and associates (2004) stated that off-pump coronary artery bypass grafting (CABG) has been rapidly increased, because of its less invasiveness with low complications.  However, graft patency rate highly depends on the operators' capability due to technical difficulties.  The SPY system, based on the fluorescence of ICG, is an innovative device that permits validation of graft patency intra-operatively.  Real time images of grafts are obtained with no need for catheterization, X-rays or iodine contrast medium.  High-quality images could be obtained in all 290 grafts of 72 off-pump CABG cases (mean of 4.0 grafts per patient).  Four anastomoses (1.4 %), including 2 proximal and 2 distal, were revised because of defects detected by SPY images.  In 1 case, the SPY system revealed no blood flow in a radial sequential graft, although transit-time flow meter measurements showed a diastolic dominant pattern.  SPY images provide critical information to surgeons to detect non-patent grafts, allowing them to be revised while the patient is still on the operating table.  The authors concluded that using the SPY system, technical failures could be completely resolved during surgery.  They stated that the use of the SPY system for intra-operative graft validation during off-pump CABG may become the gold standard for surgical management in the near future.

This technology had several drawbacks.  First, it did not provide an exact graft flow quantity measurement.  Quantitative graft flow measurement software is currently being investigated.  Second, the laser light source is of relatively low power to ensure safe clinical use.  However, this limited the penetration of the light through tissue to about 1 mm.  Thus, clear images could not be obtained when the coronary artery has a deep intra-myocardial location.  The pedicled conduits with significant amounts of overlying tissue were also less well visualized.  However, these investigators believed that full skeletonization of the arterial conduits is a very useful and important technique for complete arterial revascularization of all the coronary vascular regions.

Desai and colleagues (2006) noted that early CABG failures may be preventable if identified intra-operatively.  These researchers compared the diagnostic accuracy of 2 intra-operative graft assessment techniques -- transit-time ultrasound flow measurement and ICG fluorescent-dye graft angiography.  Patents undergoing isolated CABG with no contraindications for post-operative angiography were enrolled in the study.  Patients were randomly assigned to be evaluated with either ICG angiography (ICGA) and then transit-time ultrasonic flow measurement or transit-time flow then ICGA.  Patients underwent X-ray angiography on post-operative day 4.  The primary end-point of the trial was to determine the sensitivity and specificity of the 2 techniques versus reference standard X-ray angiography to detect graft occlusion or greater than 50 % stenosis in the graft or peri-anastomotic area.  Between February 2004 and March 2005, a total of 106 patients were enrolled and X-ray angiography was performed in 46 patients.  In total, 139 grafts were reviewed with all 3 techniques and 12 grafts (8.2 %) were demonstrated to have greater than 50 % stenosis or occlusion by the reference standard.  The sensitivity and specificity of ICGA to detect greater than 50 % stenosis or occlusion was 83.3 % and 100 %, respectively.  The sensitivity and specificity of transit-time ultrasonic flow measurement to detect greater than 50 % stenosis or occlusion was 25 % and 98.4 %, respectively.  The p value for the overall comparison of sensitivity and specificity between ICGA and transit-time flow ultrasonography was 0.011.  The difference between sensitivity for ICGA and transit-time flow measurement was 58 % with a 95 % confidence interval (CI) of 30 % to 86 %, p = 0.023.  The authors concluded that ICGA provided better diagnostic accuracy for detecting clinically significant graft errors than did transit-time ultrasound flow measurement.

In a "Letter to the Editor" regarding the afore-mentioned study by Desai et al, Kulik and colleagues (2007) stated that "We have identified limitations in their analysis and other logistical challenges that may constitute important barriers to the generalizability of their conclusions".

In a pilot study, Waseda and associates (2009) evaluated the intra-operative fluorescence imaging (IFI) system in the real-time assessment of graft patency during off-pump CABG.  Patients undergoing off-pump CABG received IFI analysis, intra-operative transit time flowmetry, and post-operative X-ray angiography.  In off-line IFI analysis, the graft washout was classified based on the number of heart beats required for ICG washout: fast washout less than or equal to 15 beats) and slow washout (greater than 15 beats).  A total of 507 grafts in 137 patients received IFI analysis.  Of all the IFI analyses, 379 (75 %) grafts were visualized clearly up to the distal anastomosis.  With regard to anastomosis location, anterior location was associated with a higher percentage of fully analyzable images (90 %).  More than 80 % of images were analyzable, irrespective of graft type; 6 grafts with acceptable transit time flowmetry results were diagnosed with graft failure by IFI, which required on-site graft revision.  All revised grafts' patency was confirmed by post-operative X-ray angiography.  Conversely, 21 grafts with unsatisfactory transit time flowmetry results demonstrated acceptable patency with IFI.  Graft revision was considered unnecessary in these grafts, and 20 grafts (95 %) were patent by post-operative X-ray angiography.  Compared with slow washout, fast washout was associated with a higher pre-operative ejection fraction, use of internal mammary artery grafts, and anterior anastomosis location.  The authors concluded that the IFI system enabled on-site assessment of graft patency, providing both morphologic and functional information.  They stated that this technique may help reduce procedure-related, early graft failures in off-pump bypass patients.

This study had several drawbacks.  First, this was a pilot study from a single-center experience, which potentially limited the generalizability of findings.  Second, this was not a randomized study and the decision to revise the grafts was based on IFI results.  Thus, these researchers were unable to calculate sensitivity and specificity of the IFI system.  Third, the results of the IFI system were only semi-quantitatively analyzed due to lack of brightness standardization.  Fourth, in this case-series, grafts were fully skeletonized for better visualization by the IFI system.  Incomplete skeletonization or pedicled conduits may interfere with image acquisition.

In an editorial that accompanied the afore-mentioned study by Waseda et al, Ward and colleagues (2009) stated that "Intraoperative fluorescence imaging uses the fluorescence properties of indocyanine green dye to image the newly constructed grafts and the native coronary circulation.  Indocyanine green may be administered via a central venous line or directly into the bypass graft (better image quality).  The maximum penetration of the laser beam is 1 to 2 mm of soft tissue.  Intraoperative fluorescence imaging has 3 important drawbacks: First, it requires direct illumination of the graft (potentially difficult on the back of the heart); second, the entire graft cannot be imaged in the same sequence by a single central venous injection; and third, it requires at least partial "skeletonization" of pedicled grafts and native coronary arteries to adequately visualize the distal anastomosis.  Because of these drawbacks, Waseda et al found that only 75 % of grafts were completely visualized.  Nine grafts that had been deemed to have acceptable flow by IFI were later found to be occluded by X-ray angiography (3.1 % false negative rate).  Although IFI appears to have an advantage over TTFM in sensitivity, it is also more cumbersome, time-consuming, and expensive … Waseda et al focus on the use of IFI technology in the specific circumstance of OP-CABG surgery.  They state, "the clinical benefits of OP-CABG are partly offset by a mildly higher rate of early graft occlusion".  In fact, several prospective randomized controlled trials and a meta-analysis suggest that grafts performed during OP-CABG have a significantly lower patency rate and have less complete revascularization than grafts constructed ON-CABG.  These results reflect the technical demands of OP-CABG procedures and may account for the surprising 27 % utilization of the intra-aortic balloon pump in the report by Waseda et al.  One group even suggested the need for informed consent if OP-CABG techniques are to be used.  Conversely, a recent publication asserts, "numerous retrospective as well as randomized prospective studies have demonstrated that OP-CABG is associated with decreased risk-adjusted morbidity and mortality compared with ON-CABG".  The disparate results described here may be explained by surgical technical ability and dedication to OP-CABG techniques.  However, the results quoted are not necessarily mutually exclusive.  To resolve the issue, we need long-term follow-up of graft patency and outcomes".

The Canadian Agency for Drugs and Technologies in Health’s guidelines on "Intraoperative assessment of coronary artery bypass grafts" (CADTH, 2011) noted that no evidence-based guidelines were identified regarding the intra-operative assessment of the integrity and patency of coronary artery bypass grafts.

The American College of Cardiology Foundation/American Heart Association guideline on "Coronary artery bypass graft surgery" (Hills et al, 2011) stated that "Over the past 20 years, the patency rate of all graft types has improved gradually, so that the present failure rate of LIMA grafts at 1 year is about 8 % and of SVGs roughly 20 %.  Many patients being referred for CABG nowadays have far advanced CAD, which is often diffuse and exhibits poor vessel runoff.  Technical issues at the time of surgery may influence graft patency, and intraoperative imaging may help to delineate technical from nontechnical issues.  Because coronary angiography is rarely available intraoperatively, other techniques have been developed to assess graft integrity at this time, most often the transit-time flow and intraoperative fluorescence imaging.  The transit-time flow is a quantitative volume-flow technique that cannot define the severity of graft stenosis or discriminate between the influence of the graft conduit and the coronary arteriolar bed on the mean graft flow.  Intraoperative fluorescence imaging, which is based on the fluorescent properties of indocyanine green, provides a "semiquantitative" assessment of graft patency with images that provide some details about the quality of coronary anastomoses.  Although both methods are valuable in assessing graft patency, neither is sufficiently sensitive or specific to allow identification of more subtle abnormalities.  It is hoped that such imaging may help to reduce the occurrence of technical errors".

Indocyanine Green Fluorescence Angiography for Intraoperative Evaluation of Residual Parathyroid Glands Function and Prediction of Post-Operative Hypocalcemia Risk after Total Thyroidectomy

Lavazza and co-workers (2016) stated that identification of the parathyroid glands during thyroid surgery may prevent their inadvertent surgical removal and thus provide a better post-operative quality of life (QOL).  Nevertheless, the most common "technique" for intra-operative evaluation of perfusion of parathyroid gland tissues during thyroid surgery is visual inspection of the physical condition of tissues, e.g., their color and bleeding edges.  Another technique is measurement of intact parathyroid hormone (PTH).  Recently, ICG-enhanced fluorescence has been used in various surgical techniques, particularly laparoscopic surgery, to improve visualization and to provide detailed anatomical information.  Fluorescent optical guidance helps surgeons to avoid inadvertent tissue injury while enhancing procedural efficiency.  The authors concluded that this technique has potential use for evaluating perfusion of the parathyroid gland in real-time intra-operative angiography.  Moreover, they stated that further large randomized prospective trials are needed to validate this new technique.  Primary end-points of future studies should include evaluation of the effectiveness of ICG-enhanced fluorescence for estimating parathyroid gland perfusion before wound closure and for identifying changes in the previously identified gland at the end of surgery.  Secondary end-points of future studies should include identification of potential technique-related failures or complications such as inability to record fluorescence, allergic or other adverse reaction to ICG injection, overall cost of the technique, and the incidence of postoperative hypocalcemia (PH).

Lang and associates (2017) stated that because the fluorescent light intensity on an indocyanine green fluorescence angiography (ICGFA) reflects the blood perfusion within a focused area, the fluorescent light intensity in the remaining in-situ parathyroid glands may predict post-operative hypocalcemia risk after total thyroidectomy.  A total of 70 patients underwent intra-operative ICGFA after total thyroidectomy.  Any parathyroid glands with a vascular pedicle was left in-situ while any parathyroid glands without pedicle or inadvertently removed was auto-transplanted.  After total thyroidectomy, an intravenous 2.5 mg ICGFA was given and real-time fluorescent images of the thyroid bed were recorded using the SPY imaging system.  The fluorescent light intensity of each ICGFA as well as the average and greatest fluorescent light intensity in each patient were calculated.  Post-operative hypocalcemia was defined as adjusted calcium of less than 2.00 mmol/L within 24 hours.  The fluorescent light intensity between discolored and normal-looking ICG fluorescence angiographies was similar (p = 0.479).  No patients with a greatest fluorescent light intensity greater than 150 % developed PH while 9 (81.8 %) patients with a greatest fluorescent light intensity less than or equal to 150 % did.  Similarly, no patients with an average fluorescent light intensity greater than 109 % developed PH while 9 (30 %) with an average fluorescent light intensity less than or equal to 109 % did.  The greatest fluorescent light intensity was more predictive than day-0 PH (p =0 .027) and % PTH drop day-0 to 1 (p < 0.001).  The authors concluded that ICGFA is a promising operative adjunct in determining residual parathyroid glands function and predicting PH risk after total thyroidectomy.

Jitpratoom and Anuwong (2017) noted that ICG-enhanced fluorescence imaging is recent innovation as the "real-time intraoperative imaging" technique.  Many clinical studies have been reported in the literature that use different devices and techniques that employ various doses and usages of ICG as a non-specific contrast agent.  Several groups have performed studies in endocrine surgery, especially with regards to parathyroid-related outcomes after thyroid and parathyroid surgery.  However, there is no consensus on the technical details that should be applied.  These investigators reviewed the current literature on potential use of intra-operative ICGA for evaluating parathyroid gland preservation.  The authors concluded that this study reviewed the current status of ICG-enhanced fluorescence imaging and parathyroid preservation in both thyroid and parathyroid surgery.  They stated that although there still are questions regarding its utility, current data suggested that a correlation does exist with regards to the relationship between parathyroid perfusion and post-operative parathyroid function.  They stated that additional studies are needed for the further validation of ICGA as an intra-operative tool in assessing real-time parathyroid preservation.

DeLong and colleagues (2018) evaluated the ease and utility of using ICGFA for intraoperative localization of the parathyroid glands; ICGFA was performed during 60 parathyroidectomies for primary hyperparathyroidism during a 22-month period.  Indocyanine green was administered intravenously to guide operative navigation using a commercially available fluorescence imaging system.  Video files were graded by 3 independent surgeons for strength of enhancement using an adapted numeric scoring system.  There were 46 (77 %) female patients and 14 (23 %) male patients whose ages ranged from 17 to 87 (average of 60) years old.  Of the 60 patients, 43 (71.6 %) showed strong enhancement, 13 (21.7 %) demonstrated mild-to-moderate vascular enhancement, and 4 (6.7 %) exhibited little or no vascular enhancement.  Of the 54 patients who had a pre-operative sestamibi scan, a parathyroid adenoma was identified in 36, while 18 failed to localize.  Of the 18 patients who failed to localize, all 18 patients (100 %) had an adenoma that fluoresced on ICG imaging.  The operations were performed safely with minimal blood loss and short operative times.  The authors concluded that ICG has the potential to assist surgeons in identifying parathyroid glands rapidly with minimal risk.

Sentinel Lymph Node Mapping for Cervical and Endometrial Cancer

Buda and co-workers (2016) compared the detection rate (DR) and bilateral optimal mapping (OM) of sentinel lymph nodes (SLNs) in women with endometrial and cervical cancer using ICG versus the standard technetium-99m radio-colloid ((99m)Tc) radiotracer plus methylene or isosulfan blue, or blue dye alone.  From October 2010 to May 2015, a total of 163 women with stage I endometrial or cervical cancer (118 endometrial and 45 cervical cancer) underwent SLN mapping with (99m)Tc with blue dye, blue dye alone, or ICG; DR and bilateral OM of ICG were compared respectively with the results obtained using the standard (99m)Tc radiotracer with blue dye, or blue dye alone.  SLN mapping with (99m)Tc radiotracer with blue dye was performed on 77 of 163 women, 38 with blue dye only and 48 with ICG.  The overall DR of SLN mapping was 97, 89, and 100 % for (99m)Tc with blue dye, blue dye alone, and ICG, respectively.  The bilateral OM rate for ICG was 85 % -- significantly higher than the 58 % obtained with (99m)Tc with blue dye (p = 0.003) and the 54 % for blue dye (p = 0.001); 31 women (19 %) had positive SLNs.  Sensitivity and negative predictive value (NPV) of SLN were 100 % for all techniques.  The authors concluded that SLNs mapping using ICG demonstrated higher DR compared to other modalities.  In addition, ICG was significantly superior to (99m)Tc with blue dye in terms of bilateral OM in women with early stage endometrial and cervical cancer.  The higher number of bilateral OM may consequently reduce the overall number of complete lymphadenectomies, reducing the duration and additional costs of surgical treatment.

Ruscito and colleagues (2016) noted that historically, blue dyes, (99)Tc or a combination of the 2 tracers have been used for SLN mapping in cervical and endometrial cancer patients; ICG has been recently introduced in this setting.  These investigators evaluated the differences in overall and bilateral detection rates as well as in false-negative rates (FNRs) among the different tracers.  The electronic databases PubMed, Medline, and Scopus were searched in January 2016 by searching the terms "sentinel lymph node" and "dye" and "indocyanine green", and "cervical cancer" or "endometrial cancer".  Series comparing different tracers injected intracervically and reporting the DR and/or SLN FNR were selected.  A total of 45 studies were retrieved; 6 studies including 538 patients met selection criteria.  Compared with blue dyes, ICG SLN mapping had higher overall (OR 0.27; 95 % CI: 0.15 to 0.50; p < 0.0001) and bilateral DRs (OR 0.27; 95 % CI: 0.19 to 0.40; p < 0.00001).  No differences were found between ICG and (99)TC, although these results were based on data of a single series.  No differences in overall and bilateral DRs were found between ICG and the combination of blue dyes and (99)TC.  The pooled analysis of FNRs data showed no difference in FNRs between tracers.  The authors concluded that in cervical and endometrial cancer, ICG SLN mapping appeared to be equivalent to the combination of blue dyes and (99)TC in terms of overall and bilateral DRs.  Its safety profile and ease of use may favor its employment respect to conventional tracers.

Soliman and associates (2017) discussed their prospective validation study of SLN mapping for high-risk endometrial cancer.  These researchers stated that SLN mapping continues to evolve in the surgical staging of endometrial cancer.  These investigators identified the sensitivity, FNR and FN predictive value (FNPV) of SLN compared to complete pelvic and para-aortic lymphadenectomy (LAD) in women with high-risk endometrial cancer.  Women with high-risk endometrial cancer (grade 3, serous, clear cell, carcinosarcoma) were enrolled in this prospective surgical trial.  All patients underwent pre-operative PET/CT and intra-operative SLN biopsy followed by LAD.  Patients with peritoneal disease on imaging or at the time of surgery were excluded.  Patients were evaluable if SLN was attempted and complete LAD was performed.  A total of 123 patients were enrolled between April 2013 and May 2016; 101 were evaluable.  At least 1 SLN was identified in 89 % (90); bilateral detection 58 %, unilateral pelvic 40 %, para-aortic only 2 %; ICG was used in 61 %, blue dye in 28 %, and blue dye and technetium in 11 %; 23 patients (23 %) had greater than or equal to 1 positive node.  In 20/23, greater than or equal to 1 SLN was identified and in 19/20 the SLN was positive.  Only 1 patient had bilateral negative SLN and positive non-SLNs on final pathology.  Overall, sensitivity of SLN was 95 % (19/20), FNR was 5 % (1/20) and FNPV was 1.4 % (1/71).  If side-specific LAD was performed when a SLN was not detected, the FNR decreased to 4.3 % (1/23).  The authors concluded that their trial demonstrated that SLN biopsy plus side-specific LAD, when SLN was not detected, was a reasonable alternative to a complete LAD in high-risk EC.

In a multi-center, retrospective, observational study, Di Martino and colleagues (2017) compared SLN mapping in women with cervical cancer stage greater than IB1 (tumor size greater than 2 cm) using ICG versus the standard technique using radioisotope Tc99m radiotracer with or without blue dye.  A total of 95 women with stage IB1 cervical cancer who underwent SLN mapping with Tc99m with or without blue dye or ICG and radical hysterectomy were included in this trial.  The DR and bilateral mapping rate were compared between ICG and standard Tc99m radiotracer with or without blue dye.  Lymphadenectomy was performed, and the FNR was assessed; 47 patients underwent SLN mapping with Tc99m with or without blue dye, and 48 did so with ICG.  All patients underwent radical hysterectomy with or without bilateral salpingo-oophorectomy between 2008 and 2016.  The overall DR of SLN mapping was 91.5 % for Tc99m with or without blue dye and 100 % for ICG.  A 91.7 % rate of bilateral migration was achieved for ICG, significantly higher than the 66 % obtained with Tc99m with or without blue dye (p = 0.025); 9 of the 23 SLN-positive patients (39.1 %) were diagnosed exclusively as a result of the ultra-staging used to identify micro-metastases or isolated tumor cells only.  The authors concluded that in advanced cervical cancer (stage IB1 greater than 2 cm), the DR and bilateral migration rate on real-time fluorescent SLN mapping were higher with ICG than with Tc99m radiotracer with or without blue dye.

Papadia and associates (2017) noted that SLN mapping in endometrial cancer is rapidly gaining acceptance in the clinical community.  As compared to a full lymphadenectomy in every patient, to a selective lymphadenectomy after frozen section of uterus in selected patients with intra-uterine risk factors or to a strategy in which a lymphadenectomy is always omitted, SLN mapping appeared to be a reasonable and oncologically safe middle ground.  Various protocols can be used when applying an SLN mapping.  These investigators reviewed the characteristics, toxicity and clinical impact of (Tc-99m, of the blue dyes (methylene blue, isosulfan blue and patent blue) and of ICG.  These researchers stated that ICG has an excellent toxicity profile, has higher overall and bilateral DRs as compared to blue dyes and higher bilateral DRs as compared to a combination of Tc-99m and blue dye.  The detrimental effect of BMI on the detection rates was attenuated when ICG was used as a tracer.  The authors concluded that the ease of use of the ICG SLN mapping was perceived by the patients as a better quality of care delivered.  The authors stated that whenever possible, ICG should be favored over the other tracers for SLN mapping in patients with endometrial cancer.

How and co-workers (2018) performed a systematic review of the literature to determine pooled estimates for SLN DR and diagnostic accuracy, while exploring impact of the SLN on adjuvant therapy and oncologic outcomes.  These researchers performed a systematic search utilizing Medline, Embase, and Web of Science electronic databases for all studies published in the English language until October 31, 2017.  Studies were included for review and potential aggregate analyses if they contained at least 30 endometrial cancer patients with undergoing SLN mapping and reported on detection rates (overall, bilateral or para-aortic) or diagnostic accuracy (sensitivity and NPV).  Pooled estimates were calculated via meta-analyses utilizing a random-effects model.  Studies reporting on the impact of SLN on adjuvant therapy, as well as studies comparing SLN mapping to completion lymphadenectomy were qualitatively reviewed and analyzed as well.  These investigators identified 48 eligible studies, which included 5,348 patients for review and inclusion in the meta-analysis for SLN detection or diagnostic accuracy.  The pooled SLN DRs were 87 % (95 % CI: 84 to 89 %, 44 studies) for overall detection, 61 % (95 % CI: 56 to 66 %, 36 studies) for bilateral detection, and 6 % (95 % CI: 3 to 9 %, 31 studies) for para-aortic detection.  The use of ICG improved overall (94 %, 95 % CI: 92 to 96 %, 19 studies) SLN DRs compared to blue tracer (86 %, 95 % CI: 83 to 89 %, 31 studies) or technetium-99 (86 %, 95 % CI: 83 to 89 %, 25 studies).  This trend was similarly observed in terms of bilateral DRs (74 % versus 59 % versus 57 %, respectively).  There was no difference in para-aortic SLN detection rate between each tracer.  The pooled estimates for diagnostic accuracy for 34 studies were 94 % (95 % CI: 91 to 96 %) for sensitivity and 100 % (95 % CI: 99 to 100 %) for NPV.  Diagnostic accuracy of SLN mapping was not negatively affected in patients with high-grade endometrial histology.  Patients with SLN mapping were more likely to receive adjuvant therapy and did not have inferior survival or recurrence outcomes compared to those undergoing completion lymphadenectomy.  The authors concluded that SLN mapping is a feasible and accurate alternative to stage patients with endometrial cancer.  Utilizing ICG resulted in the highest SLN DRs.

Furthermore, National Comprehensive Cancer Network (NCCN)’s clinical practice guideline on "Uterine neoplasms" (Version 2.2018) states that "Indocyanine green (ICG) recently emerged as a useful imaging dye that requires near-infrared camera for localization, provides a very high SLN detection rate, and is commonly used in many practices at the present time … Recent findings also suggest that ICG may be preferable to blue dyes.  Attention to detail and experience are critical to ensure optimal outcomes" .

Sentinel Lymph Node Mapping for Breast Cancer / Melanoma

Niebling and co-workers (2016) systematically reviewed different SLN biopsy (SLNB) techniques and performed a meta-analysis for corresponding identification and FNRs.  A systematic review of the literature on SLNB in patients with early stage breast carcinoma and melanoma was performed.  Only original study groups were included.  The SLN identification rate and FNR were pooled for patients with breast carcinoma or melanoma according to radio-colloid tracer, blue dye, ICG, or a combination of a radio-colloid tracer with blue dye or ICG.  Between 1992 and 2012, a total of 154 studies (88 breast carcinoma and 66 melanoma) were reported that met the eligibility criteria.  These studies included a total of 44,172 patients.  The pooled SLN identification rate in breast carcinoma and melanoma patients using solely blue dye was 85 % (range of 65 to 100 %) and 84 % (range of 59 to 100 %), while for radio-colloid alone it was 94 % (range of 67 to 100 %) and 99 % (range of 83 to 100 %), respectively.  Using a combination of radio-colloid and blue, identification rates were 95 % (range of 94 to 95 %) and 98 % (range of 98 to 98 %).  The authors concluded that the current meta-analysis provided data that favored the use of radio-colloid or radio-colloid combined with a blue dye for SLN identification.  Performing SLNB with radio-colloid alone was the technique of choice for experienced surgeons, since blue dye has multiple disadvantages.  Moreover, they stated that SLNB using ICG as a fluorescent dye appeared a promising technique for the near future.

Sugie and colleagues (2017) noted that SLN biopsy using ICG fluorescence is safe and has a high DR for SLNs.  However, the results of this novel technique are heterogeneous.  In a meta-analysis, these researchers evaluated the diagnostic performance of the ICG fluorescence method compared with the standard radioisotope (RI) method in early-stage breast cancer.  All eligible studies were identified from 2005 through 2015.  A proportion meta-analysis was performed using a fixed effects and/or random effects model based on the study heterogeneity.  A total of 12 studies met the inclusion criteria and included 1,736 women.  There was no significant difference between ICG fluorescence and RI for SLN detection using either the fixed effects model (OR 1.29, 95 % CI: 0.87 to 1.90) or the random effects model (OR 1.32, 95 % CI: 0.54 to 3.18).  There were 7 studies reporting the DR for tumor-positive SLN.  The ICG fluorescence method was significantly better than the RI method in the fixed effects model (OR 1.87, 95 % CI: 1.00 to 3.49) for staging axilla.  However, there was no difference in the random effects model (OR 1.90, 95 % CI: 0.74 to 4.86).  There was study outcome heterogeneity for the detection of SLN but not for tumor-positive SLN.  There was no publication bias observed in the studies included.  The authors concluded that the ICG fluorescence method has valid diagnostic performance for SLN detection and showed a trend toward better axilla staging compared with the RI method; ICG fluorescence is a useful alternative to RI for SLN biopsy.

Guo and associates (2017) stated that recent studies showed that near-infrared (NIR) fluorescence imaging using ICG has the potential to improve the performance of SLN mapping.  The current cohort study was designed to examine the value of the combination of ICG and methylene blue (MB) dye in breast cancer patients undergoing SLN biopsy.  Between 2010 and 2013, a total of 198 consecutive early breast cancer patients eligible for SLN biopsy were enrolled and 200 biopsy procedures were performed by injection of both ICG and MB.  SLNs were searched and removed under the guidance of fluorescence and/or blue dye.  The mapping characteristics, the DR of SLNs and positive SLNs, and the number of SLNs of ICG, MB, and ICG + MB were compared.  Injection safety of ICG and MB was evaluated.  Fluorescence imaging of lymphatic flow, which was helpful to locate the incision site, could be seen in 184 of 200 procedures.  The nodal detection rate of ICG, MB, and ICG + MB samples was 97, 89, and 99.5 % (χ 2 = 26.2, p < 0.001), respectively, with the combination method yielding a superior identification result.  The addition of ICG to the MB method resulted in the identification of more lymph nodes (median 3 versus 2) and more positive axillas (22.7 % involved axillas were discovered by fluorescence only) than either method alone.  No acute or chronic allergic reaction was observed in this study.  However, 23 patients (23/82) who received breast-conserving therapy reported temporary skin staining, and 5 patients had permanent tattooing.  Palpable subcutaneous nodules at the injection sites were reported in 9 patients.  There were no reports of skin necrosis.  The authors concluded that lymphatic navigation by ICG fluorescence detected SLNs at a high DR and improved the mapping performance when added to the MB method.  They stated that the novel ICG + MB dual tracing modality, without involvement of radioactive isotopes, exhibited great potential as an alternative to traditional standard mapping methods.

However, NCCN’s clinical practice guidelines on "Breast cancer" (Version 1.2018) and "Melanoma" (Version 2.2018) do not mention indocyanine green SLN mapping.

Sentinel Lymph Node Mapping for Colon Cancer

Chand and colleagues (2018) stated that in colon cancer, appropriate tumor excision and associated lymphadenectomy directly impact recurrence and survival outcomes.  Currently, there is no standard for mesenteric lymphadenectomy, with a lymph node yield of 12 acting as a surrogate quality marker.  In a pilot study, these researchers determined the safety and feasibility of ICG fluorescence imaging to demonstrate lymphatic drainage in colon cancer in a dose-escalation study.  A prospective study of colon cancer patients undergoing curative laparoscopic resection was performed.  At surgery, peri-tumoral sub-serosal ICG injection was done to demonstrate lymphatic drainage of the tumor.  A specialized fluorescence system excited the ICG and assessed lymphatics in real time.  The primary outcome was the feasibility of ICG fluorescent lymphangiography for lymphatic drainage in colon cancer; secondary outcomes were the optimal protocol for dose, injection site, and ICG lymphatic mapping timing.  A total of 10 consecutive patients were evaluated (6 men, mean age of 69.5 years).  In all, lymphatic channels were seen around the tumor to a varying extent; 8 (80 %) had drainage to the sentinel node.  In all cases where the lymphatic map was seen, there was no further spread 10 mins after injection.  In 2 patients (20 %), additional lymph nodes located outside of the proposed resection margins were demonstrated.  In both cases the resection was extended to include the nodes and in both patients these nodes were positive on histopathology. Factors contributing to reduced lymphatic visualization were inadequate ICG concentrations, excess India ink blocking drainage, and inflammation from tattoo placement.  The authors concluded that ICG can be safely injected into the peri-tumoral sub-serosal and demonstrated lymphatic drainage in colon cancer.  They stated that this proof of concept and proposed standards for the procedure can lead to future studies to optimize the application of image-guided precision surgery in colon cancer.  Furthermore, this technique may be of value in indicating the need for more extended lymphadenectomy.

Moreover, NCCN’s clinical practice guidelines on "Colon cancer" (Version 2.2018) does not mention indocyanine green SLN mapping.

Sentinel Lymph Node Mapping for Gastric Cancer

Takeuchi and Kitagawa (2015) stated that clinical application of SLN mapping in patients with early-stage gastric cancer has been a controversial issue for years.  However, a recent meta-analysis and a prospective multi-center trial of SLN mapping for early-stage gastric cancer have shown acceptable SLN DRs and accuracy of determination of lymph node status.  A dual-tracer method that uses radioactive colloids and blue dyes is currently considered the most reliable method for the stable detection of SLNs in patients with early-stage gastric cancer.  However, the new technologies such as ICG infrared or fluorescence imaging might revolutionize the SLN mapping procedures in gastric cancer.  For early-stage gastric cancer, the establishment of individualized, minimally invasive treatments based on SLN concept may retain the patients' quality of life.

Ohdaira and colleagues (2017) described the retrospective feasibility study of ICG fluorescence SLN mapping in back-table for early gastric cancer using PINPOINT (NOVADAQ, Canada); SLN mapping were performed as following; the day before surgery, 0.5 ml ICG was injected endoscopically in 4 quadrants of the submucosa surrounding the gastric cancer using an endoscopic puncture.  Intra-operatively, the gastro-colic ligament was divided to visualize all possible directions of lymphatic flow from the stomach.  PINPOINT was used to illuminate regional lymph nodes from the serosal side.  Positive staining was confirmed by at least 3 surgeons and an endoscopist during surgery.  Lymph node dissection and gastrectomy were performed according to the criteria of gastric cancer treatment guidelines of Japanese Gastric Cancer Association.  All 6 patients had gastrectomy with laparoscopic approach; ICG-positive lymphatic flow and lymph nodes were able to be observed in all the patients.  Final pathological diagnosis was all Stage I and curative resection.  All the patients had ICG-positive lymphatic area in left gastric artery (LGA) area; 2 patients with tumor located in L area had ICG positive flow to right gastro-epipoloic artery (RGEA) area.  The mean of ICG positive lymph nodes was 8.6; 1 patient had a metastatic lymph node in station No.4, which was positive for ICG.  The authors concluded that this method made identification of ICG-positive lymph nodes easy in SLN mapping in back-table under room light.  Moreover, they stated that although further accumulation and analysis are necessary, they may be able to apply this method for intra-operative SLN mapping of laparoscopic gastric cancer surgery.

Moreover, NCCN’s clinical practice guidelines on "Gastric cancer" (Version 2.2018) does not mention indocyanine green SLN mapping.

Sentinel Lymph Node Mapping for Ovarian Cancer

Buda and colleagues (2017) noted that SLN mapping has increased its feasibility in both early-stage cervical and endometrial cancer.  There are few SLN studies regarding the ovary because of the risk of tumor dissemination and perhaps because the ovary represents an inconvenient site for injection.  In this preliminary study, these researchers examined the feasibility of SLN mapping of the ovary with ICG during laparoscopic retroperitoneal aortic surgical staging.  The 10 women who were included in this study underwent aortic with pelvic laparoscopic staging, which included SLN biopsy, extra-fascial total hysterectomy, and bilateral salpingo-oophorectomy in case of an ovarian tumor.  The fluorescent dye was injected on the dorsal and ventral side of the proper ovarian ligament and the suspensory ligament, close to the ovary and just underneath the peritoneum.  In all cases except 1, SLNs were detected soon after the injection in the aortic compartment and in 3 cases also in the common iliac region.  Only 1 intra-operative complication occurred: a superficial lesion of the vena cava that was recovered with a laparoscopic suture.  The authors concluded that laparoscopic ovarian SLN mapping performed by means of an injection of ICG fluorescent tracer in the ovarian ligaments appeared feasible and promising.  Moreover, they stated that further investigation are needed to evaluate the possible applications of this new technique for staging patients with early-stage ovarian cancer.

Moreover, NCCN’s clinical practice guidelines on "Ovarian cancer" (Version 2.2018) does not mention indocyanine green SLN mapping.

Sentinel Lymph Node Mapping for Urological Cancers (e.g., Bladder, Kidney, Penis, and Prostate)

Aoun and colleagues (2018) stated that bilateral pelvic lymph node dissection (PLND) represents the most accurate and reliable staging procedure for the detection of lymph node invasion in prostate cancer and bladder cancer.  However, the procedure is not without complications.  In this field, ICG fluorescence-guided SLN identification is an emerging and promising technique, as accurate staging of urologic cancer could be enhanced by a thorough evaluation of the SLNs.  These researchers reviewed available evidence and performed a meta-analysis on ICG-guided SLN detection for urologic malignancies.  They carried out a systematic review to examine the clinical value of ICG for the identification of sentinel lymphatic drainage for bladder, prostate, kidney and penile cancers was undertaken, with a meta-analysis to generate pooled DR concerning patients (clinical sensitivity) and nodes basin (technical sensitivity) separately.  Studies reporting on the use of ICG for the detection of SLNs from the bladder, prostate and penile cancers were included.  A total of 10 clinical trials were included.  Using the fixed effects model and the random effects model, the pooled patient DRs and their 95 % CI were 0.88 (0.82 to 0.92) and 0.92 (0.84 to 0.96), respectively.  The pooled nodes DRs were 0.71 (95 % CI: 0.68 to 0.74) using the fixed effect model and 0.75 (95 % CI: 0.56 to 0.87) using the random effect model.  Significant heterogeneities existed among studies for patients and for nodes (I2 = 0.66, p < 0.001 and I2 = 0.96, p < 0.001, respectively).  Significant publication bias was found in patient DR (p < 0.001) and in nodes DR (p < 0.001).  The authors concluded that SLN mapping in bladder and prostate cancer is a method with a high DR, although its specificity to predict LN invasion remains poor.  Moreover, they stated that large well-constructed trails are needed to evaluate the impact of ICG-fluorescence-guided SLN dissection on uro-oncologic surgery.

Furthermore, NCCN’s clinical practice guidelines on "Bladder cancer" (Version 4.2018), "Kidney cancer" (Version 4.2018), "Penile cancer" (Version 2.2018), and "Prostate cancer" (Version 2.2018) do not mention indocyanine green SLN mapping.

Evaluation of Anastomotic Leakage in Colorectal Surgery

Mangano and co-workers (2018) stated that anastomotic leakage (AL) following r colorectal surgery is a serious complication.  One of the most important causes of AL is impaired vascularization.  A microvascular tissue deficit is very often not intra-operatively visually detected under white light.  Near-infrared ICG-enhanced fluorescence is a cutting-edge technology that may be useful for detecting microvascular impairment and potentially preventing AL.  These researchers examined the feasibility and the usefulness of intra-operative assessment of vascular anastomotic perfusion in colorectal surgery using an ICG fluorescent tracer.  A PubMed / Medline, Embase, and Scopus narrative literature review was performed, in which "colorectal surgery" and "indocyanine green" were used as key words.  The inclusion criteria were manuscripts written in English; full text was available; topic related to the use of ICG fluorescence for the assessment of tissue perfusion during laparoscopic or robotic colorectal surgery; and sample: adult patients, benign or malignant disease.  Exclusion criteria included  case reports; topic not related to the use of ICG fluorescence for the evaluation of tissue perfusion during laparoscopic or robotic colorectal surgery; manuscripts that focused solely on other applications of ICG technology; and any study type not showing original data.  These investigator found that intra-operative visual assessment of tissue viability under white light may lead to an under-estimation of microvascular blood flow impairment; and ICG could be safely used in cases of minimally invasive colonic surgery and also low anterior resections.  This technology may be useful when deciding whether to intra-operatively change a previously planned resection/anastomotic level, which could d theoretically reduce the occurrence of AL.  The authors concluded that near-infrared ICG technology is a very useful approach.  Multiple preliminary studies suggested that this technique may be used to predict AL.  However, evaluation of the ICG signal is still too subjective.  Some reliable scoring/grading parameters related to the ICG signal need to be defined.  These researchers stated that more prospective, randomized, and adequately powered studies are needed to completely reveal the true potential of this surgical technological innovation.

Mangano and associates (2019) examined the feasibility, safety and role of near-infrared ICG-enhanced fluorescence for the intra-operative assessment of peri-anastomotic tissue vascular perfusion.  From among more than 164 robotic colorectal cases performed, these researchers retrospectively analyzed 28 that were all performed by the same surgeon using near-infrared ICG-enhanced fluorescence technology: 16 left colectomies (57.1 %), 8 rectal resections (28.6 %), 3 right colectomies (10.8 %) and 1 pan-colectomy (3.6 %).  The rates of conversion, intra-operative complications, dye allergic reaction and mortality were all 0 %.  In 2 cases (7.1 %) -- 1 left and 1 right colectomy -- the level of the anastomosis was changed intra-operatively following ICG showed ischemic tissues.  Despite the application of ICG, 1 AL (after left colectomy for a chronic recurrent sigmoid diverticulitis with pericolic abscess) was observed.  The authors concluded that ICG technology may help to determine when to intra-operatively change the anastomotic level to a safer location.  In this case-series study, ICG findings led to a change in the level of the anastomosis in 7.1 % of the cases.  Despite the use of ICG, these investigators observed 1 AL.  This may have been related to vascularization-independent causes (e.g., infection in this case) or may reflect a need for better standardization of this ICG technology.  In particular, there is a need for objective evaluation of the ICG signal and the related risk of AL.  These researchers stated that more randomized, prospective, well-powered trials are needed to unveil the full potential of this innovative surgical technology.

Morales-Conde and colleagues (2020) noted that ICG-FA was introduced to provide the real-time intra-operative evaluation of the vascular supply of anastomosis.  However, further studies are needed to examine its advantages in colorectal surgery and to know in which procedure this technology has more value.  Ina retrospective study, these researchers evaluated the usefulness of the ICG-FA in the colorectal anastomosis evaluation and to examine if ICG-FA is most useful depending on type of resection performed in terms of change of section line based on the ICG-FA and AL rates.  From September 2014 to November 2018, all patients who underwent any colorectal surgical procedure with ICG-FA in the authors’ center were enrolled in the study.  Based on the type of surgery, patients were grouped in 4 categories: Group A, right hemicolectomy; Group B, segmental resection of the splenic flexure; Group C, left hemicolectomy; and Group D, anterior resection of the rectum.  A total of 192 unselected consecutive patients were enrolled: 67 in group A, 9 in B, 81 in C, and 35 in D.  Change of section line based on ICG-FA occurred in 35 cases (18.2 %): 4 in group A (6 %), 1 in group B (11.1 %), 21 in group C (25.9 %), and 9 in group D (25.7 %); ALs occurred in 5 patients (2.6 %): 2 in group A (3 %), 1 in C (1.2 %), and 2 in D (5.7 %).  The authors concluded that ICG-FA led to significantly more changes in the resection line in case of left hemicolectomy followed by anterior resection.  These researchers stated that FA is a promising optical imaging technique to reduce the AL incidence following colorectal procedures.  They stated that to confirm these findings, further studies with wider sample size and with an objective evaluation of the anastomotic perfusion are needed.

Carus and Pick (2019) stated that ICG-FA is often employed in colorectal surgery to evaluate the blood perfusion in the region of an anastomosis.  Previous studies with ICG-FA in both open and laparoscopic surgery showed a low rate of AL (e.g., the PILLAR II study with a leakage rate of 1.4 %).  These researchers presented their own findings, the current status of ICG-FA and the fields of application.  They examined if the results obtained so far with ICG-FA are sufficient to recommend an extended use of this relatively new method in colorectal surgery.  From July 2009 to June 2019, a total of 378 colorectal resections (280 colon resections and 98 rectal resections) with intra-operative examination of the anastomosis using ICG-FA were performed.  In 13 patients (3.4 %) there was reduced intra-operative perfusion, which led to a change in the operative procedure (resection of the anastomosis and new anastomosis, colostomy).  The total AL rate was 3.7 % with 8 leaks in the colon (2.9 %) and 6 in the rectum (6.1 %).  Without the intra-operative change in 13 patients the rate of ALs could have increased to 7.1 % (27/378).  The use of ICG-FA in the group of patients studied potentially led to a reduction of the leakage rate by 48 %.  Current publications showed similar results with a potential decrease in the rate of ALs in colorectal surgery.  The authors concluded that these findings demonstrated a very low rate of ALs when using ICG-FA; they stated that these results are promising in colorectal surgery; however, RCTs are lacking and should be performed before final recommendations can be given.

Nowak and colleagues (2020) noted that through the improvement and implementation of advanced intraoperative imaging, the indications for intraoperative fluorescence have spread to various fields of visceral surgery; and ICG-based FA and the imaging systems using this certain dye are currently the cornerstone of intraoperative, fluorescence-based medical imaging.  These investigators focused on principles and approaches of intraoperative fluorescence in general surgery.  They discussed the technique and possible pit-falls in the performance of intraoperative ICG-FA.  Th authors concluded that overall growing evidence suggested that intraoperative fluorescence imaging delivered valuable additional information to the surgeon, which might help to perform surgery more exactly and reduce perioperative complications.  Perfusion assessment can be a helpful tool when performing critical anastomoses.  There is evidence from prospective and randomized trials for the benefit of intraoperative ICG-FA during esophageal reconstruction, colorectal surgery, and surgery for mesenteric ischemia.  Most studies suggested the administration of 2.5 to 10 mg of ICG.  Standardized settings and documentation are essential.  The benefit of ICG fluorescence imaging for GI sentinel lymph node (SLN) detection and detection of liver tumors and colorectal metastases of the liver cannot clearly be estimated duo to the small number of prospective studies.  Critical points in the use of intraoperative fluorescence imaging remain the low standardization and reproducibility of the results and the associated difficulty in comparing the results of the existing trials.  Furthermore, little is known regarding the influence of hemodynamic parameters on the quantitative assessment of ICG fluorescence during surgery.

Alius and associates (2020) stated that nowadays, surgical innovations incorporate new technological conquests and must be validated by evidence-based medicine.  The use of augmented reality-assisted ICG fluorescence has generated a myriad of intraoperative applications such as demonstration of key anatomical landmarks, SLNs, and real-time assessment of local blood flow.  In a systematic review, these investigators examined the clinical evidence regarding the applications of ICG-NIR fluorescence in colorectal surgery.  After these researchers removed duplicate publications and screened for eligibility, a total of 36 articles were evaluated: 23 on perfusion assessment, 10 on SLN mapping, and 3 on intraoperative identification of ureters.  Lack of homogenous studies, low statistical power, and confounding evidence were found to be common among publications supporting the use of ICG in colorectal surgery, raising concerns over this seductive technique's cost efficiency and redundancy.  The compiled data showed that ICG-NIR fluorescence may be a game-changer in particular situations, as proven for low colorectal anastomosis or lateral pelvic lymph node dissection; however, it remains controversial for routine use and SLN assessment.  These researchers stated that NIR-enhanced surgery has the potential to change paradigms, but up until now, there have been no guidelines or standardized uses for this method.  Promising studies and favorable systematic reviews do not suffice when it comes to embracing a new surgical technique.  Although the safety profile of the ICG is unquestionable, the sometimes-excessive use of the method would only increase costs and the complexity of an operation.  Lack of homogenous studies, low statistical power, and confounding evidence is common among publications supporting the use of ICG in colorectal surgery.  Viewed by some investigators with skepticism, by others with enthusiasm, ICG-NIR augmented reality appeared to be shaping its place in colorectal surgery.  Adding ICG-NIR to the image acquisition software in laparoscopic and robotic surgery facilitates the use of this augmented reality when the surgeon needs more real-time information about the blood or lymphatic flow or the precise location of anatomical landmarks in order to avoid iatrogenic damage.  Although superfluous if performed by routine in colorectal surgery, ICG-NIR may be a game-changer in particular situations, as proven in low colorectal anastomosis or lateral pelvic lymph node dissection.  The authors concluded that further RCTs are needed to confirm these conclusions; they stated that future research directions should include tumor-targeted fluorescence imaging and digital software for quantitative evaluation of fluorescence.  The clinical validation of augmented reality-assisted ICG fluorescence will come in following years.

Ishii and colleagues (2020) noted that some recent studies have suggested that ICG-FA might be useful for preventing anastomotic leakage (AL) following laparoscopic colorectal surgery.  However, its efficacy has not been proven.  In a retrospective study, these researchers examined if intraoperative ICG-FA could decrease the AL rate with laparoscopic colorectal cancer surgery.  This trial included patients with colorectal cancer who underwent laparoscopic surgery at the authors’ institution between March 2014 and December 2018.  Patients were divided into 2 groups -- with or without ICG-FA; the primary outcome was the rate of AL.  A total of 488 patients were included: 223 patients in the ICG group and 265 patients in the no-ICG group.  In the ICG group, the transection line was changed to a more proximal location in 7 patients (3.1 %), including 1 patient with transverse colon surgery and 6 with rectal surgery; none of these 7 patients developed AL . There were 18 ALs (3.7 %) overall.  The AL rate was 1.8 % in the ICG group and 5.3 % in the no-ICG group.  For colon cancer, there were no significant differences in the AL rate between the groups (p = 0.278).  In rectal cancer, the AL rate was significantly lower in the ICG group than in the no-ICG group (3.5 % versus 10.5 %, p = 0.041).  After propensity score matching, the AL rate was also significantly lower in the ICG group for rectal cancer (p = 0.044).  The authors concluded that ICG-FA could potentially reduce the AL rate with laparoscopic rectal cancer surgery.

Hasegawa and co-workers (2020) stated that whether ICG-FA during rectal surgery is effective in reducing AL remains unclear.  In a retrospective, single-center, cohort study, these investigators examined the effect of intraoperative ICG-FA on AL following sphincter-sparing surgery for malignant rectal tumors.  This trial was carried out on 852 consecutive patients who underwent laparoscopic sphincter-sparing surgery from January 2007 to June 2017 at the authors’ institution.  The incidence of AL was compared between patients who underwent ICG-FA to determine the proximal resection margin and those in whom this technique was not performed, using logistic regression analysis, including propensity score.  A total of 8 patients were excluded (1 with previous low anterior resection and 7 who underwent simultaneous resection for other primary cancers), resulting in 844 patients being analyzed.  Before propensity score matching, 141 patients (16.7 %) who underwent ICG-FA were compared with 703 patients (83.3 %) in whom ICG-FA was not performed . The incidence of AL was 2.8 % (4/141) in the ICG-FA group and 12.4 % (87/703) in the control group (p = 0.001).  After propensity score matching (n = 420), the patient characteristics between the 2 groups were well-balanced, and the incidence of AL was 2.8 % (4/141) in the ICG-FA group and 13.6 % (38/279) in the control group (p = 0.001).  Logistic regression analyses using propensity score showed that patients who underwent ICG-FA had significantly lower odds of AL.  The authors concluded that intraoperative ICG-FA is a promising method to reduce anastomotic leakage following laparoscopic rectal surgery.

Liu and colleagues (2021) noted that colorectal anastomoses in patients with colorectal cancer carry a high risk of leakage; and ICG-FA is a new technique that allows surgeons to evaluate the blood perfusion of the anastomosis during operation.  In a meta-analysis, these researchers examined if ICG-FA could prevent AL in colorectal surgery.  A total of 4 data-bases (PubMed, Embase, Web of Science, and Cochrane Library) were searched to identify suitable literatures until March 2020 that compared AL rates between intraoperative use and non-use of ICG-FA in colorectal surgery for cancer.  The Review Manager 5.3 software was used to carry out the statistical analysis; evaluation of articles quality and analysis for publication bias were also performed.  A total of 13 studies (4,037 patients) were included in the meta-analysis.  The study included 1,806 patients in the ICG group and 2,231 patients in the control group.  The pooled incidence of AL in ICG group was 3.8 % compared with 7.8 % in control group.  There was a significant difference in AL rate with or without use of ICG-FA (OR 0.44; 95 % CI: 0.33 to 0.59; p < 0.00001).  Re-operation rates were 2.6 % and 6.9 % in ICG and control groups, respectively.  Application of intraoperative ICG-FA was associated with a lower risk of re-operation (OR 0.39; 95 % CI: 0.16 to 0.94; p = 0.04).  Overall complication rate was 15.6 % in the ICG group compared with 21.2 % in the control group.  Overall complications were significantly reduced when using ICG-FA (OR 0.62; 95 % CI: 0.47 to 0.82; p = 0.0008).  Mortality rate was not statistically different with or without the use of ICG-FA (OR 1.22; 95 % CI: 0.20 to 7.30; p = 0.83).  The authors concluded that the findings of this meta-analysis revealed that ICG-FA reduced risks of AL, re-operation, and overall complications for colorectal cancer patients undergoing colorectal surgery.  Moreover, these researchers stated that well-designed RCTs are needed to confirm the usefulness of intraoperative ICG-FA for preventing surgical complications like anastomotic leakage and re-operation.

In a systematic review and meta-analysis, Pang et al (2021) noted that the role of intra-operative use of ICG-fluorescence angiography (ICG-FA) in the prevention of AL in rectal cancer surgery remains controversial.  These investigators carried out a systematic review for studies examining ICG-FA in patients undergoing rectal cancer surgery in PubMed, Embase, Web of Science, and the Cochrane Library up to April 30, 2020.  The primary outcome was the incidence of AL; the analysis was performed using RevMan v5.3 and Stata v12.0 software.  A total of 18 studies comprising 4,038 patients were included.  In the present meta-analysis, intra-operative use of ICG-FA markedly reduced AL rate (OR = 0.33; 95 % CI: 0.24 to 0.45; p < 0.0001; I2 = 0 %) in rectal cancer surgery, which was still significant in surgeries limited to symptomatic AL (OR = 0.44; 95 % CI: 0.31 to 0.64; p < 0.0001; I2 = 22 %).  This intervention was also associated with shorter post-operative stays (mean difference [MD] = - 1.27; 95 % CI: - 2.42 to - 0.13; p = 0.04; I2 = 60 %).  However, re-operation rate (OR = 0.61; 95 % CI: 0.34 to 1.10; p = 0.10; I2 = 6 %), ileus rate (OR = 1.30; 95 % CI: 0.60 to 2.82; p = 0.51; I2 = 56 %), and surgical site infection rate (OR = 1.40; 95 % CI: 0.62 to 3.20; p = 0.42; I2 = 0 %) were not significantly different between the 2 groups.  The authors concluded that the use of ICG-FA was associated with a lower AL rate following rectal cancer resection.  Moreover, these researchers stated that more multi-center RCTs with large sample size are needed to further verify the value of ICG-FA in rectal cancer surgery.

The authors stated that this study had several drawbacks.  First, the predominately included studies were observational studies.  The insufficiency of RCTs may lead to increase the risk of bias, and more high-quality RCTs are needed to provide more credible evidence on this issue.  Second, the administrated dosage of ICG and imaging systems among these studies were different, which might also have caused bias due to the difference in signal detectability.  Third, the definition of AL was inconsistent in these studies.  Fourth, there might be heterogeneity in the outcome analysis.

Li et al (2021) stated that ICG-FA is a new technique that help surgeons to evaluate the blood perfusion of the anastomotic intestine.  Ina meta-analysis, these investigators examined if ICG-FA could lower the AL rate after colorectal anastomoses for rectal cancer (RC) patients.  Studies comparing AL rates between use and non-use of ICG-FA up to April 2020 were systematically searched from PubMed, Embase, Web of Science, Cochrane Library, and China National Knowledge Infrastructure.  A pooled analysis was carried out for the available data regarding the baseline features, AL rate, and other surgical outcomes.  ReMan 5.3 software was used to perform the statistical analysis.  Quality evaluation and publication bias were also conducted.  A total of 13 studies (2,593 patients -- 1,121 in the ICG group and 1,472 in the control group) undergoing colorectal anastomoses after RC surgery were included.  In the pooled analysis, the baseline data, operation time, and intra-operative blood loss in 2 groups were all comparable and without significant heterogeneity.  However, the AL rate in the ICG group was significantly lower (OR .31; 95 % CI: 0.22 to 0.44; p < 0.00001) than that in the control group.  Furthermore, ICG-FA was associated with a decreased overall complication rate (OR 0.60; 95 % CI: 0.47 to 0.76; p < 0.0001) in patients who undergo RC surgery.  The authors concluded that the findings of this study showed that ICG-FA lowered AL rate following colorectal anastomoses for RC patients.  Moreover, these researchers stated that more high-quality RCTs are needed to confirm these findings.

Tang et al (2022) stated that meta-analyses had shown that ICG could effectively prevent AL following colorectal surgery; however, recent evidence from large RCTs has suggested that ICG fluorescence angiography did not reduce the incidence of AL in colorectal surgery.  In a meta-analysis, these investigators examined the value of ICG for the prevention of AL following colorectal surgery.  Up to September 16, 2021, PubMed, Embase, China National Knowledge Infrastructure, Web of Science, Scopus, Cochrane Library, and VIP databases were searched for RCTs; and propensity-score matched (PSM) studies examining the use of ICG for prevention of AL following colorectal surgery; MDs or ORs and 95 % CI were calculated.  A total of 20 studies (5 RCTs and 15 PSM studies) with a total of 5,125 patients were included.  ICG did not reduce the re-operation rate (OR, 0.71; 95 % CI: 0.38 to 1.30), conversion rates (OR, 1.34; 95 % CI: 0.65 to 2.78), or mortality (OR, 0.50; 95 % CI: 0.13 to 1.85); however, ICG lowered the incidence of AL (OR, 0.46; 95 % CI: 0.36 to 0.59) and symptomatic AL (OR, 0.48; 95 % CI: 0.33 to 0.71), and reduced the hospital length of stay (LOS) (MD, -1.21; 95 % CI: -2.06 to -0.35) and intra-operative blood loss (MD, -9.13; 95 % CI: -17.52 to -0.74).  In addition, ICG use did not increase the incidence of total post-operative complications (OR, 0.93; 95 % CI: 0.64 to 1.35), post-operative ileus (OR, 1.26; 95 % CI: 0.53 to 2.97), wound infection (OR, 0.76; 95 % CI: 0.44 to 1.32), urinary tract infection (OR, 0.87; 95 % CI: 0.30 to 2.59), pulmonary infection (OR, 0.23; 95 % CI: 0.04 to 1.45), urinary retention (OR, 1.08; 95 % CI: 0.23 to 5.04), anastomotic bleeding (OR, 1.53; 95 % CI: 0.27 to  8.60), anastomotic stricture (OR, 0.74; 95 % CI: 0.24 to 2.29), or operative time (MD, -9.64; 95 % CI: -20.28 to 1.01).  The authors concluded that this meta-analysis showed the value of ICG in patients undergoing colorectal surgery, as evidenced by the reduced AL rate, SAL rate, and blood loss.  In addition, hospital LOS was shorter.  These researchers stated that ICG may be a potential strategy to prevent AL in colorectal surgery, and more high-quality, large RCTs are needed to confirm the benefits of ICG in colorectal surgery.

The authors stated that this meta-analysis had several drawbacks.  First, there was significant heterogeneity in some outcome measures of this study.  This may be related to inconsistent follow-up times (from 30 to 90 days) and inconsistent definitions of AL used in the included studies.  Moreover, 5 studies included patients with both malignant and benign colorectal disease.  Inconsistent disease types may be one of the sources of heterogeneity.  Second, a total of 9 fluorescence imaging systems were used.  It was unclear if the effects of different fluorescence imaging systems were consistent, which may need to be clarified in future studies.  In the included studies, there were also differences in the dose of ICG injected intravenously.  The influence of different doses on the study needs to be further examined; and finding the optimal dose may be the focus of future studies.  These may also be sources of heterogeneity.  Third, although this study showed that ICG may have potential benefits in reducing the incidence of AL following colorectal surgery, the fluorescence intensity in all the studies included in this meta-analysis was based on the subjective judgment of surgeons, lacking objective evaluation indicators.  Furthermore, even if ICG fluorescence is displayed in the colorectal, intestinal ischemia may occur if blood flow is not meeting physiological demands; thus, the use of software to quantify the fluorescence parameters and find reliable parameters for predicting AL may further confirm the benefits of ICG on AL in colorectal surgery.  Finally, some of the outcome indicators (re-operation rate, conversion rate, post-operative ileus rate, wound infection rate, urinary tract infection rate, pulmonary infection rate, urinary retention rate, anastomotic bleeding rate and anastomotic stricture rate) in the included studies were based on evidence from a small number of studies, so it was not possible to determine whether ICG would bring more benefits, and more high-quality studies are needed to examine the impact of ICG on these outcomes.

Fluorescent Imaging Using Indocyanine Green During Esophagectomy for Prevention of Surgical Morbidity

Ladak and associates (2019) stated that intra-operative evaluation with ICG-FA offers a dynamic assessment of gastric conduit perfusion and could guide anastomotic site selection during an esophagectomy.  These investigators examined the predictive value of ICG-FA for the prevention of anastomotic leak following esophagectomy.  They carried out a comprehensive search of electronic databases using the search terms "indocyanine/fluorescence" and "esophagectomy"; searches included all English articles published between January 1946 and 2018.  Articles were selected by 2 independent reviewers.  The quality of included studies was assessed using the Methodological Index for Non-Randomized Studies (MINORS) instrument.  A total of 17 studies were included for meta-analysis following screening and exclusions.  The pooled anastomotic leak rate when ICG was used was found to be 10 %.  When limited to studies without intra-operative modifications, the pooled sensitivity, specificity, and diagnostic OR (DOR) were 0.78 (95 % CI: 0.52 to 0.94; p = 0.089), 0.74 (95 % CI: 0.61 to 0.84; p = 0.012), and 8.94 (95 % CI: 1.24 to 64.21; p = 0.184), respectively. A total of 6 trials compared ICG with an intra-operative intervention to improve perfusion to no ICG; ICG with intervention was found to have a risk reduction of 69 % (OR 0.31, 95 % CI: 0.15 to 0.63).  The authors concluded that in non-randomized trials, the use of ICG as an intra-operative tool for visualizing microvascular perfusion and conduit site selection to decrease ALs was promising.  However, poor data quality and heterogeneity in reported variables limited generalizability of findings.  These researchers stated that randomized, multi-center trials are needed to account for independent risk factors for leak rates and to better examine the impact of ICG in predicting and preventing ALs.

Slooter and colleagues (2019) noted that fluorescent imaging using ICG is an emerging technique that helps the surgeon with intra-operative decision-making during upper GI cancer surgery.  In a systematic review, these researchers examined current practice of fluorescence imaging using ICG during esophagectomy, and demonstrated how this technology could prevent surgical morbidity (e.g., anastomotic leakage, chylothorax, and graft necrosis).  The Preferred Reporting Items for Systematic review and Meta-Analysis (PRISMA) standard for systematic reviews was used; PubMed and Embase database were searched to identify articles matching the systematic literature search.  Two authors screened all included articles for eligibility; risk of bias was assessed for all included articles.  A total of 25 articles were included in this review: 22 articles on perfusion assessment, and 3 on the detection of chyle fistula; 5 out of 22 articles concerning perfusion assessment evaluated fluorescence signals in quantitative values.  In 20 articles, the pooled incidence of AL and graft necrosis in the ICG group was 11.10 % (95 % CI: 8.06 to 15.09 %); and in 8 studies the pooled change in management rate was 24.55 % (95 % CI: 19.16 to 30.88 %).  After change in management, the pooled incidence of AL and graft necrosis was 14.08 % (95 % CI: 6.55 to 27.70 %).  A meta-analysis showed that less ALs and graft necrosis occurred in the ICG group (OR 0.30, 95 % CI: 0.14 to 0.63); 3 case-reports (n = 3) were identified regarding chyle fistula detection, and ICG lymphography detected the thoracic duct in all cases and the chyle fistula in 1 case.  The authors concluded that fluorescence imaging using ICG was a promising and safe technology to reduce surgical morbidity following esophagectomy with continuity restoration.  These researchers stated that ICG fluorescence angiography showed a reduction in AL and graft necrosis; future studies are needed to demonstrate the feasibility of ICG lymphography for chyle fistula detection.

ICGA for Evaluation of Anastomotic Stenosis of Reconstructed Superior Mesenteric Artery Aneurysm

Schwarte and associates (2021) noted that superior mesenteric artery (SMA) aneurysms are rare and associated with a high risk of rupture, with resultant significant morbidity and mortality.  During open repair of a SMA aneurysm (SMAA), perfusion of the involved small bowel must be evaluated when determining need for and/or extent of vascular reconstruction.  These researchers presented the case of a 51-year-old woman who underwent open repair of a non-ruptured SMAA with ligation and excision, in whom no re-vascularization was determined to be needed and the involved small bowel was able to be preserved, with intra-operative evaluation of perfusion using ICG fluorescence imaging, as an adjunct to more traditional methods of perfusion assessment.

Yamashita and colleagues (2021) performed a surgical re-vascularization of a dissecting SMAA (dSMAA).  Intra-operative ICGA revealed no problem with the intestinal blood flow in the SMA-dominant region.  However, post-operatively, the patient developed paralytic ileus associated with intestinal ischemia, and contrast‐enhanced CT scan revealed anastomotic stenosis.  The authors concluded that in the present case, intra-operative ICGA showed a slight delay in the fluorescence of the distal SMA; however, there was no defect in the fluorescence of the intestinal wall; therefore, these investigators ascertained that there was no intestinal ischemia.  As a consequence, intra-operative ICGA was unable to identify the stenosis of the distal side of the anastomosis.  The authors concluded that if a rapid and simple intra-operative evaluation method is established, re-anastomosis or bypass creation would be possible.

ICGA for Guidance in Redo IIeocolic Resection for Crohn's Disease

Freund and colleagues (2021) noted that redo ileocolic resection in patients with Crohn's disease (CD) is associated with significant technical challenges that may be associated with high complication rates.  In a retrospective analysis, these researchers examined the feasibility of NIRF angiography ICG, often used to evaluate blood supply to the anastomosis in CD patients undergoing repeat ileocolic resection.  This study included patients who underwent redo ileocolic resection using ICG bowel perfusion assessment between 2015 and 2021.  Patients were matched and compared on a 1:2 basis with a control group undergoing the same procedure without perfusion assessment.  A total of 12 patients underwent redo ileocolic resection with ICG perfusion assessment (ICG group).  These were compared with 24 patients who underwent the procedure without ICG (control group).  Both groups were similar in demographics and operative characteristics including median operating time (255 versus 255.5 mins, p = 0.39) and conversion rate (22 % versus 36.8 %, p = 0.68).  Median estimated blood loss (EBL) was significantly higher in the ICG group [150 (50 to 400) versus 100 ml (20 to 125)].  Successful ICG perfusion assessment was observed in all patients in the ICG group and did not change management in any case.  Overall post-operative complication rates were comparable between the groups (58.3 % versus 54.1 %, p = 0.72).  No anastomotic leaks occurred in the ICG group compared with 1 (1/24, 4.2 %) in the control group (p = 0.99).  The authors concluded that NIRF ICG perfusion assessment was feasible and safe in redo ileocolic resection in patients with CD.  Moreover, these researchers stated that larger studies are needed to examine if this technique should be routinely used in these complex surgical interventions.

ICGA for Identification of the Superficial Temporal Artery and Vein in Forehead Flaps for Facial Reconstruction

Zang and colleagues (2022) noted that the superficial temporal artery (STA) frontal branch flap is susceptible to venous congestion because of its unpredictable and variable outflow.  These researchers employed ICGA in identifying the superficial temporal vessels to help surgeons with proper flap designs to avoid severe complications.  They carried out a retrospective review from 2015 to 2020.  All the patients who underwent ICGA before forehead flap transfer for facial defect reconstruction were reviewed.  The STA and superficial temporal vein (STV) were observed using ICGA pre-operatively.  The relationship between the STA and STV was examined.  The venous anatomy was analyzed to guide the pedicle design.  The survival of the flap and complications were evaluated.  A total of 12 patients were identified and included in this study; ICGA allowed clear visualization of the detailed anatomy of the STA and STV.  The frontal branch of the vein had great variations and generally diverged from the arterial branch.  The tiny venae comitantes provided sufficient drainage for 2 small forehead flaps.  The frontal branch of the STV entered the forehead and was used as the outflow channel in 4 patients.  The parietal branch of the STV, which consistently gave off secondary tributaries to the superior forehead, was included in the pedicle in 6 patients.  All flaps survived without complications.  The authors concluded that ICGA provided accurate localization of the superficial temporal vessels; and this technique may be helpful in the precise planning forehead flap surgeries and in avoiding the risk of venous congestion.  These preliminary findings need to be validated by well-designed studies.

Near-Infrared Angiography with Indocyanine Green for Evaluation of Anastomotic Perfusion after Bowel Resection for Recto-Sigmoid Endometriosis

Raimondo and colleagues (2022) examined effectiveness and reproducibility of qualitative and quantitative NIR-ICG analyses as a tool for anastomotic perfusion assessment after full-thickness bowel resection for recto-sigmoid endometriosis (RSE).  This study included symptomatic women with RSE undergoing minimally invasive full-thickness surgical excision of RSE and NIR-ICG evaluation from November 2019 to July 2020.  Study outcomes were the accuracy of qualitative and quantitative NIR-ICG analyses in predicting bowel fistula and their reproducibility.  NIR-ICG predictive accuracy was evaluated by calculating sensitivity, specificity, and area under the curve (AUC) on receiver operating characteristic curves with 95 % CI.  NIR-ICG reproducibility was examined via Cohen's k coefficient to determine inter-operator agreement between 2 observers.  Of 33 patients, 2 (6 %) developed bowel fistula.  In predicting bowel fistula, qualitative and quantitative NIR-ICG evaluations showed sensitivity of 100 % and 100 %, specificity of 71 % and 93 %, and AUC of 0.86 (95 % CI: 0.67 to 1.00) and 0.96 (95 % CI: 0 to 1.00), respectively.  Regarding inter-operator agreement rate, it was reported as excellent for the qualitative analysis and very good for the quantitative analysis.  The authors concluded that qualitative and quantitative NIR-ICG evaluations might be effective and reproducible tools for anastomotic perfusion assessment after discoid or segmental resection for RSE; and quantitative evaluation might be even more effective than qualitative evaluation in predicting bowel fistula.

Indocyanine Green Angiography for Evaluation of Perfusion of the Supraclavicular Artery Island Flap in Head and Neck Reconstruction

In a consecutive, case-series study, Bigcas et al (2022) discussed the use of ICG-A in supraclavicular artery island flap (SCAIF) in head and neck reconstruction.  ICG-A was used consecutively between April 2014 and July 2015 to examine its use in flap design, inset, and intra-operative decision-making in 5 patients undergoing head and neck reconstruction.  A total of 6 SCAIFs were harvested in 5 patients where ICG-A was used as the primary tool for flap design by visually mapping the supraclavicular artery under fluorescence.  Each flap was harvested around the mapped course of the artery.  Confirmatory Doppler ultrasound was present in each flap raised with this technique.  In all 5 patients, ICG-A was used to evaluate flap perfusion after inset.  The authors stated that this case-series study showed ICG-A as another tool for SCAIF design in head and neck reconstruction.  This technology provided direct visualization of the pedicle before harvest.  It could also be used as an intra-operative tool to visualize the blood supply once the flap is rotated to evaluate flap perfusion and detect areas that may be compromised; thus, improving flap survival.  These researchers stated that this case series demonstrated the use of ICG-A as a potential primary tool in the planning and implementation of the SCAIF for head and neck reconstruction.  The standard technique of designing SCAIFs includes mapping the course of the supraclavicular artery and letting primary closure dictate the optimal flap harvest while minimizing morbidity; ICG-A could provide complementary information regarding patterns of perfusion to avoid flap failure.  These preliminary findings need to be validated by well-designed studies.

Indocyanine Green Angiography (ICG) with Fluorescein Angiography for the Diagnosis of Non-Arteritic Ischemic Optic Neuropathy

Hirsch et al (2011) examined the retinal hemodynamics and optic disc leakage by FA in patients with non-arteritic anterior ischemic optic neuropathy (NAION) and correlated FA findings with the extent and topography of visual field loss.  A total of 26 patients with acute NAION were included in the study; FA was carried out by means of a scanning laser ophthalmoscope.  The extent of early-phase optic disc leakage was examined using a semi-quantitative approach (focal versus diffuse type of leakage).  Retinal arterio-venous passage (AVP) times were measured using dye dilution curves and digital image analysis for each hemisphere.  The number of defective visual field points (StatPac: p < 0.5 %, uncorrected deviation plot) were evaluated (30/2 SITA, Humphrey-Zeiss) for the hemifields and different sectors.  In this study of patients with NAION the mean AVP was 1.79 s ± 0.43, which was not significantly correlated to the number of defective points.  In addition, AVP was not significantly different in focal versus diffuse optic disc leakage.  The number of defective points were not significantly different in focal versus diffuse leakage of the optic disc (p = 0.57).  The authors concluded that retinal perfusion was not linked to the type and topography of disc leakage or the extent and topography of visual field damage in NAION.  These researchers stated that a global circulatory disorder (e.g., due to a compartment syndrome of the optic nerve) might account for these results.

Rizzo et al (2019) stated that NAION is the 2nd most common optic neuropathy in adults.  Despite extensive study, the etiology of NAION is still unclear.  The best evidence suggested that NAION is caused by an infarction in the region of the optic nerve head (ONH), which is perfused by para-optic short posterior ciliary arteries (sPCAs) and their branches.  To examine the gaps in knowledge that defies the understanding of NAION, these investigators carried out a historical review both of anatomical investigations of the ONH and its relevant blood vessels and the evolution of clinical understanding of NAION.  Notably, almost all of the in-vitro vascular research was conducted before the current understanding of NAION, which has largely precluded a hypothesis-based laboratory approach to study the etiological conundrum of NAION.  More recent investigative techniques, like FA, have provided valuable insight into vascular physiology; however, such light-based techniques have been unable to image blood vessels located within or behind the dense connective tissue of the sclera and laminar cribrosa, sites that are likely culpable in NAION.  The lingering gaps in knowledge clarify investigative paths that might be taken to uncover the pathogenesis of NAION and possibly glaucoma, the most common optic neuropathy for which evidence of a vascular pathology also exists.

These researchers stated that few histopathological studies are available of NAION.  Although age-associated vascular changes occur, pathology sufficient to explain NAION has not been uncovered.  Clues may be obscured by insufficient knowledge of complex ONH dynamics; lack of extensive 3D characterization of relevant human vasculature; as well as current inability of in-vivo techniques to image retro-laminar vasculature in humans.  The latter has created a technical blind spot of the dynamic interplay among factors, including autoregulation, that influence ONH blood flow, although recent advances in OCT-A methodology have enabled imaging of the immediate retro-laminar vessels in monkeys (personal communication, Brad Fortune; October 29, 2019).  To paraphrase an aphorism attributed to Martin Rees (2019), the lack of identified pathology does not exclude identifiable pathology; thus, there is further investigation to be carried out to establish the etiology of NAION.

UpToDate reviews on “Nonarteritic anterior ischemic optic neuropathy: Clinical features and diagnosis” (Tamhankar and Volpe, 2022a) and “Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies” (Tamhankar and Volpe, 2022b) do not mention ICG as a management / therapeutic option. The chapter on diagnosis states that fluorescien angiography often reveals delayed filling of the prelaminar layers of the edematous optic disc in acute NAION, and that poor or absent filling of the choroid is not typical of NAION and suggests giant cell arteritis.

Furthermore, American Academy of Ophthalmology (AAO)’s EyeWiki on “Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)” (Dugan et al, 2022) states that “The diagnosis of NAION is a clinical one.  In patients who present with the typical history of acute, painless, unilateral vision loss and who have the classic findings on examination including a hyperemic and swollen optic nerve with peripapillary splinter hemorrhages and a fellow eye with a small cup to disc ratio, no additional testing is required”.    The EyeWiki states that NAION is presumed to result from a circulatory insufficiency, or infarct, within the retrolaminar portion of the optic nerve head that is supplied by the short posterior ciliary arteries (SPCA). The EyeWiki explains that "This presumption is based upon indirect evidence from atypical forms of NAION. Additional fluorescein and indocyanine studies have shown delayed optic disc filling in the prelaminar layers of the optic disc with normal choroidal circulation suggesting that the vasculopathy is located in the para-optic branches of the SPCA after their branching from the choroidal branches rather than in the short ciliary arteries themselves."

ICG Video-Angiography for Removal of Deep-Seated Arterio-Venous Malformation

Grzyb and Church (2022) noted that ICG video-angiography (ICG-VA) with FLOW 800 (Carl Zeiss AG) has been employed as a visualization tool to guide arterio-venous malformation (AVM) surgery since 2011.  In a systematic review, these investigators examined the quality of evidence available on this topic.  Furthermore, they presented a series of their own cases showing the use of ICG-VA in the localization and removal of deep-seated AVMs.  Using the PRISMA guidelines for systematic reviews, these researchers identified studies related to ICG-VA with FLOW 800 in AVM surgeries using search terms.  The studies were screened and reviewed, and the quality of evidence was analyzed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) criteria.  These investigators carried out a retrospective review of their own cases of AVM removal with ICG-VA and FLOW 800.  The search revealed 27 relevant studies, 17 of which met the inclusion criteria.  The quality of the body of evidence was determined to be "very low" using the GRADE criteria.  These researchers used ICG-VA with FLOW 800 analysis for 14 cases of microsurgical AVM removal.  This technique provided unique insights into the localization of deep-seated AVMs in 8 cases (57 %).  No residual AVM was observed when evaluated by the 6-month follow-up angiography.  The authors presented cases highlighting the usefulness of this technique for the localization of certain AVMs.  They believed the use of ICG-VA could guide the removal of deep-seated AVMs, because it could reveal surface feeders and draining veins that can be followed to a hidden nidus.  Moreover, these investigators stated that larger, registry-based studies are needed to confirm these findings and improve the overall quality of evidence.

Intra-Operative ICG for Evaluation of Flap Perfusion in Skull Base Reconstruction

In a systematic review, Shaikh et al (2022) studied the current use of intra-operative ICG-angiography during skull base reconstruction and examined its effectiveness in predicting post-operative magnetic resonance imaging (MRI) enhancement and flap.  The Embase, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and Google Scholar databases were searched from the date of inception until August 2020 for studies of ICG flap perfusion assessment during skull base reconstruction.  The primary outcome of interest was the development of cerebrospinal fluid (CSF) leak after skull base reconstruction.  Secondary outcomes of interest included post-operative meningitis, flap MRI enhancement, flap necrosis, flap perfusion measurements, and total complications.  Search results yielded 189 studies, from which 7 studies with a total of 104 patients were included in the final analysis.  There were 44 naso-septal flaps (NSF), 2 lateral nasal wall flaps (LNWF), 14 peri-cranial flaps (PCF), and 44 microvascular free flaps.  The rates of CSF leak and post-operative MRI enhancement were 11 % and 94 %, respectively.  There was 1 case of post-operative meningitis.  Pooled analysis of the available data demonstrated that intra-operative ICG flap perfusion was associated with flap enhancement on post-operative MRI (p = 0.008) and CSF leak (p = 0.315) by Fisher's exact test.  The authors concluded that the available literature suggested that intra-operative ICG enhancement was associated with post-operative MRI enhancement.  Given the small sample sizes in the literature and the rarity of complications associated with skull base reconstruction, intra-operative ICG enhancement has not been predictive of flap necrosis or post-operative complications such as CSF leak or meningitis.  Moreover, these researchers stated that a large, multi-center study with direct assessments of CSF leak severity, post-operative lumbar drain use, cranial fossa defect location, flap type, and standardized flap pedicle, and body enhancement assessments and timing is needed to better understand the ability of ICG-angiography to prevent rare complications.  Level of Evidence = III.

The authors stated that this review had many drawbacks.  First, none of the included studies was randomized and all studies had at least a moderate risk of bias.  Second, none of the included studies had a defined control group at the start of the data collection for identifying patients who did not demonstrate flap perfusion or for patients who did not receive an ICG injection.  Third, among the included studies, the types of skull base defects varied regarding tumor size, pathology, defect location (anterior cranial fossa versus posterior cranial fossa), and type of CSF leak (low versus high flow).  Fourth, most of the studies had a small sample size.  Fifth, there were multiple flap types; some of which were more difficult to harvest than others (i.e., lateral nasal wall flap, revision naso-septal flaps, or temporoparietal fascia flap).  Sixth, the lack of standardized or quantitative assessment of flap perfusion among most of the studies.  Seventh, poor flap perfusion, post-operative flap necrosis, meningitis, and CSF leak are rare events at high-volume, endoscopic skull base centers.  The present data, collected from such centers, were unable to demonstrate a significant association between poor flap perfusion as detected by ICG-angiography and the development of post-operative CSF fistula in pooled analysis secondary to a lack of power for these rare events and the few instances of poor ICG enhancement.  Indeed, only 3 patients were observed to have poor intra-operative perfusion.  A post-hoc power analysis, using the rates of post-operative CSF leak and meningitis in this systematic review, suggested that a total of 504 patients would be needed to detect a significant association between lack of intra-operative enhancement and the development of CSF leak and/or meningitis as complications.  Thus, a large multi-center study was designed to answer this question that would be needed to determine whether or not flap perfusion correlates with the development of post-operative CSF leak, pneumocephalus, and meningitis.

Near-Infrared Angiography with ICG for Anatomical Dissection During Robot-Assisted Radical Prostatectomy

Nguyen et al (2016) stated that SLN detection techniques have the potential to change the standard of surgical care for patients with prostate cancer (PCa).  These investigators carried out a lymphatic mapping study and determined the value of fluorescence SLN detection with ICG for the detection of LN metastases in intermediate- and high-risk patients undergoing radical prostatectomy and extended pelvic lymph node dissection (LND).  A total of 42 patients received systematic or specific ICG injections into the prostate base, the mid-portion, the apex, the left lobe, or the right lobe.  They found that external and internal iliac regions encompass the majority of SLNs; that common iliac regions contain up to 22 % of all SLNs; that a prostatic lobe can drain into the contralateral group of pelvic LNs; and that the fossa of Marcille also receives significant drainage.  Among the 12 patients who received systematic ICG injections, 5 (42 %) had a total of 29 LN metastases.  Of these, 16 nodes were ICG-positive, yielding 55 % sensitivity.  The authors concluded that the complex drainage pattern of the prostate and the low sensitivity of ICG for the detection of LN metastases reported in this trial highlighted the difficulties related to the implementation of SNL techniques in PCa.

Amara et al (2023) noted that landmark artery identification in the neuro-vascular bundle (NVB) is important for nerve-sparing in radical prostatectomy.  In a retrospective, single-center study, these investigators examined intra-operative angiography using ICG and NIRF (ICG-NIRF) during robot-assisted radical prostatectomy (RARP) to identify the NVB, visualize vascularization and hemostasis, and preserve erectile function.  This trial was carried out in consecutive localized prostate cancer RARP patients (stage T1/T2, prostate-specific antigen [PSA] of less than 10 ng/ml) who underwent ICG-NIRF angiography in France (2016 to 2021).  When ready to dissect the NVB, the anesthesiologist intravenously injected 3-ml ICG; the surgeon used alternating standard light or fluorescence to optimize NVB visualization and facilitate microdissection.  Primary outcomes included safety and feasibility of ICG-NIRF.  Secondary outcomes included functional erectile dysfunction (Sexual Health Inventory for Men (SHIM) questionnaire) over 9 months, proportion of bilateral NVBs identified, ICG-related complications.  Standard descriptive statistics were used; t-test determined the significance of changes in SHIM scores versus baseline.  A total of 91 patients received intra-operative angiography.  The NVB was identified in all cases, without difficulties.  No ICG-related complications or allergies were observed.  There was no significant difference in the SHIM score at 9 months compared with baseline (p = 0.331), and erectile dysfunction returned to baseline levels in almost all patients.  The authors concluded that intra-operative, real-time ICG-NIRF angiography was simple, non-invasive, and improved identification of key anatomical landmarks to optimize micro-preservation of the NVB during RARP and preserve erectile function.  Moreover, these researchers stated that larger clinical studies are needed to confirm these preliminary findings.

Xie et al (2023) noted that ICG with NIR fluorescence absorption is approved by the Food and Drug Administration (FDA) for clinical applications in angiography, blood flow evaluation, and liver function assessment.  It has strong optical absorption in the near-infrared region, where light can penetrate deepest into biological tissue.  These investigators examined the value of NIR fluorescence absorption in guiding PCa treatment.  All related literature at PubMed from January 2000 to December 2020 were reviewed.  Multiple pre-clinical studies have shown the usefulness of ICG in identifying PCa by using different engineering techniques.  Clinical studies have reported the usefulness of ICG in guiding sentinel node dissection during radical prostatectomy, and possible better preservation of neurovascular bundle by identifying landmark prostatic arteries.  New techniques such as adding fluorescein in additional to ICG were tested in a limited number of patients with encouraging result.  Furthermore, the use of the ICG was shown to be safe.  Even though there are encouraging results, it does not carry sufficient sensitivity and specificity in replacing extended pelvic LND during radical prostatectomy.  The authors concluded that multiple pre-clinical as well as clinical studies have shown the usefulness of ICG in identifying and guiding treatment for PCa.  Moreover, these researchers stated that larger, prospective, randomized studies are needed to further test its usefulness and find new modified approaches.

Małkiewicz et al (2023) stated that LN metastases have a significant negative impact on the prognosis of urological malignancies.  Unfortunately, current imaging modalities are insufficient when it comes to detecting micro-metastases; therefore, surgical LN removal is commonly used.  However, there is still no established ideal LND template, leading to unnecessary invasive staging and the possibility of missing LN metastases located outside the standard template.  To address this issue, the SLN concept has been proposed.  This technique entails identifying and removing the 1st group of draining LNs, which can accurately stage cancer.  While successful in breast cancer and melanoma, the SLN technique in urologic oncology is still considered experimental due to high false-negative rates and lack of data in prostate, bladder, and kidney cancer.  Nevertheless, the development of new tracers, imaging modalities, and surgical techniques may improve the potential of the SLN procedures in urological oncology.  The authors discussed the current knowledge and future contributions of the SLN procedure in the management of urological malignancies.  These researchers stated that the European Association of Urology (EAU) guidelines point toward the insufficiency of evidence supporting SLNB.  This state may be due to various factors, including significant heterogeneity and inconsistency of definitions, thresholds, types of tracers, surgical approaches, detection methods, and outcome measurements.  SLNB in PCa was first described in 1999.  Now, almost 25 years later, SLNB is still considered an experimental procedure in PCa.

An UpToDate review on “Radical prostatectomy for localized prostate cancer” (Klein, 2023) does NOT mention intraoperative sentinel lymph node mapping as a management option.    

Furthermore, National Comprehensive Cancer Network’s clinical practice guideline on “Prostate Cancer” (Version 4.2023) does NOT mention intraoperative sentinel lymph node mapping.

Breast Reconstruction Surgery

Yoo et al (2022) stated that the DIEP is a widely known reliable option for autologous breast reconstruction.  One common complication of DIEP procedures is fat necrosis.  Consequences of fat necrosis include wound healing complications, pain, infection, and the psychological distress of possible cancerous recurrence.  Clinical judgment alone is an imperfect method to detect at-risk segments of adipose tissue.  Objective methods to evaluate perfusion may improve fat necrosis complication rates, reducing additional surgeries to exclude cancer and improve cosmesis for patients.  In a retrospective review, these researchers examined DIEP flap vascularity with or without intra-operative ICGA.  Flap perfusion was assessed using intravenous ICGA and was quantified with both relative and absolute value units of fluorescence.  Tissue with observed values of less than 25 % to 30 % relative value units (RVUs) was resected.  Post-operative outcomes and fat necrosis incidence were collected.  A total of 355 DIEP flaps were included in the study, 187 (52.7 %) of which were assessed intra-operatively with ICGA; 39 patients (10.9 %) experienced operable fat necrosis.  No statistically significant difference in incidence of post-operative fat necrosis was found between the 2 groups (p = 0.732).  However, a statistically significant relationship was found between fat necrosis incidence and BMI as both a continuum (p = 0.001) and when categorized as greater than 35 (p = 0.038).  The authors concluded that although ICGA was useful for a variety of plastic surgery procedures, this retrospective review did not show a reduction in operable fat necrosis when using this technology.

Park et al (2022) evaluated perfusion of the DIEP flap according to vertical location and vertical spacing of perforators during DIEP flap breast reconstruction.  In 67 patients who underwent unilateral DIEP flap breast reconstruction between November 2018 and August 2021, flap perfusion was examined intra-operatively using ICGA.  Perforators located at or above the umbilicus were defined as vertical zone 1 perforators and those below the umbilicus as vertical zone 2 perforators.  Perfusion assessment was carried out in 2 stages: at stage 1, perfusion solely by single dominant perforators was assessed.  At stage 2, the perfusion increment effected by adding a single additional perforator was assessed.  Perfused area proportions were compared between patients with dominant perforators in zone 1 versus zone 2.  The effect of adding an additional perforator to another vertical zone ("vertical spacing") was also assessed.  The perfused proportion was significantly higher among vertical zone 2 perforators compared with zone 1 perforators in the evaluation of single dominant perforators (70 % versus 56 %; p < 0.001).  In the evaluation of incremented perfusion by single additional perforators, the perfused proportion was significantly higher in the vertical-spacing group compared to the no-vertical-spacing group (17 % versus 12 %; p = 0.004).  Fat necrosis developed in 4.5 % of the patients over at least 6 months of follow-up.  The authors concluded that DIEP flap perfusion could be affected by the vertical location of perforators, and flap perfusion can be augmented effectively by vertical spacing of perforators.  These researchers stated that there is still no strong consensus on objective measurements from ICGA to predict perfusion outcomes in abdomen-based breast reconstruction; however, RVUs have been demonstrated to be superior to absolute values because absolute values could be affected by patient-related variables, such as obesity, smoking, and diabetes.

In commenting on the study by Park et al (2022), Lauritzen and Damsgaard (2023) stated that “ … as the authors state, the use and assessment of ICG-A is subjective and international consensus on the intraoperative application and interpretation has yet to be established.  Several stages of applying ICG-A for autologous breast reconstruction, including the intraoperative dose of ICG, interpretation of perfusion (i.e., fluorescence intensity) and cut-off scores (absolute- or relative values), remain unstandardized”.

Furthermore, an UpToDate review on “Overview of breast reduction” (Hansen and Chang, 2023) does not mention indocyanine green angiography/ICG angiography as a management option.

Bariatric Surgery

Hsu et al (2023) noted that ICG is a fluorescent dye that can be used intra-operatively to evaluate tissue perfusion; and conduct testing for leak.  In a systematic review, these investigators examined published manuscripts on outcomes of ICG use and reduction of complications compared to traditional leak test and tissue perfusion evaluation in bariatric surgery.  They carried out a PubMed search using "ICG and bariatric surgery", "ICG and gastric sleeve", "ICG and gastric bypass", and "ICG and revisional bariatric surgery".  The proportion of patients who underwent an intra-operative decision change due to ICG was 3.8 % (95 % CI: 2.0 % to 7.2 %).  The authors concluded that ICG fluorescent imaging in bariatric surgery is a useful tool; however, further studies are needed to confirm its routine utility in both standard, and complex cases in bariatric surgery.

Furthermore, UpToDate reviews on “Bariatric surgery: Postoperative and long-term management” (Hamad, 2023), and “Bariatric operations: Late complications with subacute presentations” (Ellsmere, 2023) do not mention ICG fluorescent imaging as a management option.

Endometrial Intraepithelial Neoplasia

Yu et al (2022) stated that total hysterectomy with lymph node assessment is the current standard-of-care (SOC) for surgical staging in apparent early-stage endometrial cancer (EC).  Compared to the traditional complete pelvic lymphadenectomy with or without para-aortic lymphadenectomy, SLN mapping results in fewer surgical complications, decreased operative time, and lower rates of chronic lymphedema.  The technique is endorsed by the NCCN and the Society of Gynecologic Oncology guidelines, and over the last 20 years the majority of gynecologic oncologists worldwide have adopted SLN mapping into their practice.  However, as the results of the initial SLN studies were mostly based on low-grade tumors, adoption of the technique in high-grade tumors has been slower and more controversial.  These investigators discussed the most recent studies examining the SLN mapping in high-grade ECs.  The results of these studies suggested that the SLN detection rate is acceptably high, and the NPV is sufficiently low to support the use of SLN mapping in high-grade endometrial tumors to replace complete lymphadenectomy.  Validity of SLN mapping techniques does, however, require following a standard algorithm, and success depends also on surgeon expertise.  Moreover, the impact of SLN mapping on overall survival (OS) in high-grade tumors requires future prospective randomized studies.  Finally, a transition toward near-universal SLN mapping techniques for ECs could significantly impact on the adequacy of gynecologic oncology fellows' surgical training and competency in lymphadenectomy.

In a prospective, multi-center study, Burg et al (2022) examined the incidence of SLN metastases and the contribution of SLN mapping in presumed low- and intermediate-risk EC.  Patients underwent SLN mapping using cervical injections of ICG and a minimally invasive hysterectomy with bilateral salpingo-oophorectomy.  The primary outcome was the incidence of SLN metastases, leading to adjusted adjuvant treatment.  Secondary outcomes were the SLN detection rate and the occurrence of complications.  Descriptive statistics and univariate general linear model analyses were used.  A total of 152 patients were enrolled, with overall and bilateral SLN detection rates of 91 % and 61 %, respectively.  At final histology, 78.9 % of patients (n = 120) had truly low- and intermediate-risk EC.  Macro- and micro-metastases were present in 11.2 % (n = 17/152), and 3 patients had isolated tumor cells (2.0 %); 9 patients (5.9 %) had addition of adjuvant radiotherapy (RT) based on SLN metastases only.  In 2.0 % of patients with high-risk disease, adjuvant therapy was more limited due to negative SLNs.  The authors concluded that the findings of this study emphasized the importance of SLN mapping in presumed early-stage, grade-1 and grade-2 EC, leading to individualized adjuvant management, resulting in less under-treatment and over-treatment.

Raffone et al (2022) stated that in EC patients, SLNB has shown the potential to reduce post-operative morbidity and long-term complications, and to improve the detection of low-volume metastasis through ultra-staging.  However, while it has shown high sensitivity and feasibility in low-risk EC patient groups, its role in high-risk groups is still unclear.  These researchers examined the role of SLNB through the cervical injection of ICG in high-risk groups of early-stage EC patients.  Among the several tracers and injection sites proposed for SLN mapping, the cervical injection of fluorescent dye ICG has shown the highest bilateral pelvic detection rate and is recommended at the present time.  A total of 7 electronic databases were searched from their inception to February 2021 for studies that allowed data extraction about detection rate and accuracy of SLNB through the cervical injection of ICG in high-risk groups of early-stage EC patients.  These investigators calculated pooled sensitivity, false negative (FN) rate, detection rate of SLN per hemipelvis (DRh), detection rate of SLN per patients (DRp), and bilateral detection rate of SLN (DRb), with 95 % CI.  A total of 5 observational cohort studies (3 prospective and 2 retrospective) assessing 578 high risk EC patients were included.  SLNB sensitivity in detecting EC metastasis was 0.90 (95 % CI: 0.03 to 0.95); FN rate was 2.8 % (95 % CI: 0.6 % to 11.6 %); DRh was 88.4 % (95 % CI: 86 % to 90.5 %); DRp was 96.6 % (95 % CI: 94.7 % to 97.8 %); and DRb was 80 % (95 % CI: 75.4 % to 83.9 %).  The authors concluded that SLN biopsy through ICG cervical injection may be routinely adopted instead of systematic pelvic and para-aortic lymphadenectomy in surgical staging for high-risk groups of early-stage EC patients, as well as in low-risk groups.

In a retrospective study, Mueller et al (2023) compared outcomes of patients with pre-malignant endometrial pathology undergoing hysterectomy with or without SLN removal.  Outcomes of interest included surgical adverse events (AEs), cancer status on final pathology, post-operative treatment, and The Cancer Genome Atlas (TCGA) molecular risk profiles.  These researchers identified patients with pre-malignant pathology on pre-operative endometrial biopsy who underwent hysterectomy with or without SLN mapping/excision at their institution from January 1, 2017 to December 31, 2021.  Clinical, pathologic, surgical, and TCGA profiling data were abstracted.  Appropriate statistical tests were used.  Of 221 patients identified, 161 (73 %) underwent hysterectomy with SLN excision and 60 (27 %) underwent hysterectomy without SLN excision.  Median age and BMI were similar between groups.  Median operative time was 130 mins for those who underwent SLN mapping/excision versus 136 mins for those who did not (p = 0.6); 30-day post-operative AE rates were 9 % (n = 15/161) and 13 % (n = 8/60), respectively (p = 0.9); 98 (44 %) of 221 patients had grade-1 to grade-2 endometrioid EC on final pathology (4 [4 %] were stage IB or higher); 10 (10 %) of 98 patients, all within the SLN group, received adjuvant treatment.  Among all patients, of 33 (15 %) with TCGA molecular classification data, 27 (82 %) had copy number-low, 3 (9 %) micro-satellite instability (MSI)-high, 2 (6 %) POLE-ultra-mutated, and 1 (3 %) copy number-high disease.  The authors concluded that SLN assessment appeared safe, detected a small number of occult nodal metastases for those up-staged, and provided additional staging information that could guide adjuvant treatment.  These investigators stated that SLN mapping should be discussed in pre-operative counseling and offered using a shared decision-making approach.

In a retrospective study, Bogani et al (2023) compared outcomes after hysterectomy and hysterectomy plus sentinel node mapping (SNM) in EC patients.  These researchers collected data of EC patients treated between 2006 and 2016 in 9 referral centers.  The study population included 398 (69.5 %) and 174 (30.5 %) patients having hysterectomy and hysterectomy plus SNM.  As the results of the adoption of a propensity-score matched analysis, these investigators selected 2 homogeneous cohort of patients (150 having hysterectomy only versus 150 having hysterectomy plus SNM).  The SNM group had a longer operative time; but did not correlate with hospital LOS and EBL.  Overall severe complication rates were similar between groups (0.7 % in the hysterectomy group versus 1.3 % in the hysterectomy plus SNM group; p = 0.561).  No lymphatic-specific complication occurred.  Overall, 12.6 % of patients having SNM were diagnosed with disease harboring in their lymph nodes.  Adjuvant therapy administration rate was similar between groups.  Considering patients having SNM, 4 % of patients received adjuvant therapy on the basis of nodal status alone; all the other patients received adjuvant therapy also on the basis of uterine risk factors.  The 5-year disease-free survival (DFS) (p = 0.720) and OS (p = 0.632) survival was not influenced by surgical approach.  The authors concluded that hysterectomy (with or without SNM) was a safe and effective method for managing EC patients.  Potentially, these data support the omission of side specific lymphadenectomy in case of unsuccessful mapping.

Furthermore, National Comprehensive Cancer Network’s clinical practice guideline on “Uterine neoplasms ” (Version 1.2024) states that “SLN identification should always be done prior to hysterectomy, except in cases where a bulky uterus must be removed to allow access to iliac vessels and lymph nodes”.

ICG Angiography for Evaluation of Choroidal Hemangioma

Schalenbourg et al (2000) stated that ICG-A is a new diagnostic modality that was suggested, in small series, to provide a typical angiographic pattern in cases of choroidal hemangioma.  This study, through an exceptionally large series of 75 patients, assessed in a prospective way whether a typical ICG pattern of choroidal hemangioma exists and what would be its possible variations.  The most constant feature is the sequence of the different ICG angiographic phases.  The arterial phase demonstrated the filling of intra-tumoral vessels on a hypo-fluorescent tumoral background.  During the venous phase, the hemangioma reaches a stage of maximal ICG-A fluorescence, with superimposed hyper- and hypo-fluorescent spots.  Sturge-Weber cases have also extra-tumoral hyper-fluorescent spots.  The late phase showed a hypo-fluorescent lesion with residual hyper-fluorescent caverns and a well-delineated, but complex border structure.

Snyers and De Potter (2002) noted that ICG-A is a well-known ancillary test for evaluation of choroidal tumors.  The authors reviewed the different images observed in choroidal nevus, melanoma, metastasis, hemangioma, osteoma, and vortex vein varix.  They stated that ICG-A appeared to be useful for the diagnosis of non-pigmented choroidal tumors.  Furthermore, ICG-A provided good information on the limits of pigmented tumors, especially for the follow-up of a growing tumor and the choice of treatment.

Mashayekhi and Shields (2003) stated that circumscribed choroidal hemangioma (CCH) is an uncommon, benign vascular tumor manifesting as an orange-red mass in the posterior pole of the eye.  Serous retinal detachment accounts for decreased vision in most patients.  Diagnosis of this tumor is challenging with many patients initially misdiagnosed with choroidal melanoma or metastasis.  Several ancillary tests such as ultrasonography (US), FA, ICG-A, and MRI aid in differentiating this tumor from other simulating lesions.  Asymptomatic lesions should be observed, but visually-threatening or visually-impairing lesions require treatment.  Photodynamic therapy (PDT), laser photocoagulation, and trans-pupillary thermotherapy may be used for primary management of this tumor.  Patients who fail to respond to previous treatment or those with extensive serous retinal detachment can be treated using radio-therapeutic modalities.  Long interval between onset of symptoms and treatment, poor visual acuity (VA) at presentation, and presence of chronic retinal or retinal pigment epithelial changes were associated with poor long-term vision.

Munteanu et al (2013) noted that choroidal hemangiomas are benign vascular hamartomas that typically present from 2nd to 4th decade of life, when they can cause visual disturbance due to exudative retinal detachment.  They represent uncommon benign choroidal vascular tumors, usually occurring sporadically in the absence of systemic disease.  These investigators reported the case of a young female patient, presenting with a juxta-papillary CCH complicated with serous macular detachment.  The patient underwent PDT with verteporfin.  Systematic follow-up using ophthalmoscopy, US, FA, and ICG-A was performed.  The patient presented regression with flattening of tumor, resolution of the sub-retinal fluid, and significant improvement of vision.  The authors concluded that mostly asymptomatic, the choroidal hemangiomas can be associated with serous retinal detachment, leading to reduced vision and metamorphopsia; in those cases, the long-term visual prognosis was poor, even in adequately treated patients.  PDT was effective in eliminating the sub-retinal fluid and improving vision in patients with CCH.

Panova et al (2020) examined the use of US color Doppler imaging and ICG-A for identification of malignant vasculature of choroidal tumors.  This trial included 46 patients (46 eyes) with tumors of the choroid: 19 men and 26 women aged 22 to 89 years, average age of 53.2 ± 17.1 years.  All patients underwent ICG-A and Doppler US imaging.  At the time of examination, thickness of the tumors ranged from 1.1 mm to 3.0 mm, and the base diameter from 4.0 mm to 13.0 mm.  Choroidal melanoma was diagnosed in 27 patients, choroidal nevus in 10, choroidal hemangioma in 5, and choroidal metastasis in 4 patients.  The results of ICG-A showed that the pathological malignant vasculature was determined: nevi was diagnosed in 7 out of 10 patients, choroidal melanoma in 16 out of 27, metastasis in 2 out of 4, and hemangioma in none of the 5 patients.  Pathological malignant vasculature was determined in most patients with choroidal melanoma (77.8 %), in all patients with choroidal hemangioma, and in 3 patients with choroidal metastases.  Ultrasound imaging revealed malignant vasculature in 15 of 27 (56 %) patients with choroidal melanoma, it could be identified in all patients with hemangioma in 2 patients and with choroidal metastases, and in 0 patients with choroidal nevi.  The authors concluded that ICG-A aided in verifying malignant vasculature in 77.8 % of patients with small and medium sized choroidal melanomas.  Angio-architecture of choroidal tumors visualized with ICG-A is characterized by variability of patterns, which should be considered in the differential diagnosis of various pathological diseases.

Tesar et al (2021) noted that pachy-choroid disease of retina is a spectrum of diseases manifested by thickening and hyper-perfusion of the choroid with changes in the sensory part of the retina.  The main unit of this group is central serous chorioretinopathy (CSC).  In practice, these investigators often encounter other conditions, which are manifested by thickening of the choroid and changes in the retina, but they could not be classified as pachy-choroid diseases.  They described 3 case-reports that demonstrated the difficulties in the differential diagnosis of retinal diseases in which thickening of the choroid was observed.  Case report 1: A 42-year-old patient treated for CSC.  After OCT, FA, and ICG-A, the diagnosis was changed to choroidal hemangioma, and he was treated with PDT that resulted in a reduction of the hemangioma.  Case report 2: A 30-year-old patient treated for ankylosing spondylitis exhibited visual impairment in the left eye.  On OCT, the condition resembled chronic CSC.  The patient suffered from a febrile exanthema a few days ago.  Serological testing for coxsackievirus was positive and the diagnosis was changed to acute chorioretinitis in coxsackievirus infection.  Oral treatment with prednisone was successful.  Case report 3: A 46-year-old patient was treated conservatively for CSC.  After FA and ICG-A, a solitary dilated choroidal vessel was found in the area of the papillo-macular bundle with leakage under the sensory epithelium that was diagnosed as choroidal macro-vessel.  These investigators carried out PDT with a very good anatomical effect.  The authors concluded that precise differentiation of the afore-mentioned diseases from pachy-choroid retinal diseases was essential in choosing the appropriate therapy.  The use of all modern imaging methods of the retina and choroid plays a key role in determining the diagnosis.

Roelofs et al (2021) stated that CCH has several characteristic clinical and angiographic features.  These researchers compared ICG-A findings of CCH captured on a traditional digital camera system (DCS) to newer scanning laser ophthalmoscopy (SLO) platforms.  A total of 35 patients over a 10-year period diagnosed with CCH using ICG-A were included (18 imaged with DCS and 17 with SLO).  On early ICG frames, intrinsic vessels were apparent in two-thirds (12/18; 67 %) of the DCS group compared with all of eyes in the SLO group (p = 0.020).  Furthermore, at maximal hyper-fluorescence, most eyes imaged with DCS had a feathery appearance (16/18; 89 %) compared with those in the SLO group which all (17/17; 100 %) displayed a granular appearance (p < 0.001).  The presence of hot spots at maximal hyper-fluorescence was also more common in the SLO group (12/17; 71 %) versus the DCS group (0/18; 0 %) (p < 0.001).  Finally, intrinsic vessels and vascular loops could be identified throughout the entire duration of the ICG-A in 100 % of the SLO cases (17/17) versus only 11 % (2/18) of DCS cases (p < 0.001).  The authors concluded that the visualization of intrinsic vessels, vascular loops, and "hot spots" in CCH was significantly enhanced with SLO compared with DCS.  Many characteristic mid-late angiographic findings of CCH were more optimally visualized on SLO that may negate the need for late frames (longer than 30 mins) without compromising diagnostic accuracy.

ICG Angiography for Follow-Up of Branch Retinal Vein Occlusion Status Post Bevacizumab

The Prescribing Information (PI) of Avastin (bevacizumab) notes that posterior reversible encephalopathy syndrome (PRES) was reported in less than 0.5 % of patients across clinical studies.  The onset of symptoms occurred from 16 hours to 1 year after the 1st dose.  PRES is a neurological disorder that can present with headache, seizure, lethargy, confusion, blindness and other visual and neurologic disturbances.  Mild-to-severe hypertension may be present.  Magnetic resonance imaging (MRI) is needed to confirm the diagnosis of PRES.  The PI does NOT mention fluorescein angiography/ICG.  

Furthermore, an UpToDate review on “Retinal vein occlusion: Epidemiology, clinical manifestations, and diagnosis” (Han and Ahmad, 2023) states that “Fluorescein angiography is a procedure lasting approximately 10 to 20 minutes in which fluorescein dye is injected into a peripheral vein, and a special camera is used to visualize retinal blood flow.  It is the definitive test to confirm the diagnosis of RVO and to assess the degree of retinal nonperfusion.  The fluorescein angiogram may reveal delayed venous filling, staining of affected retinal veins, and angiographic macular leakage in RVOs of recent and longstanding duration.  In patients in whom the diagnosis of RVO is clear on the basis of ophthalmoscopic findings alone and the area of retinal involvement is less than 10 disk areas, the value of performing fluorescein angiography lies mainly in determining whether laser photocoagulation therapy or intraocular injections of vascular endothelial growth factor (VEGF) inhibitors should be considered”.  This UTD review does NOT mention fluorescein angiography and indocyanine-green angiography as a management option.

ICG Angiography for Monitoring Birdshot Chorioretinitis

Bousquet et al (2022) noted that birdshot chorioretinopathy is a bilateral chronic inflammation of the eye with no extraocular manifestations.  These investigators stated that multi-modal imaging, including FA, ICGA, fundus auto-fluorescence (FAF), and OCT, are useful in confirming the diagnosis and monitoring disease activity.  They noted that FA is a useful tool for monitoring retinal inflammation, more specifically, retinal vein vasculitis, which is characterized by vascular leakage and irregular venous caliber; and ICGA is a useful tool for the diagnosis of BSCR when the birdshot lesions are not obvious on ophthalmoscopy, for monitoring disease activity and assessing the effects of treatment.

StatPearls’ webpage on “Birdshot retinopathy” (Bergstrom and Czyz, 2023) states that FA often shows leaking from the retinal vessels and nerve head.  Leakage can often produce cystoid macular edema and is thought to be the leading cause of visual loss in patients with birdshot chorioretinopathy (BCR).  If there is clinical suspicion for BCR, the following can help confirm the diagnosis: HLA-A29, syphilis serology, ACE level in all cases; interferon-gamma release assay and/or a Mantoux test in selected high-risk cases; chest X-ray (looking for evidence of sarcoidosis or TB) in all cases; ICGA, FA, and electroretinography (ERG) in all cases.

Furthermore, American Academy of Ophthalmology’s EyeWiki on “Birdshot retinochoroidopathy” (O’Keefe et al, 2023) noted that FA and ICGA are used for monitoring of the disease.  With FA; initially, there will be hypo-fluorescent lesions with subtle late staining, however, ICGA is a better test for following lesions.  FA is more useful for monitoring disease progression (i.e., cystoid macular edema, optic nerve head leakage, vasculitis).

Intra-Operative ICG Angiography for Pancreas Stump Perfusion Assessment During Pancreaticoduodenectomy

Robertson et al (2023) noted that post-operative pancreatic fistula (POPF) is the primary cause of morbidity following pancreaticoduodenectomy.  Rates of POPF have remained high despite well-known risk factors.  The theory that hypoperfusion of the pancreatic stump results in anastomotic failure has recently gained interest.  In a systematic review, these investigators examined the published literature regarding intra-operative pancreas perfusion assessment and its correlation with POPF.  They carried out a systematic search of available literature in November 2022.  Data extracted included study characteristics, method of assessment of pancreas stump perfusion, POPF and other post-pancreatic surgery specific complications.  A total of 5 eligible studies comprised 2 prospective, non-randomised studies and 3 case-reports, totaling 156 patients; 4 studies used ICG fluorescence angiography to evaluate the pancreatic stump, with the remaining study examining pancreas perfusion by visual inspection of arterial bleeding of the pancreatic stump.  There was significant heterogeneity in the definition of POPF.  Studies had a combined POPF rate of 12 %; intra-operative perfusion assessment revealed hypoperfusion was present in 39 % of patients who developed POPF.  The rate of POPF was 11 % in patients with no evidence of hypoperfusion and 13 % in those with evidence of hypoperfusion, suggesting that not all hypoperfusion result in POPF; and further investigation is needed to determine if there is a clinically relevant cut-off.  Significant variance in practice was observed in the pancreatic stump management once hypoperfusion was identified.  The authors concluded that the available evidence around pancreas perfusion during pancreaticoduodenectomy was of poor quality; it did not support a causative link between hypoperfusion and POPF.  These researchers stated that further prospective, well-designed studies are needed to investigate this.

Intra-operative ICG Angiography for Prevention of Anastomotic Leakage After Rectal Cancer Surgery

Xia et al (2023) stated that anastomotic leakage is a serious complication following rectal cancer surgery.  Intra-operative use of ICG fluorescence angiography (ICGFA) can aid in preventing anastomotic leakage; however, its use is controversial.  In a systematic review and meta-analysis, these investigators examined the effectiveness of ICGFA in reducing anastomotic leakage.  Relevant data and research published until September 30, 2022, was retrieved from the PubMed, Embase, and Cochrane Library databases, and the difference in the incidence of anastomotic leakage after rectal cancer resection between ICGFA and standard treatment was compared.  This meta-analysis included 22 studies with a total of 4,738 patients.  The results showed that ICGFA use during surgery decreased the incidence of anastomotic leakage after rectal cancer surgery [risk ratio (RR) = 0.46; 95 % CI: 0.39 to 0.56; p < 0.001].  Simultaneously, in subgroup analyses for different regions, ICGFA was found to be used to reduce the incidence of anastomotic leakage after rectal cancer surgery in Asia (RR = 0.33; 95 % CI: 0.23 to 0.48; p < 0.00001) and Europe (RR = 0.38; 95 % CI: 0.27 to 0.53; p < 0.00001); but not in North America (RR = 0.72; 95 % CI: 0.40 to 1.29; p = 0.27).  Regarding different levels of anastomotic leakage, ICGFA reduced the incidence of post-operative type A anastomotic leakage (RR = 0.25; 95 % CI: 0.14 to 0.44; p < 0.00001), but did not reduce the incidence of type B (RR = 0.70; 95 % CI: 0.38 to 1.31; p = 0.27) and type C (RR = 0.97; 95 % CI: 0.51 to 1.97; p = 0.93) anastomotic leakages.  The authors concluded that ICGFA has been linked to a reduction in anastomotic leakage after rectal cancer resection.  Moreover, these researchers stated that multi-center RCTs with larger sample sizes are needed for further validation.

The authors stated that this study had several drawbacks.  First, the diagnosis of anastomotic leakage varied across the studies.  Some studies were diagnosed solely via radiology, whereas others were diagnosed via physical examination and endoscopy as well.  Second, the dose of ICG administered and timing of the included studies were inconsistent.  Third, restricted by the studies included, this systematic review could not be analyzed according to the level of rectal cancer.  Fourth, the number of RCTs in the study was insufficient, which may increase the risk of deviation.  These drawbacks may result in heterogeneity in the analysis of research findings.

References

The above policy is based on the following references:

1. Alberta Provincial Breast Tumour Team. Breast reconstruction following prophylactic or therapeutic mastectomy for breast cancer. Clinical Practice Guideline BR-016, version 2. Edmonton, AB: Alberta Health Services; February 2017. 
2. Alius C, Tudor C, Badiu CD, et al. Indocyanine green-enhanced colorectal surgery -- between being superfluous and being a game-changer. Diagnostics (Basel). 2020;10(10):742.
3. Altaweel M. Best disease. Medscape. October 10, 2016. Available at: http://emedicine.medscape.com/article/1227128-overview. Accessed October 14, 2016.
4. Amara N, Youssef TA, Massa J, et al. Intraoperative angiography of the neurovascular bundle using indocyanine green and near-infrared fluorescence improves anatomical dissection during robot-assisted radical prostatectomy: Initial clinical experience. J Robot Surg. 2023;17(2):687-694. 
5. American Academy of Ophthalmology (AAO), Retina Panel. Idiopathic macular hole. Preferred Practice Pattern. San Francisco, CA: AAO; 2003.
6. American Academy of Ophthalmology (AAO). Age-related macular degeneration. Preferred Practice Pattern. San Francisco, CA: AAO; 2006.
7. American Academy of Ophthalmology (AAO). Comprehensive adult medical eye evaluation. Preferred Practice Pattern. San Francisco, CA: AAO; September 2005.
8. American Academy of Ophthalmology. Indocyanine green angiography. Ophthalmology. 1998;105(8):1564-1569.
9. Aoun F, Albisinni S, Zanaty M, et al. Indocyanine green fluorescence-guided sentinel lymph node identification in urologic cancers: A systematic review and meta-analysis. Minerva Urol Nefrol. 2018;70(4):361-369.
10. Bergstrom R, Czyz CN. Birdshot retinopathy. StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing: August 8, 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK554416/. Accessed January 25, 2024.
11. Beutel J, Dahmen G, Ziegler A, Hoerauf H. Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: A randomized trial. Arch Ophthalmol. 2007;125(3):326-332.
12. Bigcas JLM, DeBiase CA, Ho T. Indocyanine green angiography as the principal design and perfusion assessment tool for the supraclavicular artery island flap in head and neck reconstruction. Cureus. 2022;14(9):e29007.
13. Blanco-Colino R, Espin-Basany E. Intraoperative use of ICG fluorescence imaging to reduce the risk of anastomotic leakage in colorectal surgery: A systematic review and meta-analysis. Tech Coloproctol. 2018;22(1):15-23.
14. Bogani G, Di Donato V, Papadia A, et al. Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: Perioperative and long-term results from a propensity-score based study. Eur J Surg Oncol. 2023;49(5):1037-1043.
15. Boni L, David G, Dionigi G, et al. Indocyanine green-enhanced fluorescence to assess bowel perfusion during laparoscopic colorectal resection. Surg Endosc. 2016;30(7):2736-2742.
16. Bouchenaki N, Herbort CP. Indocyanine green angiography guided management of vogt-koyanagi-harada disease. J Ophthalmic Vis Res. 2011;6(4):241-248.
17. Bousquet E, Duraffour P, Debillon L, etal. Birdshot chorioretinopathy: A review. J Clin Med. 2022;11(16):4772.
18. Brancato R, Trabucchi G. Fluorescein and indocyanine green angiography in vascular chorioretinal diseases. Semin Ophthalmol. 1998;13(4):189-198.
19. Braun JD, Trinidad-Hernandez M, Perry D, et al. Early quantitative evaluation of indocyanine green angiography in patients with critical limb ischemia. J Vasc Surg. 2013;57(5):1213-1218.
20. Buda A, Crivellaro C, Elisei F, et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: Comparison with conventional radiotracer (99m)Tc and/or blue dye. Ann Surg Oncol. 2016;23(7):2183-2191.
21. Buda A, Passoni P, Corrado G, et al. Near-infrared fluorescence-guided sentinel node mapping of the ovary with indocyanine green in a minimally invasive setting: A feasible study. J Minim Invasive Gynecol. 2017;24(1):165-170.
22. Burg LC, Kruitwagen RFPM, de Jong A, et al. Sentinel lymph node mapping in presumed low- and intermediate-risk endometrial cancer management (SLIM): A multicenter, prospective cohort study in the Netherlands. Cancers (Basel). 2022;15(1):271.
23. Campbell C, Reames MK, Robinson M, et al. Conduit vascular evaluation is associated with reduction in anastomotic leak after esophagectomy. J Gastrointest Surg. 2015;19(5):806-812.
24. Canadian Agency for Drugs and Technologies in Health (CADTH). Intraoperative assessment of coronary artery bypass grafts: Guidelines. Rapid Response Report: Reference List. Edmonton, ON: CADTH; July 7, 2011.
25. Carus T, Pick P. Intraoperative fluorescence angiography in colorectal surgery. Chirurg. 2019;90(11):887-890.
26. Chand M, Keller DS, Joshi HM, et al. Feasibility of fluorescence lymph node imaging in colon cancer: FLICC. Tech Coloproctol. 2018;22(4):271-277.
27. Chatterjee A. A comparison of free autologous breast reconstruction with and without the use of laser-assisted indocyanine green angiography: A cost-effectiveness analysis. Plast Reconstr Surg. 2013;131(5):693e-701e.
28. Chee SP, Jap A. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2013;97(2):130-133.
29. Cheng SN, Yang TC, Ho JD, et al. Ocular toxicity of intravitreal indocyanine green. J Ocul Pharmacol Ther. 2005;21(1):85-93.
30. Ciulla TA, Harris A, Martin BJ. Ocular perfusion and age-related macular degeneration. Acta Ophthalmol Scand. 2001;79(2):108-115.
31. Colavita PD, Wormer BA, Belyansky I, et al. Intraoperative indocyanine green fluorescence angiography to predict wound complications in complex ventral hernia repair. Hernia. 2016;20(1):139-149.
32. Connolly PH, Meltzer AJ, Spector JA, Schneider DB. Indocyanine green angiography aids in prediction of limb salvage in vascular trauma. Annals of Vascular Surgery. 2015;29(7):1453e1-1453-e4.
33. Cordero E, Enseñat J, Macho J, et al. Intraoperative videoangiography using green indocyanine during aneurysm surgery. Neurocirugia (Astur). 2010;21(4):302-305.
34. Dashti R, Laakso A, Niemelä M, et al. Microscope-integrated near-infrared indocyanine green videoangiography during surgery of intracranial aneurysms: The Helsinki experience. Surg Neurol. 2009;71(5):543-550; discussion 550.
35. d'Avella E, Volpin F, Manara R, et al. Indocyanine green videoangiography (ICGV)-guided surgery of parasagittal meningiomas occluding the superior sagittal sinus (SSS). Acta Neurochir (Wien). 2013;155(3):415-420.
36. de Oliveira JG, Beck J, Seifert V, et al. Assessment of flow in perforating arteries during intracranial aneurysm surgery using intraoperative near-infrared indocyanine green videoangiography. Neurosurgery. 2007;61(3 Suppl):63-72; discussion 72-73.
37. Degett TH, Andersen HS, Gogenur I. Indocyanine green fluorescence angiography for intraoperative assessment of gastrointestinal anastomotic perfusion: A systematic review of clinical trials. Langenbecks Arch Surg. 2016;401(6):767-775.
38. Della Puppa A, Rustemi O, Gioffre G, et al. Application of indocyanine green video angiography in parasagittal meningioma surgery. Neurosurg Focus. 2014;36(2):E13.
39. DeLong JC, Ward EP, Lwin TM, et al. Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism. Surgery. 2018;163(2):388-392.
40. Desai ND, Miwa S, Kodama D, et al. A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts. J Thorac Cardiovasc Surg. 2006;132(3):585-594.
41. Di Martino G, Crivellaro C, De Ponti E, et al. Indocyanine green versus radiotracer with or without blue dye for sentinel lymph node mapping in stage >IB1 cervical cancer (>2 cm). J Minim Invasive Gynecol. 2017;24(6):954-959.
42. Dugan C, Cestari D, Pineles Sl, et al. Non-arteritic anterior ischemic optic neuropathy (NAION). American Academy of Ophthalmology (AAO). EyeWiKi. September 11, 2022. Available at: https://eyewiki.aao.org/Non-Arteritic_Anterior_Ischemic_Optic_Neuropathy_(NAION). Accessed January 25, 2023.
43. Duggal CS. An outcome analysis of intraoperative angiography for postmastectomy breast reconstruction. Aesthetic Surgery Journal. 2014;34(1):61-65.
44. Ellsmere JXC. Bariatric operations: Late complications with subacute presentations. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2023.
45. Fourman MS, Phillips BT, Crawford L, et al. Indocyanine green dye angiography accurately predicts survival in the zone of ischemia in a burn comb model. Burns. Burns. 2014;40(5):940-946.
46. Freund MR, Kent I, Agarwal S, Wexner SD. Use of indocyanine green fluorescence guidance in redo ileocolic resection for Crohn's disease. Colorectal Dis. 2021;23(12):3190-3195.
47. Ganley JP, Kooragayala LM. Acute multifocal posterior placoid pigment epitheliopathy. eMedicine Ophthalmology. Topic 422. Omaha, NE: eMedicine.com; updated August 22, 2001. Available at: http://www.emedicine.com/oph/topic422.htm. Accessed January 21, 2004.
48. Gedik S, Akova Y, Yilmaz G, Bozbeyoglu S. Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease. Ocul Immunol Inflamm. 2005;13(1):51-58.
49. Griffiths M, Chae MP, Rozen WM. Indocyanine green-based fluorescent angiography in breast reconstruction. Gland Surg. 2016;5(2):133-149.
50. Grzyb CC, Church EW. Role of indocyanine green with FLOW 800 in removal of hidden arteriovenous malformations. World Neurosurg. 2022;164:e203-e213.
51. Guo J, Yang H, Wang S, et al. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: A prospective cohort study. World J Surg Oncol. 2017;15(1):196.
52. Gurtner GC, Jones GE, Neliga PC, et al. Intraoperative laser angiography using the SPY system: Review of the literature and recommendations for use. Ann Surg Innov Res. 2013;7(1):1.
53. Guyer DR, Puliafito CA, Monas JM, et al. Digital indocyanine-green angiography in chorioretinal disorders. Ophthalmology. 1992;99(2):287-291.
54. Hamad G. Bariatric surgery: Postoperative and long-term management. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2023.
55. Hanel RA, Nakaji P, Spetzler RF. Use of microscope-integrated near-infrared indocyanine green videoangiography in the surgical treatment of spinal dural arteriovenous fistulae. Neurosurgery. 2010;66(5):978-984.
56. Hansen J, Chang S. Overview of breast reduction. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2023.
57. Harless CA, Jacobson SR. Tailoring through technology: A retrospective review of a single surgeon's experience with implant-based breast reconstruction before and after implementation of laser-assisted indocyanine green angiography. Breast J. 2016;22(3):274-281.
58. Harless CA, Visscher S, Jacobson SR. The clinical efficacy and financial impact of laser-assisted indocyanine green angiography on implant-based breast reconstruction at a large academic medical center [abstract]. Plast Reconstr Surg. 2015;135 (5S):53.
59. Hasegawa H, Tsukada Y, Wakabayashi M, et al. Impact of intraoperative indocyanine green fluorescence angiography on anastomotic leakage after laparoscopic sphincter-sparing surgery for malignant rectal tumors. Int J Colorectal Dis. 2020;35(3):471-480.
60. Herbort CP, Cimino L, Abu El Asrar AM. Ocular vasculitis: A multidisciplinary approach. Curr Opin Rheumatol. 2005;17(1):25-33.
61. Hettige S, Walsh D. Indocyanine green video-angiography as an aid to surgical treatment of spinal dural arteriovenous fistulae. Acta Neurochir (Wien). 2010;152(3):533-536.
62. Hillenkamp J, Saikia P, Herrmann WA, et al. Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: A randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol. 2007;245(7):973-979.
63. Hirsch T, Remky A, Plange N, Kaup M. Quantification of fluorescein angiography in patients with non-arteritic anterior ischemic optic neuropathy. Ophthalmologe. 2011;108(8):728-732.
64. Horio N, Horiguchi M. Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol. 2004;122(7):992-996.
65. How JA, O'Farrell P, Amajoud Z, et al. Sentinel lymph node mapping in endometrial cancer: A systematic review and meta-analysis. Minerva Ginecol. 2018;70(2):194-214.
66. Hsu A, Mu SZ, James A, et al. Indocyanine green in bariatric surgery: A systematic review. Obes Surg. 2023;33(11):3539-3544.
67. Husson-Danan A, Glacet-Bernard A, Soubrane G, Coscas G. Clinical evaluation of the use of indocyanine green for peeling the internal limiting membrane in macular hole surgery. Graefes Arch Clin Exp Ophthalmol. 2006;244(3):291-297.
68. Imizu S, Kato Y, Sangli A, et al. Assessment of incomplete clipping of aneurysms intraoperatively by a near-infrared indocyanine green-video angiography (Niicg-Va) integrated microscope. Minim Invasive Neurosurg. 2008;51(4):199-203.
69. Ishii M, Hamabe A, Okita K, et al. Efficacy of indocyanine green fluorescence angiography in preventing anastomotic leakage after laparoscopic colorectal cancer surgery. Int J Colorectal Dis. 2020;35(2):269-275.
70. Jafari MD, Wexner SD, Martz JE, et al. Perfusion assessment in laparoscopic left-sided/anterior resection (PILLAR II): A multi-institutional study. J Am Coll Surg. 2015;220(1):82-92.
71. James DR, Ris F, Yeung TM, et al. Fluorescence angiography in laparoscopic low rectal and anorectal anastomoses with pinpoint perfusion imaging -- a critical appraisal with specific focus on leak risk reduction. Colorectal Dis. 2015;17 Suppl 3:16-21.
72. Jeon FHK, Varghese J, Griffin M, et al. Systematic review of methodologies used to assess mastectomy flap viability. BJS Open. 2018;2(4):175-184. 
73. Jitpratoom P, Anuwong A. The use of ICG enhanced fluorescence for the evaluation of parathyroid gland preservation. Gland Surg. 2017;6(5):579-586.
74. Jones GE, Garcia CA, Murray J, et al. Fluorescent intraoperative tissue angiography for the evaluation of the viability of pedicled TRAM flaps [abstract]. Plast Reconstr Surg. 2010;124(4S):53.
75. Karampinis I, Ronellenfitsch U, Mertens C, et al. Indocyanine green tissue angiography affects anastomotic leakage after esophagectomy. A retrospective, case-control study. Int J Surg. 2017;48:210-214.
76. Keller DS, Ishizawa T, Cohen R, Chand M. Indocyanine green fluorescence imaging in colorectal surgery: Overview, applications, and future directions. Lancet Gastroenterol Hepatol. 2017;2(10):757-766.
77. Kin C, Vo H, Welton L, Welton M. Equivocal effect of intraoperative fluorescence angiography on colorectal anastomotic leaks. Dis Colon Rectum. 2015;58(6):582-587.
78. Klein EA. Radical prostatectomy for localized prostate cancer. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2023.
79. Komorowska-Timek E, Gurtner GC. Intraoperative perfusion mapping with laser-assisted indocyanine green imaging can predict and prevent complications in immediate breast reconstruction. Plast Reconstr Surg. 2010;125(4):1065-1073.
80. Korn JM, Tellez-Diaz A, Bartz-Kurycki M, Gastman B. Indocyanine green SPY elite-assisted sentinel lymph node biopsy in cutaneous melanoma. . Plast Reconstr Surg. 2014;133(4):914-922.
81. Kulik A, Rubens FD, Ruel M. Intraoperative indocyanine green angiography: Ready for prime time? J Thorac Cardiovasc Surg. 2007;133(2):592-593.
82. Kumar V, Jagetia A, Singh D, et al. Comparison of efficacy of intraoperative indocyanine green videoangiography in clipping of anterior circulation aneurysms with postoperative digital subtraction angiography. J Neurosci Rural Pract. 2017;8(3):342-345.
83. Kwok AK, Lai TY, Yuen KS. Epiretinal membrane surgery with or without internal limiting membrane peeling. Clin Experiment Ophthalmol. 2005;33(4):379-385.
84. Ladak F, Dang JT, Switzer N, et al. Indocyanine green for the prevention of anastomotic leaks following esophagectomy: A meta-analysis. Surg Endosc. 2019;33(2):384-394.
85. Lang BH, Wong CK, Hung HT, et al.  Indocyanine green fluorescence angiography for quantitative evaluation of in situ parathyroid gland perfusion and function after total thyroidectomy. Surgery. 2017;161(1):87-95.
86. Lauricella S, Peyser D, Carrano FM, Sylla P. Intraluminal anastomotic assessment using indocyanine green near-infrared imaging for left-sided colonic and rectal resections: A systematic review. J Gastrointest Surg. 2023;27(3):615-625.
87. Lauritzen E, Damsgaard TE. Localization of perforators in autologous breast reconstruction with deep inferior epigastric perforator (DIEP)-flap-the indocyanine green angiography perspective. Gland Surg. 2023;12(2):129-133.
88. Lauritzen E, Damsgaard TE. Use of indocyanine green angiography decreases the risk of complications in autologous- and implant-based breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2021;74(8):1703-1717.
89. Lavazza M, Liu X, Wu C, et al. Indocyanine green-enhanced fluorescence for assessing parathyroid perfusion during thyroidectomy. Gland Surg. 2016;5(5):512-521.
90. Li J, Lan Z, He M, You C. Assessment of microscope-integrated indocyanine green angiography during intracranial aneurysm surgery: A retrospective study of 120 patients. Neurol India. 2009;57(4):453-459.
91. Li Z, Zhou Y, Tian G, et al. Meta-analysis on the efficacy of indocyanine green fluorescence angiography for reduction of anastomotic leakage after rectal cancer surgery. Am Surg. 2021;87(12):1910-1919.
92. Liberale G, Bourgeois P, Larsimont D, et al. Indocyanine green fluorescence-guided surgery after IV injection in metastatic colorectal cancer: A systematic review. Eur J Surg Oncol. 2017;43(9):1656-1667. 
93. Lim WK, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Surv Ophthalmol. 2005;50(3):231-244.
94. Liu D, Liang L, Liu L, Zhu Z. Does intraoperative indocyanine green fluorescence angiography decrease the incidence of anastomotic leakage in colorectal surgery? A systematic review and meta-analysis. Int J Colorectal Dis. 2021;36(1):57-66. 
95. Liu DZ, Mathes DW, Zenn MR, Neligan PC. The application of indocyanine green fluorescence angiography in plastic surgery. J Reconstr Microsurg. 2011;27(6):355-364.
96. Liu EH, Zhu SL, Hu J, et al. Intraoperative SPY reduces post-mastectomy skin flap complications: A systematic review and meta-analysis. Plast Reconstr Surg Glob Open. 2019;7(4):e2060.
97. Lohman RF, Ozturk CN, Ozturk C, et al. An analysis of current techniques used for intraoperative flap evaluation. Ann Plast Surg. 2015;75(6):679-685.
98. Ma CY, Shi JX, Wang HD, et al. Intraoperative indocyanine green angiography in intracranial aneurysm surgery: Microsurgical clipping and revascularization. Clin Neurol Neurosurg. 2009;111(10):840-846.
99. Małkiewicz B, Kiełb P, Kobylański M, et al. Sentinel lymph node techniques in urologic oncology: Current knowledge and application. Cancers (Basel). 2023;15(9):2495.
100. Mandava N, Guyer DR, Yannuzzi LA, et al. Indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization. Ophthalmic Surg Lasers. 1997;28(10):844-852.
101. Mangano A, Fernandes E, Gheza F, et al. Near-infrared indocyanine green-enhanced fluorescence and evaluation of the bowel microperfusion during robotic colorectal surgery: A retrospective original paper. Surg Technol Int. 2019;34:93-100
102. Mangano A, Masrur MA, Bustos R, et al. Near-infrared indocyanine green-enhanced fluorescence and minimally invasive colorectal surgery: Review of the literature. Surg Technol Int. 2018;33:77-83.
103. Mashayekhi A, Shields CL. Circumscribed choroidal hemangioma. Curr Opin Ophthalmol. 2003;14(3):142-149.
104. McCulloch DK. Diabetic retinopathy: Screening. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed October 2015.
105. Mizrahi I, Abu-Gazala M, Rickles AS, et al. Indocyanine green fluorescence angiography during low anterior resection for low rectal cancer: Results of a comparative cohort study. Tech Coloproctol. 2018;22(7):535-540.
106. Mookiah MR, Acharya UR, Fujita H, et al. Application of different imaging modalities for diagnosis of diabetic macular edema: A review. Comput Biol Med. 2015;66:295-315.
107. Morales-Conde S, Alarcon I, Yang T, et al. Fluorescence angiography with indocyanine green (ICG) to evaluate anastomosis in colorectal surgery: Where does it have more value? Surg Endosc. 2020;34(9):3897-3907.
108. Moyer H, Losken A. Predicting mastectomy skin flap necrosis with indocyanine green angiography: The gray area defined. Plast Reconstr Surg. 2012;129(5):1043-1048.
109. Mueller JJ, Rios-Doria E, Park KJ, et al. Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon? Gynecol Oncol. 2023;168:1-7.
110. Munabi N, Olorunnipa OB, Goltsman D, et al. The ability of intra-operative perfusion mapping with laser-assisted indocyanine green angiography to predict mastectomy flap necrosis in breast reconstruction: A prospective trial. J Plast Reconstr Aesthet Surg. 2014;67(4):449-455.
111. Munteanu M, Giuri S, Rosca C, et al. Serous macular detachment associated with circumscribed choroidal hemangioma: A case report. Oftalmologia. 2013;57(3):35-41.
112. Nahabedian M. Breast reconstruction in women with breast cancer. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed October 2013.
113. Nahabedian M. Overview of breast reconstruction. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed May 2017.
114. Nakamura H, Hayakawa K, Imaizumi A, et al. Persistence of retinal indocyanine green dye following vitreous surgery. Ophthalmic Surg Lasers Imaging. 2005;36(1):37-45.
115. National Comprehensive Cancer Network (NCCN). Breast cancer. NCCN Clinical Practice Guidelines in Oncology, Version 1.2018. Fort Washington, PA: NCCN; 2018.
116. National Comprehensive Cancer Network (NCCN). Colon cancer. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
117. National Comprehensive Cancer Network (NCCN). Gastric Cancer. NCCN Clinical Practice Guidelines in Oncology,  Version 2.2018. Fort Washington, PA: NCCN; 2018.
118. National Comprehensive Cancer Network (NCCN). Ovarian cancer. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
119. National Comprehensive Cancer Network (NCCN). Bladder cancer. NCCN Clinical Practice Guidelines in Oncology, Version 4.2018. Fort Washington, PA: NCCN; 2018.
120. National Comprehensive Cancer Network (NCCN). Kidney cancer. NCCN Clinical Practice Guidelines in Oncology, Version 4.2018. Fort Washington, PA: NCCN; 2018.
121. National Comprehensive Cancer Network (NCCN). Melanoma. NCCN Clinical Practice Guideline in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
122. National Comprehensive Cancer Network (NCCN). Penile cancer. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
123. National Comprehensive Cancer Network (NCCN). Prostate cancer. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN;; 2018.
124. National Comprehensive Cancer Network (NCCN). Prostate cancer. NCCN Clinical Practice Guideline in Oncology, Version 4.2023.  Plymouth Meeting, PA: NCCN; 2023.
125. National Comprehensive Cancer Network (NCCN). Uterine neoplasms. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
126. National Comprehensive Cancer Network (NCCN). Uterine neoplasms. NCCN Clinical Practice Guideline in Oncology, Version 1.2024. Plymouth Meeting, PA: NCCN; 2023.
127. National Institute for Health and Clinical Excellence (NICE). Intraoperative fluorescence angiography for the evaluation of coronary artery bypass graft patency. Interventional Procedure Guidance 98 [IPG 98]. London, UK: NICE; October 2004.
128. Newman MI, Jack MC, Samson MC.. SPY-Q analysis toolkit values potentially predict mastectomy flap necrosis. Ann Plast Surg. 2013;70(5):595-598.
129. Newman MI, Samson MC, Tamburrino JF, Swartz KA. Intraoperative laser-assisted indocyanine green angiography for the evaluation of mastectomy flaps in immediate breast reconstruction. J Reconstr Microsurg. 2010;26(7):487-492.
130. Nguyen CL, Barry N, Lindsay A, et al. Indocyanine green angiography in breast reconstruction surgery: A systematic review of cost-analysis studies. J Plast Reconstr Aesthet Surg. 2021;74(11):3196-3211.
131. Nguyen DP, Huber PM, Metzger TA, et al. A specific mapping study using fluorescence sentinel lymph node detection in patients with intermediate- and high-risk prostate cancer undergoing extended pelvic lymph node dissection. Eur Urol. 2016;70(5):734-737.
132. Niebling MG, Pleijhuis RG, Bastiaannet E, et al. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol. 2016 r;42(4):466-473.
133. Nowak K, Karampinis I, Gerken ALH. Application of fluorescent dyes in visceral surgery: State of the art and future perspectives. Visc Med. 2020;36(2):80-87.
134. Ogura S, Yasukawa T, Kato A, et al. Indocyanine green angiography-guided focal laser photocoagulation for diabetic macular edema. Ophthalmologica. 2015;234(3):139-150.
135. Ohdaira H, Yoshida M, Okada S, et al. New method of indocyanine green fluorescence sentinel node mapping for early gastric cancer. Ann Med Surg (Lond). 2017;20:61-65.
136. Oie Y, Emi K, Takaoka G, Ikeda T. Effect of indocyanine green staining in peeling of internal limiting membrane for retinal detachment resulting from macular hole in myopic eyes. Ophthalmology. 2007;114(2):303-306.
137. O'Keefe GD, Leung E, Read RW, et al. Birdshot retinochoroidopathy. American Academy of Ophthalmology (AAO) EyeWiki. San Francisco, CA: AAO; June 17, 2023. Available at: https://eyewiki.aao.org/Birdshot_Retinochoroidopathy. Accessed January 25, 2024.
138. Pang H-Y, Chen X-L, Song X-H, et al. Indocyanine green fluorescence angiography prevents anastomotic leakage in rectal cancer surgery: A systematic review and meta-analysis. Langenbecks Arch Surg. 2021;406(2):261-271.
139. Panova IE, Samkovich EV, Melikhova MV, Grigoryeva NN. Indocyanine green angiography in the diagnostics of choroidal tumors. Vestn Oftalmol. 2020;136(5):5-13.
140. Papadia A, Gasparri ML, Buda A, Mueller MD. Sentinel lymph node mapping in endometrial cancer: Comparison of fluorescence dye with traditional radiocolloid and blue. J Cancer Res Clin Oncol. 2017;143(10):2039-2048.
141. Park JK. Meningioma: Clinical presentation and diagnosis. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed April 2015.
142. Park J-W, Lee MK, Woo K-J. Influence of vertical location and spacing of perforators on perfusion in deep inferior epigastric artery perforator flap breast reconstruction: Quantitative analysis using indocyanine green angiography. Gland Surg. 2022;11(12):1851-1863.
143. Phillips BT, Lanier ST, Conkling N, et al. Intraoperative perfusion techniques can accurately predict mastectomy skin flap necrosis in breast reconstruction: Results of a prospective trial. Plast Reconstr Surg. 2012;129(5):778e-788e.
144. Polom K, Murawa D, Rho YS, et al. Current trends and emerging future of indocyanine green usage in surgery and oncology: A literature review. Cancer. 2011;117(21):4812-4822.
145. Protyniak B, Dinallo AM, Boyan WP Jr, et al. Intraoperative indocyanine green fluorescence angiography -- an objective evaluation of anastomotic perfusion in colorectal surgery. Am Surg. 2015;81(6):580-584.
146. Raabe A, Beck J, Seifert V. Technique and image quality of intraoperative indocyanine green angiography during aneurysm surgery using surgical microscope integrated near-infrared video technology. Zentralbl Neurochir. 2005;66(1):1-6; discussion 7-8.
147. Raffone A, Raimondo D, Travaglino A, et al. Sentinel lymph node biopsy in surgical staging for high-risk groups of endometrial carcinoma patients. Int J Environ Res Public Health. 2022;19(6):3716.
148. Raimondo D, Maletta M, Malzoni M, et al. Indocyanine green fluorescence angiography after full-thickness bowel resection for rectosigmoid endometriosis: A multicentric experience with quantitative analysis. Int J Gynaecol Obstet. 2022;158(3):679-688. 
149. Regillo CD. The present role of indocyanine green angiography in ophthalmology. Curr Opin Ophthalmol. 1999;10(3):189-196.
150. Ris F, Hompes R, Cunningham C, et al. Near-infrared (NIR) perfusion angiography in minimally invasive colorectal surgery. Surg Endosc. 2014;28(7):2221-2226.
151. Ris F, Liot E, Kraus R, e tal; Near-Infrared Anastomotic Perfusion Assessment Network VOIR. Multicentre phase II trial of near-infrared imaging in elective colorectal surgery. Br J Surg. 2018;105(10):1359-1367.
152. Riva M, Amin-Hanjani S, Giussani C, et al. Indocyanine green videoangiography in aneurysm surgery: Systematic review and meta-analysis. Neurosurgery. 2018;83(2):166-180.
153. Rizzo JF, 3rd. Unraveling the enigma of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2019;39(4):529-544.
154. Robertson FP, Spiers HVM, Lim WB, et al. Intraoperative pancreas stump perfusion assessment during pancreaticoduodenectomy: A systematic scoping review. World J Gastrointest Surg. 2023;15(8):1799-1807.
155. Robertson SA, Jeevaratnam JA, Agrawal A, Cutress RI. Mastectomy skin flap necrosis: Challenges and solutions. Breast Cancer (Dove Med Press). 2017;9:141-152.
156. Roelofs KA, Sia DIT, O'Day R, et al. Circumscribed choroidal haemangioma: Indocyanine green angiography features on scanning laser ophthalmoscopy versus traditional digital fundus photography. Eye (Lond). 2021;35(4):1178-1186.
157. Rother R, Lang W, Horch RE, et al. Pilot assessment of the angiosome concept by intra-operative fluorescence angiography after tibial bypass surgery. Eur J Vasc Endovasc Surg. 2018;55(2):215-221.
158. Ruscito I, Gasparri ML, Braicu EI, et al. Sentinel node mapping in cervical and endometrial cancer: Indocyanine green versus other conventional dyes -- A meta-analysis. Ann Surg Oncol. 2016;23(11):3749-3756.
159. Schalenbourg A, Piguet B, Zografos L. Indocyanine green angiographic findings in choroidal hemangiomas: A study of 75 cases. Ophthalmologica. 2000;214(4):246-252.
160. Schlottmann F, Patti MG. Evaluation of gastric conduit perfusion during esophagectomy with indocyanine green fluorescence imaging. J Laparoendosc Adv Surg Tech A. 2017;27(12):1305-1308.
161. Schwarte B, Sigdel A, Dwivedi AJ, Wayne EJ. Use of indocyanine green during repair of a superior mesenteric artery aneurysm. Ann Vasc Surg. 2021;75:531.e15-531.e18.
162. Settembre N, KauhanenP, Ablack A, et al. Quality control of the foot revascularization using indocyanine green fluorescence imaging. World Journal of Surgery. 2017;41(7):1919-1926.
163. Shaikh N, O'Brien D, Makary C, Turner M. Intraoperative indocyanine green angiography for assessing flap perfusion in skull base reconstruction: A systematic review. J Neurol Surg B Skull Base. 2021;83(Suppl 2):e492-e500.
164. Shen R, Zhang Y, Wang T. Indocyanine green fluorescence angiography and the incidence of anastomotic leak after colorectal resection for colorectal cancer: A meta-analysis. Dis Colon Rectum. 2018;61(10):1228-1234.
165. Shibata Y, Kurihara S, Arai S, et al. Efficacy of microsurgical subinguinal varicocelectomy using indocyanine green fluorescence angiography: A pilot study. Nihon Hinyokika Gakkai Zasshi. 2015;106(4):293-298.
166. Skrovina M, Bencurik V, Holaskova E, et al. Fluorescence angiography in the detection of anastomotic perfusion during rectal and sigmoid resection - preliminary report. Rozhl Chir. 2016;95(10):354-358.
167. Slakter JS, Yannuzzi LA, Sorenson JA, et al. A pilot study of indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthal. 1994;112(4):465-472.
168. Slooter MD, Eshuis WJ, Cuesta MA, et al. Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: A systematic review and meta-analysis. J Thorac Dis. 2019;11(Suppl 5):S755-S765.
169. Snyers B, De Potter P. Advantages of digital indocyanine green angiography for diagnosing choroidal tumors. J Fr Ophtalmol. 2002;25(2):212-220.
170. Soliman PT, Westin SN, Dioun S, et al. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017;146(2):234-239.
171. Sood M, Glat P. Potential of the SPY intraoperative perfusion assessment system to reduce ischemic complications in immediate postmastectomy breast reconstruction. Ann Surg Innov Res. 2013;7(1):9.
172. Sorenson JA, Yannuzzi LA, Slakter JS, et al. A pilot study of digital indocyanine green videoangiography for recurrent occult choroidal neovascularization in age-related macular degeneration. Arch Ophthal. 1994;112(4):473-479.
173. Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: Indications and interpretation: An evidence-based update. Ophthalmology. 2003;110(1):15-21; quiz 22-23.
174. Starker PM, Chinn B. Using outcomes data to justify instituting new technology: A single institution’s experience. Surgical Endoscopy. Surg Endosc. 2018;32(3):1586-1592.
175. Sugie T, Ikeda T, Kawaguchi A, et al. Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: A meta-analysis. Int J Clin Oncol. 2017;22(1):11-17.
176. Takahashi M, Ishikawa T, Higashidani K, Katoh H. SPY: an innovative intra-operative imaging system to evaluate graft patency during off-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2004;3(3):479-483.
177. Takeuchi H, Kitagawa Y. Sentinel lymph node biopsy in gastric cancer. Cancer J. 2015;21(1):21-24.
178. Tamhankar M, Volpe NJ. Nonarteritic anterior ischemic optic neuropathy: Clinical features and diagnosis. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2022a.
179. Tamhankar M, Volpe NJ. Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2022b.
180. Tang G, Du D, Tao J, Wei Z. Effect of indocyanine green fluorescence angiography on anastomotic leakage in patients undergoing colorectal surgery: A meta-analysis of randomized controlled trials and propensity-score-Matched studies. Front Surg. 2022;9:815753.
181. Tesar J, Sin M, Nemec P, Studnicka J. Diagnosis that mimic pachychoroid diseases of macula – Case reports. Cesk Slov Oftalmol. 2021r;77(1):36-44.
182. Tognetto D, Haritoglou C, Kampik A, Ravalico G. Macular edema and visual loss after macular pucker surgery with ICG-assisted internal limiting membrane peeling. Eur J Ophthalmol. 2005;15(2):289-291.
183. Uemoto R, Yamamoto S, Takeuchi S. Changes in retinal pigment epithelium after indocyanine green-assisted internal limiting lamina peeling during macular hole surgery. Am J Ophthalmol. 2005;140(4):752-755.
184. van den Bos J, Al-Taher M, Schols RM, et al. Near-infrared fluorescence imaging for real-time intraoperative guidance in anastomotic colorectal surgery: A systematic review of literature. J Laparoendosc Adv Surg Tech A.2018;28(2):157-167.
185. Wang S, Liu L, Zhao YL, et al. Effects of surgical microscope-based indocyanine green videoangiography during aneurysm surgery. Zhonghua Yi Xue Za Zhi. 2009;89(3):146-150.
186. Ward HB, Kelly RF, Weir EK. Assessment of graft patency during coronary artery bypass graft surgery: Mitigating the risk. JACC Cardiovasc Imaging. 2009;2(5):613-615.
187. Waseda K, Ako J, Hasegawa T, et al. Intraoperative fluorescence imaging system for on-site assessment of off-pump coronary artery bypass graft. JACC Cardiovasc Imaging. 2009;2(5):604-612.
188. Wen PY. Systemic treatment of recurrent meningioma. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed April 2015.
189. Writing Committee Members, Hillis LD, Smith PK, Anderson JL, et al. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Circulation. 2011;124:e652-e735.
190. Wu C, Kim S, Halvorson EG. Laser-assisted indocyanine green angiography: A critical appraisal. Ann Plast Surg. 2013;70(5):613-619.
191. Xia S, Wu W, Luo L, et al. Indocyanine green fluorescence angiography decreases the risk of anastomotic leakage after rectal cancer surgery: A systematic review and meta-analysis. Front Med (Lausanne). 2023:10:1157389.
192. Xie D, Gu D, Lei M, et al. The application of indocyanine green in guiding prostate cancer treatment. Asian J Urol. 2023;10(1):1-8.
193. Yamashita S, Shibuya K, Nagao K, et al. Anastomotic stenosis of a reconstructed dissecting superior mesenteric artery aneurysm undetectable by intraoperative indocyanine green angiography: A case report. Clin Case Rep. 2021;9(10):e04923.
194. Yannuzzi LA, Slakter JS, Sorenson JA, et al. Digital indocyanine green videoangiography and choroidal neovascularization. Retina. 1992;12(3):191-223.
195. Yoo A, Palines PA, Mayo JL, et al. The impact of indocyanine green angiography on fat necrosis in deep inferior epigastric perforator flap breast reconstruction. Ann Plast Surg. 2022;88(4):415-419.
196. Yoshimatsu H, Yamamoto T, Iida T. Indocyanine green angiography for prediction of thrombosis in the internal jugular vein. Microsurgery. 2015;35(6):469-473.
197. Yu R, Matthews BJ, Beavis AL. The role of sentinel lymph node mapping in high-grade endometrial cancer. Curr Treat Options Oncol. 2022;23(10):1339-1352.
198. Zang M, Zhu S, Chen B, et al. Use of indocyanine green angiography to identify the superficial temporal artery and vein in forehead flaps for facial reconstruction. J Craniofac Surg. 2022;33(5):1322-1326.

1. Alberta Provincial Breast Tumour Team. Breast reconstruction following prophylactic or therapeutic mastectomy for breast cancer. Clinical Practice Guideline BR-016, version 2. Edmonton, AB: Alberta Health Services; February 2017. 
2. Alius C, Tudor C, Badiu CD, et al. Indocyanine green-enhanced colorectal surgery -- between being superfluous and being a game-changer. Diagnostics (Basel). 2020;10(10):742.
3. Altaweel M. Best disease. Medscape. October 10, 2016. Available at: http://emedicine.medscape.com/article/1227128-overview. Accessed October 14, 2016.
4. Amara N, Youssef TA, Massa J, et al. Intraoperative angiography of the neurovascular bundle using indocyanine green and near-infrared fluorescence improves anatomical dissection during robot-assisted radical prostatectomy: Initial clinical experience. J Robot Surg. 2023;17(2):687-694. 
5. American Academy of Ophthalmology (AAO), Retina Panel. Idiopathic macular hole. Preferred Practice Pattern. San Francisco, CA: AAO; 2003.
6. American Academy of Ophthalmology (AAO). Age-related macular degeneration. Preferred Practice Pattern. San Francisco, CA: AAO; 2006.
7. American Academy of Ophthalmology (AAO). Comprehensive adult medical eye evaluation. Preferred Practice Pattern. San Francisco, CA: AAO; September 2005.
8. American Academy of Ophthalmology. Indocyanine green angiography. Ophthalmology. 1998;105(8):1564-1569.
9. Aoun F, Albisinni S, Zanaty M, et al. Indocyanine green fluorescence-guided sentinel lymph node identification in urologic cancers: A systematic review and meta-analysis. Minerva Urol Nefrol. 2018;70(4):361-369.
10. Bergstrom R, Czyz CN. Birdshot retinopathy. StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing: August 8, 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK554416/. Accessed January 25, 2024.
11. Beutel J, Dahmen G, Ziegler A, Hoerauf H. Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: A randomized trial. Arch Ophthalmol. 2007;125(3):326-332.
12. Bigcas JLM, DeBiase CA, Ho T. Indocyanine green angiography as the principal design and perfusion assessment tool for the supraclavicular artery island flap in head and neck reconstruction. Cureus. 2022;14(9):e29007.
13. Blanco-Colino R, Espin-Basany E. Intraoperative use of ICG fluorescence imaging to reduce the risk of anastomotic leakage in colorectal surgery: A systematic review and meta-analysis. Tech Coloproctol. 2018;22(1):15-23.
14. Bogani G, Di Donato V, Papadia A, et al. Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: Perioperative and long-term results from a propensity-score based study. Eur J Surg Oncol. 2023;49(5):1037-1043.
15. Boni L, David G, Dionigi G, et al. Indocyanine green-enhanced fluorescence to assess bowel perfusion during laparoscopic colorectal resection. Surg Endosc. 2016;30(7):2736-2742.
16. Bouchenaki N, Herbort CP. Indocyanine green angiography guided management of vogt-koyanagi-harada disease. J Ophthalmic Vis Res. 2011;6(4):241-248.
17. Bousquet E, Duraffour P, Debillon L, etal. Birdshot chorioretinopathy: A review. J Clin Med. 2022;11(16):4772.
18. Brancato R, Trabucchi G. Fluorescein and indocyanine green angiography in vascular chorioretinal diseases. Semin Ophthalmol. 1998;13(4):189-198.
19. Braun JD, Trinidad-Hernandez M, Perry D, et al. Early quantitative evaluation of indocyanine green angiography in patients with critical limb ischemia. J Vasc Surg. 2013;57(5):1213-1218.
20. Buda A, Crivellaro C, Elisei F, et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: Comparison with conventional radiotracer (99m)Tc and/or blue dye. Ann Surg Oncol. 2016;23(7):2183-2191.
21. Buda A, Passoni P, Corrado G, et al. Near-infrared fluorescence-guided sentinel node mapping of the ovary with indocyanine green in a minimally invasive setting: A feasible study. J Minim Invasive Gynecol. 2017;24(1):165-170.
22. Burg LC, Kruitwagen RFPM, de Jong A, et al. Sentinel lymph node mapping in presumed low- and intermediate-risk endometrial cancer management (SLIM): A multicenter, prospective cohort study in the Netherlands. Cancers (Basel). 2022;15(1):271.
23. Campbell C, Reames MK, Robinson M, et al. Conduit vascular evaluation is associated with reduction in anastomotic leak after esophagectomy. J Gastrointest Surg. 2015;19(5):806-812.
24. Canadian Agency for Drugs and Technologies in Health (CADTH). Intraoperative assessment of coronary artery bypass grafts: Guidelines. Rapid Response Report: Reference List. Edmonton, ON: CADTH; July 7, 2011.
25. Carus T, Pick P. Intraoperative fluorescence angiography in colorectal surgery. Chirurg. 2019;90(11):887-890.
26. Chand M, Keller DS, Joshi HM, et al. Feasibility of fluorescence lymph node imaging in colon cancer: FLICC. Tech Coloproctol. 2018;22(4):271-277.
27. Chatterjee A. A comparison of free autologous breast reconstruction with and without the use of laser-assisted indocyanine green angiography: A cost-effectiveness analysis. Plast Reconstr Surg. 2013;131(5):693e-701e.
28. Chee SP, Jap A. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2013;97(2):130-133.
29. Cheng SN, Yang TC, Ho JD, et al. Ocular toxicity of intravitreal indocyanine green. J Ocul Pharmacol Ther. 2005;21(1):85-93.
30. Ciulla TA, Harris A, Martin BJ. Ocular perfusion and age-related macular degeneration. Acta Ophthalmol Scand. 2001;79(2):108-115.
31. Colavita PD, Wormer BA, Belyansky I, et al. Intraoperative indocyanine green fluorescence angiography to predict wound complications in complex ventral hernia repair. Hernia. 2016;20(1):139-149.
32. Connolly PH, Meltzer AJ, Spector JA, Schneider DB. Indocyanine green angiography aids in prediction of limb salvage in vascular trauma. Annals of Vascular Surgery. 2015;29(7):1453e1-1453-e4.
33. Cordero E, Enseñat J, Macho J, et al. Intraoperative videoangiography using green indocyanine during aneurysm surgery. Neurocirugia (Astur). 2010;21(4):302-305.
34. Dashti R, Laakso A, Niemelä M, et al. Microscope-integrated near-infrared indocyanine green videoangiography during surgery of intracranial aneurysms: The Helsinki experience. Surg Neurol. 2009;71(5):543-550; discussion 550.
35. d'Avella E, Volpin F, Manara R, et al. Indocyanine green videoangiography (ICGV)-guided surgery of parasagittal meningiomas occluding the superior sagittal sinus (SSS). Acta Neurochir (Wien). 2013;155(3):415-420.
36. de Oliveira JG, Beck J, Seifert V, et al. Assessment of flow in perforating arteries during intracranial aneurysm surgery using intraoperative near-infrared indocyanine green videoangiography. Neurosurgery. 2007;61(3 Suppl):63-72; discussion 72-73.
37. Degett TH, Andersen HS, Gogenur I. Indocyanine green fluorescence angiography for intraoperative assessment of gastrointestinal anastomotic perfusion: A systematic review of clinical trials. Langenbecks Arch Surg. 2016;401(6):767-775.
38. Della Puppa A, Rustemi O, Gioffre G, et al. Application of indocyanine green video angiography in parasagittal meningioma surgery. Neurosurg Focus. 2014;36(2):E13.
39. DeLong JC, Ward EP, Lwin TM, et al. Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism. Surgery. 2018;163(2):388-392.
40. Desai ND, Miwa S, Kodama D, et al. A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts. J Thorac Cardiovasc Surg. 2006;132(3):585-594.
41. Di Martino G, Crivellaro C, De Ponti E, et al. Indocyanine green versus radiotracer with or without blue dye for sentinel lymph node mapping in stage >IB1 cervical cancer (>2 cm). J Minim Invasive Gynecol. 2017;24(6):954-959.
42. Dugan C, Cestari D, Pineles Sl, et al. Non-arteritic anterior ischemic optic neuropathy (NAION). American Academy of Ophthalmology (AAO). EyeWiKi. September 11, 2022. Available at: https://eyewiki.aao.org/Non-Arteritic_Anterior_Ischemic_Optic_Neuropathy_(NAION). Accessed January 25, 2023.
43. Duggal CS. An outcome analysis of intraoperative angiography for postmastectomy breast reconstruction. Aesthetic Surgery Journal. 2014;34(1):61-65.
44. Ellsmere JXC. Bariatric operations: Late complications with subacute presentations. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2023.
45. Fourman MS, Phillips BT, Crawford L, et al. Indocyanine green dye angiography accurately predicts survival in the zone of ischemia in a burn comb model. Burns. Burns. 2014;40(5):940-946.
46. Freund MR, Kent I, Agarwal S, Wexner SD. Use of indocyanine green fluorescence guidance in redo ileocolic resection for Crohn's disease. Colorectal Dis. 2021;23(12):3190-3195.
47. Ganley JP, Kooragayala LM. Acute multifocal posterior placoid pigment epitheliopathy. eMedicine Ophthalmology. Topic 422. Omaha, NE: eMedicine.com; updated August 22, 2001. Available at: http://www.emedicine.com/oph/topic422.htm. Accessed January 21, 2004.
48. Gedik S, Akova Y, Yilmaz G, Bozbeyoglu S. Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease. Ocul Immunol Inflamm. 2005;13(1):51-58.
49. Griffiths M, Chae MP, Rozen WM. Indocyanine green-based fluorescent angiography in breast reconstruction. Gland Surg. 2016;5(2):133-149.
50. Grzyb CC, Church EW. Role of indocyanine green with FLOW 800 in removal of hidden arteriovenous malformations. World Neurosurg. 2022;164:e203-e213.
51. Guo J, Yang H, Wang S, et al. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: A prospective cohort study. World J Surg Oncol. 2017;15(1):196.
52. Gurtner GC, Jones GE, Neliga PC, et al. Intraoperative laser angiography using the SPY system: Review of the literature and recommendations for use. Ann Surg Innov Res. 2013;7(1):1.
53. Guyer DR, Puliafito CA, Monas JM, et al. Digital indocyanine-green angiography in chorioretinal disorders. Ophthalmology. 1992;99(2):287-291.
54. Hamad G. Bariatric surgery: Postoperative and long-term management. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2023.
55. Hanel RA, Nakaji P, Spetzler RF. Use of microscope-integrated near-infrared indocyanine green videoangiography in the surgical treatment of spinal dural arteriovenous fistulae. Neurosurgery. 2010;66(5):978-984.
56. Hansen J, Chang S. Overview of breast reduction. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2023.
57. Harless CA, Jacobson SR. Tailoring through technology: A retrospective review of a single surgeon's experience with implant-based breast reconstruction before and after implementation of laser-assisted indocyanine green angiography. Breast J. 2016;22(3):274-281.
58. Harless CA, Visscher S, Jacobson SR. The clinical efficacy and financial impact of laser-assisted indocyanine green angiography on implant-based breast reconstruction at a large academic medical center [abstract]. Plast Reconstr Surg. 2015;135 (5S):53.
59. Hasegawa H, Tsukada Y, Wakabayashi M, et al. Impact of intraoperative indocyanine green fluorescence angiography on anastomotic leakage after laparoscopic sphincter-sparing surgery for malignant rectal tumors. Int J Colorectal Dis. 2020;35(3):471-480.
60. Herbort CP, Cimino L, Abu El Asrar AM. Ocular vasculitis: A multidisciplinary approach. Curr Opin Rheumatol. 2005;17(1):25-33.
61. Hettige S, Walsh D. Indocyanine green video-angiography as an aid to surgical treatment of spinal dural arteriovenous fistulae. Acta Neurochir (Wien). 2010;152(3):533-536.
62. Hillenkamp J, Saikia P, Herrmann WA, et al. Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: A randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol. 2007;245(7):973-979.
63. Hirsch T, Remky A, Plange N, Kaup M. Quantification of fluorescein angiography in patients with non-arteritic anterior ischemic optic neuropathy. Ophthalmologe. 2011;108(8):728-732.
64. Horio N, Horiguchi M. Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol. 2004;122(7):992-996.
65. How JA, O'Farrell P, Amajoud Z, et al. Sentinel lymph node mapping in endometrial cancer: A systematic review and meta-analysis. Minerva Ginecol. 2018;70(2):194-214.
66. Hsu A, Mu SZ, James A, et al. Indocyanine green in bariatric surgery: A systematic review. Obes Surg. 2023;33(11):3539-3544.
67. Husson-Danan A, Glacet-Bernard A, Soubrane G, Coscas G. Clinical evaluation of the use of indocyanine green for peeling the internal limiting membrane in macular hole surgery. Graefes Arch Clin Exp Ophthalmol. 2006;244(3):291-297.
68. Imizu S, Kato Y, Sangli A, et al. Assessment of incomplete clipping of aneurysms intraoperatively by a near-infrared indocyanine green-video angiography (Niicg-Va) integrated microscope. Minim Invasive Neurosurg. 2008;51(4):199-203.
69. Ishii M, Hamabe A, Okita K, et al. Efficacy of indocyanine green fluorescence angiography in preventing anastomotic leakage after laparoscopic colorectal cancer surgery. Int J Colorectal Dis. 2020;35(2):269-275.
70. Jafari MD, Wexner SD, Martz JE, et al. Perfusion assessment in laparoscopic left-sided/anterior resection (PILLAR II): A multi-institutional study. J Am Coll Surg. 2015;220(1):82-92.
71. James DR, Ris F, Yeung TM, et al. Fluorescence angiography in laparoscopic low rectal and anorectal anastomoses with pinpoint perfusion imaging -- a critical appraisal with specific focus on leak risk reduction. Colorectal Dis. 2015;17 Suppl 3:16-21.
72. Jeon FHK, Varghese J, Griffin M, et al. Systematic review of methodologies used to assess mastectomy flap viability. BJS Open. 2018;2(4):175-184. 
73. Jitpratoom P, Anuwong A. The use of ICG enhanced fluorescence for the evaluation of parathyroid gland preservation. Gland Surg. 2017;6(5):579-586.
74. Jones GE, Garcia CA, Murray J, et al. Fluorescent intraoperative tissue angiography for the evaluation of the viability of pedicled TRAM flaps [abstract]. Plast Reconstr Surg. 2010;124(4S):53.
75. Karampinis I, Ronellenfitsch U, Mertens C, et al. Indocyanine green tissue angiography affects anastomotic leakage after esophagectomy. A retrospective, case-control study. Int J Surg. 2017;48:210-214.
76. Keller DS, Ishizawa T, Cohen R, Chand M. Indocyanine green fluorescence imaging in colorectal surgery: Overview, applications, and future directions. Lancet Gastroenterol Hepatol. 2017;2(10):757-766.
77. Kin C, Vo H, Welton L, Welton M. Equivocal effect of intraoperative fluorescence angiography on colorectal anastomotic leaks. Dis Colon Rectum. 2015;58(6):582-587.
78. Klein EA. Radical prostatectomy for localized prostate cancer. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2023.
79. Komorowska-Timek E, Gurtner GC. Intraoperative perfusion mapping with laser-assisted indocyanine green imaging can predict and prevent complications in immediate breast reconstruction. Plast Reconstr Surg. 2010;125(4):1065-1073.
80. Korn JM, Tellez-Diaz A, Bartz-Kurycki M, Gastman B. Indocyanine green SPY elite-assisted sentinel lymph node biopsy in cutaneous melanoma. . Plast Reconstr Surg. 2014;133(4):914-922.
81. Kulik A, Rubens FD, Ruel M. Intraoperative indocyanine green angiography: Ready for prime time? J Thorac Cardiovasc Surg. 2007;133(2):592-593.
82. Kumar V, Jagetia A, Singh D, et al. Comparison of efficacy of intraoperative indocyanine green videoangiography in clipping of anterior circulation aneurysms with postoperative digital subtraction angiography. J Neurosci Rural Pract. 2017;8(3):342-345.
83. Kwok AK, Lai TY, Yuen KS. Epiretinal membrane surgery with or without internal limiting membrane peeling. Clin Experiment Ophthalmol. 2005;33(4):379-385.
84. Ladak F, Dang JT, Switzer N, et al. Indocyanine green for the prevention of anastomotic leaks following esophagectomy: A meta-analysis. Surg Endosc. 2019;33(2):384-394.
85. Lang BH, Wong CK, Hung HT, et al.  Indocyanine green fluorescence angiography for quantitative evaluation of in situ parathyroid gland perfusion and function after total thyroidectomy. Surgery. 2017;161(1):87-95.
86. Lauricella S, Peyser D, Carrano FM, Sylla P. Intraluminal anastomotic assessment using indocyanine green near-infrared imaging for left-sided colonic and rectal resections: A systematic review. J Gastrointest Surg. 2023;27(3):615-625.
87. Lauritzen E, Damsgaard TE. Localization of perforators in autologous breast reconstruction with deep inferior epigastric perforator (DIEP)-flap-the indocyanine green angiography perspective. Gland Surg. 2023;12(2):129-133.
88. Lauritzen E, Damsgaard TE. Use of indocyanine green angiography decreases the risk of complications in autologous- and implant-based breast reconstruction: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2021;74(8):1703-1717.
89. Lavazza M, Liu X, Wu C, et al. Indocyanine green-enhanced fluorescence for assessing parathyroid perfusion during thyroidectomy. Gland Surg. 2016;5(5):512-521.
90. Li J, Lan Z, He M, You C. Assessment of microscope-integrated indocyanine green angiography during intracranial aneurysm surgery: A retrospective study of 120 patients. Neurol India. 2009;57(4):453-459.
91. Li Z, Zhou Y, Tian G, et al. Meta-analysis on the efficacy of indocyanine green fluorescence angiography for reduction of anastomotic leakage after rectal cancer surgery. Am Surg. 2021;87(12):1910-1919.
92. Liberale G, Bourgeois P, Larsimont D, et al. Indocyanine green fluorescence-guided surgery after IV injection in metastatic colorectal cancer: A systematic review. Eur J Surg Oncol. 2017;43(9):1656-1667. 
93. Lim WK, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Surv Ophthalmol. 2005;50(3):231-244.
94. Liu D, Liang L, Liu L, Zhu Z. Does intraoperative indocyanine green fluorescence angiography decrease the incidence of anastomotic leakage in colorectal surgery? A systematic review and meta-analysis. Int J Colorectal Dis. 2021;36(1):57-66. 
95. Liu DZ, Mathes DW, Zenn MR, Neligan PC. The application of indocyanine green fluorescence angiography in plastic surgery. J Reconstr Microsurg. 2011;27(6):355-364.
96. Liu EH, Zhu SL, Hu J, et al. Intraoperative SPY reduces post-mastectomy skin flap complications: A systematic review and meta-analysis. Plast Reconstr Surg Glob Open. 2019;7(4):e2060.
97. Lohman RF, Ozturk CN, Ozturk C, et al. An analysis of current techniques used for intraoperative flap evaluation. Ann Plast Surg. 2015;75(6):679-685.
98. Ma CY, Shi JX, Wang HD, et al. Intraoperative indocyanine green angiography in intracranial aneurysm surgery: Microsurgical clipping and revascularization. Clin Neurol Neurosurg. 2009;111(10):840-846.
99. Małkiewicz B, Kiełb P, Kobylański M, et al. Sentinel lymph node techniques in urologic oncology: Current knowledge and application. Cancers (Basel). 2023;15(9):2495.
100. Mandava N, Guyer DR, Yannuzzi LA, et al. Indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization. Ophthalmic Surg Lasers. 1997;28(10):844-852.
101. Mangano A, Fernandes E, Gheza F, et al. Near-infrared indocyanine green-enhanced fluorescence and evaluation of the bowel microperfusion during robotic colorectal surgery: A retrospective original paper. Surg Technol Int. 2019;34:93-100
102. Mangano A, Masrur MA, Bustos R, et al. Near-infrared indocyanine green-enhanced fluorescence and minimally invasive colorectal surgery: Review of the literature. Surg Technol Int. 2018;33:77-83.
103. Mashayekhi A, Shields CL. Circumscribed choroidal hemangioma. Curr Opin Ophthalmol. 2003;14(3):142-149.
104. McCulloch DK. Diabetic retinopathy: Screening. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed October 2015.
105. Mizrahi I, Abu-Gazala M, Rickles AS, et al. Indocyanine green fluorescence angiography during low anterior resection for low rectal cancer: Results of a comparative cohort study. Tech Coloproctol. 2018;22(7):535-540.
106. Mookiah MR, Acharya UR, Fujita H, et al. Application of different imaging modalities for diagnosis of diabetic macular edema: A review. Comput Biol Med. 2015;66:295-315.
107. Morales-Conde S, Alarcon I, Yang T, et al. Fluorescence angiography with indocyanine green (ICG) to evaluate anastomosis in colorectal surgery: Where does it have more value? Surg Endosc. 2020;34(9):3897-3907.
108. Moyer H, Losken A. Predicting mastectomy skin flap necrosis with indocyanine green angiography: The gray area defined. Plast Reconstr Surg. 2012;129(5):1043-1048.
109. Mueller JJ, Rios-Doria E, Park KJ, et al. Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon? Gynecol Oncol. 2023;168:1-7.
110. Munabi N, Olorunnipa OB, Goltsman D, et al. The ability of intra-operative perfusion mapping with laser-assisted indocyanine green angiography to predict mastectomy flap necrosis in breast reconstruction: A prospective trial. J Plast Reconstr Aesthet Surg. 2014;67(4):449-455.
111. Munteanu M, Giuri S, Rosca C, et al. Serous macular detachment associated with circumscribed choroidal hemangioma: A case report. Oftalmologia. 2013;57(3):35-41.
112. Nahabedian M. Breast reconstruction in women with breast cancer. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed October 2013.
113. Nahabedian M. Overview of breast reconstruction. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed May 2017.
114. Nakamura H, Hayakawa K, Imaizumi A, et al. Persistence of retinal indocyanine green dye following vitreous surgery. Ophthalmic Surg Lasers Imaging. 2005;36(1):37-45.
115. National Comprehensive Cancer Network (NCCN). Breast cancer. NCCN Clinical Practice Guidelines in Oncology, Version 1.2018. Fort Washington, PA: NCCN; 2018.
116. National Comprehensive Cancer Network (NCCN). Colon cancer. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
117. National Comprehensive Cancer Network (NCCN). Gastric Cancer. NCCN Clinical Practice Guidelines in Oncology,  Version 2.2018. Fort Washington, PA: NCCN; 2018.
118. National Comprehensive Cancer Network (NCCN). Ovarian cancer. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
119. National Comprehensive Cancer Network (NCCN). Bladder cancer. NCCN Clinical Practice Guidelines in Oncology, Version 4.2018. Fort Washington, PA: NCCN; 2018.
120. National Comprehensive Cancer Network (NCCN). Kidney cancer. NCCN Clinical Practice Guidelines in Oncology, Version 4.2018. Fort Washington, PA: NCCN; 2018.
121. National Comprehensive Cancer Network (NCCN). Melanoma. NCCN Clinical Practice Guideline in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
122. National Comprehensive Cancer Network (NCCN). Penile cancer. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
123. National Comprehensive Cancer Network (NCCN). Prostate cancer. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN;; 2018.
124. National Comprehensive Cancer Network (NCCN). Prostate cancer. NCCN Clinical Practice Guideline in Oncology, Version 4.2023.  Plymouth Meeting, PA: NCCN; 2023.
125. National Comprehensive Cancer Network (NCCN). Uterine neoplasms. NCCN Clinical Practice Guidelines in Oncology, Version 2.2018. Fort Washington, PA: NCCN; 2018.
126. National Comprehensive Cancer Network (NCCN). Uterine neoplasms. NCCN Clinical Practice Guideline in Oncology, Version 1.2024. Plymouth Meeting, PA: NCCN; 2023.
127. National Institute for Health and Clinical Excellence (NICE). Intraoperative fluorescence angiography for the evaluation of coronary artery bypass graft patency. Interventional Procedure Guidance 98 [IPG 98]. London, UK: NICE; October 2004.
128. Newman MI, Jack MC, Samson MC.. SPY-Q analysis toolkit values potentially predict mastectomy flap necrosis. Ann Plast Surg. 2013;70(5):595-598.
129. Newman MI, Samson MC, Tamburrino JF, Swartz KA. Intraoperative laser-assisted indocyanine green angiography for the evaluation of mastectomy flaps in immediate breast reconstruction. J Reconstr Microsurg. 2010;26(7):487-492.
130. Nguyen CL, Barry N, Lindsay A, et al. Indocyanine green angiography in breast reconstruction surgery: A systematic review of cost-analysis studies. J Plast Reconstr Aesthet Surg. 2021;74(11):3196-3211.
131. Nguyen DP, Huber PM, Metzger TA, et al. A specific mapping study using fluorescence sentinel lymph node detection in patients with intermediate- and high-risk prostate cancer undergoing extended pelvic lymph node dissection. Eur Urol. 2016;70(5):734-737.
132. Niebling MG, Pleijhuis RG, Bastiaannet E, et al. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol. 2016 r;42(4):466-473.
133. Nowak K, Karampinis I, Gerken ALH. Application of fluorescent dyes in visceral surgery: State of the art and future perspectives. Visc Med. 2020;36(2):80-87.
134. Ogura S, Yasukawa T, Kato A, et al. Indocyanine green angiography-guided focal laser photocoagulation for diabetic macular edema. Ophthalmologica. 2015;234(3):139-150.
135. Ohdaira H, Yoshida M, Okada S, et al. New method of indocyanine green fluorescence sentinel node mapping for early gastric cancer. Ann Med Surg (Lond). 2017;20:61-65.
136. Oie Y, Emi K, Takaoka G, Ikeda T. Effect of indocyanine green staining in peeling of internal limiting membrane for retinal detachment resulting from macular hole in myopic eyes. Ophthalmology. 2007;114(2):303-306.
137. O'Keefe GD, Leung E, Read RW, et al. Birdshot retinochoroidopathy. American Academy of Ophthalmology (AAO) EyeWiki. San Francisco, CA: AAO; June 17, 2023. Available at: https://eyewiki.aao.org/Birdshot_Retinochoroidopathy. Accessed January 25, 2024.
138. Pang H-Y, Chen X-L, Song X-H, et al. Indocyanine green fluorescence angiography prevents anastomotic leakage in rectal cancer surgery: A systematic review and meta-analysis. Langenbecks Arch Surg. 2021;406(2):261-271.
139. Panova IE, Samkovich EV, Melikhova MV, Grigoryeva NN. Indocyanine green angiography in the diagnostics of choroidal tumors. Vestn Oftalmol. 2020;136(5):5-13.
140. Papadia A, Gasparri ML, Buda A, Mueller MD. Sentinel lymph node mapping in endometrial cancer: Comparison of fluorescence dye with traditional radiocolloid and blue. J Cancer Res Clin Oncol. 2017;143(10):2039-2048.
141. Park JK. Meningioma: Clinical presentation and diagnosis. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed April 2015.
142. Park J-W, Lee MK, Woo K-J. Influence of vertical location and spacing of perforators on perfusion in deep inferior epigastric artery perforator flap breast reconstruction: Quantitative analysis using indocyanine green angiography. Gland Surg. 2022;11(12):1851-1863.
143. Phillips BT, Lanier ST, Conkling N, et al. Intraoperative perfusion techniques can accurately predict mastectomy skin flap necrosis in breast reconstruction: Results of a prospective trial. Plast Reconstr Surg. 2012;129(5):778e-788e.
144. Polom K, Murawa D, Rho YS, et al. Current trends and emerging future of indocyanine green usage in surgery and oncology: A literature review. Cancer. 2011;117(21):4812-4822.
145. Protyniak B, Dinallo AM, Boyan WP Jr, et al. Intraoperative indocyanine green fluorescence angiography -- an objective evaluation of anastomotic perfusion in colorectal surgery. Am Surg. 2015;81(6):580-584.
146. Raabe A, Beck J, Seifert V. Technique and image quality of intraoperative indocyanine green angiography during aneurysm surgery using surgical microscope integrated near-infrared video technology. Zentralbl Neurochir. 2005;66(1):1-6; discussion 7-8.
147. Raffone A, Raimondo D, Travaglino A, et al. Sentinel lymph node biopsy in surgical staging for high-risk groups of endometrial carcinoma patients. Int J Environ Res Public Health. 2022;19(6):3716.
148. Raimondo D, Maletta M, Malzoni M, et al. Indocyanine green fluorescence angiography after full-thickness bowel resection for rectosigmoid endometriosis: A multicentric experience with quantitative analysis. Int J Gynaecol Obstet. 2022;158(3):679-688. 
149. Regillo CD. The present role of indocyanine green angiography in ophthalmology. Curr Opin Ophthalmol. 1999;10(3):189-196.
150. Ris F, Hompes R, Cunningham C, et al. Near-infrared (NIR) perfusion angiography in minimally invasive colorectal surgery. Surg Endosc. 2014;28(7):2221-2226.
151. Ris F, Liot E, Kraus R, e tal; Near-Infrared Anastomotic Perfusion Assessment Network VOIR. Multicentre phase II trial of near-infrared imaging in elective colorectal surgery. Br J Surg. 2018;105(10):1359-1367.
152. Riva M, Amin-Hanjani S, Giussani C, et al. Indocyanine green videoangiography in aneurysm surgery: Systematic review and meta-analysis. Neurosurgery. 2018;83(2):166-180.
153. Rizzo JF, 3rd. Unraveling the enigma of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2019;39(4):529-544.
154. Robertson FP, Spiers HVM, Lim WB, et al. Intraoperative pancreas stump perfusion assessment during pancreaticoduodenectomy: A systematic scoping review. World J Gastrointest Surg. 2023;15(8):1799-1807.
155. Robertson SA, Jeevaratnam JA, Agrawal A, Cutress RI. Mastectomy skin flap necrosis: Challenges and solutions. Breast Cancer (Dove Med Press). 2017;9:141-152.
156. Roelofs KA, Sia DIT, O'Day R, et al. Circumscribed choroidal haemangioma: Indocyanine green angiography features on scanning laser ophthalmoscopy versus traditional digital fundus photography. Eye (Lond). 2021;35(4):1178-1186.
157. Rother R, Lang W, Horch RE, et al. Pilot assessment of the angiosome concept by intra-operative fluorescence angiography after tibial bypass surgery. Eur J Vasc Endovasc Surg. 2018;55(2):215-221.
158. Ruscito I, Gasparri ML, Braicu EI, et al. Sentinel node mapping in cervical and endometrial cancer: Indocyanine green versus other conventional dyes -- A meta-analysis. Ann Surg Oncol. 2016;23(11):3749-3756.
159. Schalenbourg A, Piguet B, Zografos L. Indocyanine green angiographic findings in choroidal hemangiomas: A study of 75 cases. Ophthalmologica. 2000;214(4):246-252.
160. Schlottmann F, Patti MG. Evaluation of gastric conduit perfusion during esophagectomy with indocyanine green fluorescence imaging. J Laparoendosc Adv Surg Tech A. 2017;27(12):1305-1308.
161. Schwarte B, Sigdel A, Dwivedi AJ, Wayne EJ. Use of indocyanine green during repair of a superior mesenteric artery aneurysm. Ann Vasc Surg. 2021;75:531.e15-531.e18.
162. Settembre N, KauhanenP, Ablack A, et al. Quality control of the foot revascularization using indocyanine green fluorescence imaging. World Journal of Surgery. 2017;41(7):1919-1926.
163. Shaikh N, O'Brien D, Makary C, Turner M. Intraoperative indocyanine green angiography for assessing flap perfusion in skull base reconstruction: A systematic review. J Neurol Surg B Skull Base. 2021;83(Suppl 2):e492-e500.
164. Shen R, Zhang Y, Wang T. Indocyanine green fluorescence angiography and the incidence of anastomotic leak after colorectal resection for colorectal cancer: A meta-analysis. Dis Colon Rectum. 2018;61(10):1228-1234.
165. Shibata Y, Kurihara S, Arai S, et al. Efficacy of microsurgical subinguinal varicocelectomy using indocyanine green fluorescence angiography: A pilot study. Nihon Hinyokika Gakkai Zasshi. 2015;106(4):293-298.
166. Skrovina M, Bencurik V, Holaskova E, et al. Fluorescence angiography in the detection of anastomotic perfusion during rectal and sigmoid resection - preliminary report. Rozhl Chir. 2016;95(10):354-358.
167. Slakter JS, Yannuzzi LA, Sorenson JA, et al. A pilot study of indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthal. 1994;112(4):465-472.
168. Slooter MD, Eshuis WJ, Cuesta MA, et al. Fluorescent imaging using indocyanine green during esophagectomy to prevent surgical morbidity: A systematic review and meta-analysis. J Thorac Dis. 2019;11(Suppl 5):S755-S765.
169. Snyers B, De Potter P. Advantages of digital indocyanine green angiography for diagnosing choroidal tumors. J Fr Ophtalmol. 2002;25(2):212-220.
170. Soliman PT, Westin SN, Dioun S, et al. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. 2017;146(2):234-239.
171. Sood M, Glat P. Potential of the SPY intraoperative perfusion assessment system to reduce ischemic complications in immediate postmastectomy breast reconstruction. Ann Surg Innov Res. 2013;7(1):9.
172. Sorenson JA, Yannuzzi LA, Slakter JS, et al. A pilot study of digital indocyanine green videoangiography for recurrent occult choroidal neovascularization in age-related macular degeneration. Arch Ophthal. 1994;112(4):473-479.
173. Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: Indications and interpretation: An evidence-based update. Ophthalmology. 2003;110(1):15-21; quiz 22-23.
174. Starker PM, Chinn B. Using outcomes data to justify instituting new technology: A single institution’s experience. Surgical Endoscopy. Surg Endosc. 2018;32(3):1586-1592.
175. Sugie T, Ikeda T, Kawaguchi A, et al. Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: A meta-analysis. Int J Clin Oncol. 2017;22(1):11-17.
176. Takahashi M, Ishikawa T, Higashidani K, Katoh H. SPY: an innovative intra-operative imaging system to evaluate graft patency during off-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2004;3(3):479-483.
177. Takeuchi H, Kitagawa Y. Sentinel lymph node biopsy in gastric cancer. Cancer J. 2015;21(1):21-24.
178. Tamhankar M, Volpe NJ. Nonarteritic anterior ischemic optic neuropathy: Clinical features and diagnosis. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2022a.
179. Tamhankar M, Volpe NJ. Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed December 2022b.
180. Tang G, Du D, Tao J, Wei Z. Effect of indocyanine green fluorescence angiography on anastomotic leakage in patients undergoing colorectal surgery: A meta-analysis of randomized controlled trials and propensity-score-Matched studies. Front Surg. 2022;9:815753.
181. Tesar J, Sin M, Nemec P, Studnicka J. Diagnosis that mimic pachychoroid diseases of macula – Case reports. Cesk Slov Oftalmol. 2021r;77(1):36-44.
182. Tognetto D, Haritoglou C, Kampik A, Ravalico G. Macular edema and visual loss after macular pucker surgery with ICG-assisted internal limiting membrane peeling. Eur J Ophthalmol. 2005;15(2):289-291.
183. Uemoto R, Yamamoto S, Takeuchi S. Changes in retinal pigment epithelium after indocyanine green-assisted internal limiting lamina peeling during macular hole surgery. Am J Ophthalmol. 2005;140(4):752-755.
184. van den Bos J, Al-Taher M, Schols RM, et al. Near-infrared fluorescence imaging for real-time intraoperative guidance in anastomotic colorectal surgery: A systematic review of literature. J Laparoendosc Adv Surg Tech A.2018;28(2):157-167.
185. Wang S, Liu L, Zhao YL, et al. Effects of surgical microscope-based indocyanine green videoangiography during aneurysm surgery. Zhonghua Yi Xue Za Zhi. 2009;89(3):146-150.
186. Ward HB, Kelly RF, Weir EK. Assessment of graft patency during coronary artery bypass graft surgery: Mitigating the risk. JACC Cardiovasc Imaging. 2009;2(5):613-615.
187. Waseda K, Ako J, Hasegawa T, et al. Intraoperative fluorescence imaging system for on-site assessment of off-pump coronary artery bypass graft. JACC Cardiovasc Imaging. 2009;2(5):604-612.
188. Wen PY. Systemic treatment of recurrent meningioma. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed April 2015.
189. Writing Committee Members, Hillis LD, Smith PK, Anderson JL, et al. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Circulation. 2011;124:e652-e735.
190. Wu C, Kim S, Halvorson EG. Laser-assisted indocyanine green angiography: A critical appraisal. Ann Plast Surg. 2013;70(5):613-619.
191. Xia S, Wu W, Luo L, et al. Indocyanine green fluorescence angiography decreases the risk of anastomotic leakage after rectal cancer surgery: A systematic review and meta-analysis. Front Med (Lausanne). 2023:10:1157389.
192. Xie D, Gu D, Lei M, et al. The application of indocyanine green in guiding prostate cancer treatment. Asian J Urol. 2023;10(1):1-8.
193. Yamashita S, Shibuya K, Nagao K, et al. Anastomotic stenosis of a reconstructed dissecting superior mesenteric artery aneurysm undetectable by intraoperative indocyanine green angiography: A case report. Clin Case Rep. 2021;9(10):e04923.
194. Yannuzzi LA, Slakter JS, Sorenson JA, et al. Digital indocyanine green videoangiography and choroidal neovascularization. Retina. 1992;12(3):191-223.
195. Yoo A, Palines PA, Mayo JL, et al. The impact of indocyanine green angiography on fat necrosis in deep inferior epigastric perforator flap breast reconstruction. Ann Plast Surg. 2022;88(4):415-419.
196. Yoshimatsu H, Yamamoto T, Iida T. Indocyanine green angiography for prediction of thrombosis in the internal jugular vein. Microsurgery. 2015;35(6):469-473.
197. Yu R, Matthews BJ, Beavis AL. The role of sentinel lymph node mapping in high-grade endometrial cancer. Curr Treat Options Oncol. 2022;23(10):1339-1352.
198. Zang M, Zhu S, Chen B, et al. Use of indocyanine green angiography to identify the superficial temporal artery and vein in forehead flaps for facial reconstruction. J Craniofac Surg. 2022;33(5):1322-1326.